Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),A1BG,Alpha-1B-glycoprotein,23803,149,0.77 [0.32-1.86],0.5619522321517498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AAMDC,Mth938 domain-containing protein,23148,148,1.09 [0.81-1.46],0.5646784903188674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AARSD1,Alanyl-tRNA editing protein Aarsd1,27133,172,1.06 [0.84-1.34],0.6382910752419368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABCA2,ATP-binding cassette sub-family A member 2,22998,148,1.14 [0.75-1.74],0.5312216386080837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABHD14B,Protein ABHD14B,26987,171,1.08 [0.86-1.36],0.497554080206006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABL1,Tyrosine-protein kinase ABL1,27133,172,1.10 [0.91-1.33],0.3411478725736681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABO,Histo-blood group ABO system transferase,23771,148,1.02 [0.92-1.14],0.6740518659725728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABRAXAS2,BRISC complex subunit Abraxas 2,22998,148,1.08 [0.85-1.36],0.5275867167336017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",26616,166,1.17 [1.00-1.37],0.0512676480567402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23310,148,1.14 [0.95-1.37],0.1665843732963252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23762,150,1.17 [0.99-1.38],0.0604242844419483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAN,Aggrecan core protein,27013,171,0.91 [0.56-1.46],0.688257751371551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE,Angiotensin-converting enzyme,23771,148,2.44 [1.44-4.15],0.0009844681461575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE2,Angiotensin-converting enzyme 2,26751,160,1.50 [1.19-1.89],0.0006126775971393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACHE,Acetylcholinesterase,23256,143,1.15 [0.70-1.87],0.5793276693663438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOT13,Acyl-coenzyme A thioesterase 13,23636,148,1.12 [0.98-1.29],0.1078838568981565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27255,172,1.24 [0.99-1.57],0.0650296855196861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP1,Low molecular weight phosphotyrosine protein phosphatase,23084,146,0.72 [0.49-1.05],0.0918196804276374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP5,Tartrate-resistant acid phosphatase type 5,27380,171,1.40 [0.95-2.08],0.0930876445903124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP6,Lysophosphatidic acid phosphatase type 6,27437,171,1.20 [0.97-1.50],0.0969670805713995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRBP,Acrosin-binding protein,23623,149,1.33 [0.94-1.87],0.1081442964294645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRV1,Acrosomal protein SP-10,23084,146,0.82 [0.52-1.30],0.4044826809073587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACSL1,Long-chain-fatty-acid--CoA ligase 1,22998,148,1.01 [0.67-1.52],0.9798140439904438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",26751,160,1.19 [0.89-1.58],0.2432316934351693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN2,Alpha-actinin-2,22998,148,1.21 [0.93-1.58],0.1498189724439591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN4,Alpha-actinin-4,26707,161,1.11 [0.74-1.66],0.6149213207880175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,27031,171,1.36 [0.78-2.36],0.273093729346291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY1,Aminoacylase-1,27255,172,1.15 [0.93-1.42],0.1944026076230988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,22998,148,1.20 [0.92-1.57],0.17600744147099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACYP1,Acylphosphatase-1,23160,143,1.09 [0.86-1.39],0.4696991840022662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA,Adenosine deaminase,27538,173,0.97 [0.65-1.43],0.8718398064283344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,27083,172,1.63 [1.21-2.21],0.00148206488952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23084,146,1.33 [0.90-1.96],0.1475505096539692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,26751,160,1.01 [0.63-1.60],0.9759217538840764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27073,171,1.07 [0.73-1.58],0.7174507602222007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,27538,173,1.22 [0.82-1.82],0.3169699469494627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,27449,174,1.30 [0.81-2.09],0.2720767711672368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23636,148,2.14 [1.38-3.32],0.0006473411856172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23084,146,1.22 [0.76-1.94],0.415012758260371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,27587,172,1.04 [0.58-1.86],0.8923817680165784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27133,172,1.18 [0.86-1.60],0.3081121905849469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,26751,160,1.03 [0.65-1.62],0.9130499040138792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23084,146,1.15 [0.74-1.78],0.5243931210657945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27351,173,0.78 [0.58-1.04],0.0932989825571759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL2,ADAMTS-like protein 2,23755,147,1.80 [1.15-2.82],0.0098106124964258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL4,ADAMTS-like protein 4,23148,148,1.09 [0.55-2.16],0.7945016211064924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL5,ADAMTS-like protein 5,23762,150,1.02 [0.68-1.53],0.9121033378574755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,26616,166,0.96 [0.65-1.43],0.8530225317497987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADD1,Alpha-adducin,23256,143,1.18 [0.94-1.48],0.1586249355085416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRB3,Adhesion G protein-coupled receptor B3,27031,171,1.65 [1.11-2.44],0.0124825445579637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRD1,Adhesion G-protein coupled receptor D1,23256,143,1.93 [1.28-2.89],0.0016290757167675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,23636,148,1.14 [0.86-1.50],0.366552135192062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE2,Adhesion G protein-coupled receptor E2,27391,171,1.18 [0.73-1.91],0.4985681022353341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE5,Adhesion G protein-coupled receptor E5,27453,172,1.13 [0.73-1.77],0.5790032353281838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRF5,Adhesion G protein-coupled receptor F5,23762,150,1.54 [0.92-2.58],0.1033338852156326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG1,Adhesion G-protein coupled receptor G1,27133,172,1.42 [1.20-1.67],3.045939827237993e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG2,Adhesion G-protein coupled receptor G2,27255,172,0.81 [0.49-1.34],0.4105455599750386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRV1,Adhesion G-protein coupled receptor V1,22986,143,1.12 [0.92-1.38],0.2587236116470023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH1B,All-trans-retinol dehydrogenase,23256,143,1.19 [0.98-1.45],0.0830634362599619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,26751,160,0.96 [0.82-1.14],0.6678340881787215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADIPOQ,Adiponectin,23803,149,0.99 [0.79-1.25],0.9461522257199382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,27485,171,2.00 [1.19-3.35],0.0088425208514696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADRA2A,Alpha-2A adrenergic receptor,22998,148,0.96 [0.76-1.20],0.7035189871905811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFAP1,Actin filament-associated protein 1,23256,143,1.01 [0.84-1.22],0.912421410787728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFM,Afamin,23803,149,1.89 [0.83-4.28],0.1272527611272773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFP,Alpha-fetoprotein,26992,171,1.05 [0.86-1.28],0.6383604815487282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGBL2,Cytosolic carboxypeptidase 2,22986,143,0.98 [0.82-1.17],0.8423013026799544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGER,Advanced glycosylation end product-specific receptor,27210,168,1.47 [1.07-2.03],0.0188252532365897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR2,Anterior gradient protein 2 homolog,26351,161,1.26 [1.10-1.43],0.0006156153144397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR3,Anterior gradient protein 3,26570,166,1.20 [0.96-1.49],0.1038023443130617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,27391,171,1.61 [1.11-2.34],0.0126353033624565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRP,Agouti-related protein,27538,173,1.26 [0.98-1.63],0.0721149601639401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGT,Angiotensinogen,23771,148,1.26 [0.67-2.37],0.4818385441519542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGXT,Serine--pyruvate aminotransferase,27255,172,1.09 [0.92-1.29],0.3193275264742084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHCY,Adenosylhomocysteinase,27255,172,1.13 [0.93-1.38],0.2015555099790603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK,Neuroblast differentiation-associated protein AHNAK,23148,148,1.17 [0.72-1.90],0.5302436924649541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK2,Protein AHNAK2,23148,148,1.57 [0.96-2.57],0.0695522502654914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23623,149,1.22 [1.01-1.47],0.0403390941632859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSG,Alpha-2-HS-glycoprotein,23771,148,1.74 [0.98-3.09],0.0604480246966515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSP,Alpha-hemoglobin-stabilizing protein,27220,173,1.04 [0.89-1.20],0.6416717934325014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIDA,"Axin interactor, dorsalization-associated protein",23097,146,1.01 [0.83-1.21],0.9549419471594436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1,Allograft inflammatory factor 1,26616,166,1.20 [0.93-1.55],0.1700462593452553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1L,Allograft inflammatory factor 1-like,23148,148,1.03 [0.79-1.35],0.8129787257660138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27082,172,1.08 [0.95-1.22],0.2407771167449801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK1,Adenylate kinase isoenzyme 1,27255,172,0.89 [0.73-1.10],0.2986075218079801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK2,"Adenylate kinase 2, mitochondrial",23705,149,1.15 [0.99-1.33],0.0628067230815178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKAP12,A-kinase anchor protein 12,23256,143,0.97 [0.47-2.03],0.9451588999151732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B1,Aldo-keto reductase family 1 member B1,26616,166,1.17 [0.98-1.39],0.0852150286460292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B10,Aldo-keto reductase family 1 member B10,23097,146,1.16 [0.92-1.47],0.2168770133509904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1C4,Aldo-keto reductase family 1 member C4,26751,160,0.97 [0.75-1.26],0.8232663794256255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR7L,Aflatoxin B1 aldehyde reductase member 4,23084,146,1.25 [1.04-1.52],0.0202930805150202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT1S1,Proline-rich AKT1 substrate 1,26588,162,1.07 [0.87-1.31],0.5492725643711485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT2,RAC-beta serine/threonine-protein kinase,23723,148,1.04 [0.92-1.18],0.509031932078253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT3,RAC-gamma serine/threonine-protein kinase,26488,165,1.28 [1.01-1.63],0.0402874389148492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALCAM,CD166 antigen,27587,172,2.44 [1.25-4.77],0.0088254923884838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH1A1,Retinal dehydrogenase 1,27261,173,1.06 [0.84-1.34],0.629622440810945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH2,"Aldehyde dehydrogenase, mitochondrial",23623,149,1.25 [1.00-1.57],0.0511093279257492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27165,171,0.94 [0.76-1.16],0.5579346407030464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23723,148,1.35 [1.01-1.80],0.044368785533787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALMS1,Alstrom syndrome protein 1,23310,148,1.20 [0.90-1.59],0.2217522399114184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPI,Intestinal-type alkaline phosphatase,23084,146,1.09 [0.96-1.24],0.190603285466188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPP,"Alkaline phosphatase, placental type",27133,172,0.96 [0.84-1.09],0.5019748937448003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBN,Ameloblastin,26707,161,0.40 [0.22-0.73],0.0030124890548958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,27448,171,1.95 [1.01-3.78],0.0481724688905145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23755,147,1.32 [0.71-2.45],0.388354135069483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,26588,162,1.13 [0.93-1.39],0.2220999069881946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO1,Amphoterin-induced protein 1,23097,146,1.25 [0.98-1.59],0.072168403586662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO2,Amphoterin-induced protein 2,27133,172,1.50 [0.82-2.71],0.1850201736327695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMN,Protein amnionless,26707,161,1.23 [0.93-1.63],0.1496485381149038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOT,Angiomotin,23256,143,1.31 [0.89-1.91],0.1659415679457511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOTL2,Angiomotin-like protein 2,23543,147,1.00 [0.72-1.39],0.9790697157049532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMPD3,AMP deaminase 3,23705,149,0.91 [0.74-1.13],0.3923378892133546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22248,141,0.98 [0.70-1.36],0.8978871990935031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2A,Pancreatic alpha-amylase,26180,165,0.97 [0.72-1.30],0.836100658152231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2B,Alpha-amylase 2B,25392,159,0.99 [0.74-1.33],0.9480566974962448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANG,Angiogenin,27167,172,1.46 [1.01-2.10],0.0437467159352431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT1,Angiopoietin-1,27160,168,1.21 [1.02-1.42],0.0241745618182791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT2,Angiopoietin-2,27485,171,1.32 [0.93-1.88],0.11828771793017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL1,Angiopoietin-related protein 1,26886,170,1.36 [0.86-2.16],0.1903963361540528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL2,Angiopoietin-related protein 2,27305,170,1.09 [0.78-1.52],0.6193787453818733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL3,Angiopoietin-related protein 3,27256,172,1.26 [0.87-1.82],0.2261205307950686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL4,Angiopoietin-related protein 4,27344,169,1.23 [0.91-1.67],0.169059000771564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL7,Angiopoietin-related protein 7,27485,171,1.11 [0.77-1.59],0.5825294353230568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANK2,Ankyrin-2,22998,148,1.01 [0.82-1.25],0.929082873792317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23084,146,1.17 [0.96-1.42],0.1203166521597149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRA2,Ankyrin repeat family A protein 2,22891,140,0.96 [0.72-1.29],0.7939727637080894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRD54,Ankyrin repeat domain-containing protein 54,26616,166,1.20 [0.97-1.47],0.0921414646824167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23148,148,1.31 [0.98-1.74],0.0646915999217414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANPEP,Aminopeptidase N,27301,172,1.85 [1.21-2.82],0.0044009399102574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA1,Annexin A1,23112,141,1.29 [0.94-1.76],0.109542826693838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA10,Annexin A10,26588,162,1.21 [1.04-1.40],0.013360592781129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA11,Annexin A11,27171,172,1.06 [0.87-1.30],0.5692612234696758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA2,Annexin A2,22789,142,1.09 [0.87-1.35],0.4596739196000272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA3,Annexin A3,27449,174,1.18 [0.97-1.42],0.091921302902891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA4,Annexin A4,27115,171,1.12 [0.93-1.34],0.2267344171355221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA5,Annexin A5,26507,162,0.86 [0.54-1.38],0.5391504125207467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC1,Amiloride-sensitive amine oxidase [copper-containing],26707,161,1.10 [0.88-1.36],0.3948519136354209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC3,Membrane primary amine oxidase,27347,172,1.54 [0.99-2.40],0.053912692446443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP1G2,AP-1 complex subunit gamma-like 2,23623,149,1.13 [0.94-1.37],0.1950184435776195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP2B1,AP-2 complex subunit beta,23097,146,0.96 [0.69-1.33],0.8025821357994678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3B1,AP-3 complex subunit beta-1,23636,148,1.21 [0.99-1.47],0.0664162912269927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3S2,AP-3 complex subunit sigma-2,23705,149,1.15 [0.84-1.59],0.373830230925796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27133,172,1.02 [0.76-1.38],0.8872698470523872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APCS,Serum amyloid P-component,23589,147,0.82 [0.53-1.27],0.3689378391860116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,27389,170,1.14 [0.91-1.42],0.2495117686663483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APLP1,Amyloid-like protein 1,27255,172,0.91 [0.70-1.18],0.4877433258619873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA1,Apolipoprotein A-I,23803,149,0.67 [0.35-1.25],0.2081722723809041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA2,Apolipoprotein A-II,23771,148,1.28 [0.93-1.76],0.1243299714715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA4,Apolipoprotein A-IV,23803,149,1.39 [0.97-2.00],0.0730602611077133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOB,Apolipoprotein B-100,23771,148,2.55 [1.27-5.14],0.0088546517401841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOBR,Apolipoprotein B receptor,23148,148,0.93 [0.64-1.35],0.7138852578560497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOC1,Apolipoprotein C-I,23752,148,0.65 [0.41-1.04],0.0711966351371449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOD,Apolipoprotein D,22702,135,0.85 [0.55-1.32],0.4798389406675637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOE,Apolipoprotein E,23803,149,0.93 [0.73-1.18],0.5701711041105478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOF,Apolipoprotein F,23771,148,0.65 [0.44-0.94],0.0213764502354852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOH,Beta-2-glycoprotein 1,27261,173,1.32 [0.92-1.89],0.1261257818052351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOL1,Apolipoprotein L1,23771,148,1.07 [0.85-1.34],0.571970988677339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOM,Apolipoprotein M,27300,172,1.02 [0.62-1.68],0.9424844689663584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APP,Amyloid-beta precursor protein,27221,173,1.23 [1.01-1.49],0.0382617052363937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APPL2,DCC-interacting protein 13-beta,23256,143,1.10 [0.95-1.27],0.2058169943751929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APRT,Adenine phosphoribosyltransferase,27034,171,1.08 [0.81-1.43],0.5932037510594337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARAF,Serine/threonine-protein kinase A-Raf,23310,148,1.31 [1.08-1.59],0.0056072508246554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,27133,172,1.68 [1.33-2.12],1.1746259018289589e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARF6,ADP-ribosylation factor 6,23636,148,1.16 [1.00-1.35],0.0562268193909773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARFIP1,Arfaptin-1,23723,148,1.09 [0.87-1.36],0.4734543071631072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,27110,169,0.87 [0.68-1.12],0.2689970253350116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG2,"Arginase-2, mitochondrial",23623,149,1.20 [0.88-1.64],0.2431802620698895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP1,Rho GTPase-activating protein 1,26616,166,1.13 [0.84-1.53],0.4150338190868814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP25,Rho GTPase-activating protein 25,26616,166,1.00 [0.79-1.27],0.9841632640964098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP30,Rho GTPase-activating protein 30,23310,148,1.04 [0.69-1.56],0.8657898689002149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP45,Rho GTPase-activating protein 45,23256,143,1.14 [0.94-1.39],0.1836983513252367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP5,Rho GTPase-activating protein 5,22891,140,1.16 [0.97-1.39],0.1134677372436234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF1,Rho guanine nucleotide exchange factor 1,23705,149,1.09 [0.91-1.29],0.3452901269600946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF10,Rho guanine nucleotide exchange factor 10,23723,148,1.09 [0.92-1.28],0.3344227454469055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF12,Rho guanine nucleotide exchange factor 12,27207,172,1.07 [0.94-1.22],0.3225726289728128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF5,Rho guanine nucleotide exchange factor 5,22986,143,1.18 [0.97-1.43],0.0924705497595884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID3A,AT-rich interactive domain-containing protein 3A,22986,143,0.89 [0.59-1.35],0.5869202755389663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID4B,AT-rich interactive domain-containing protein 4B,26588,162,0.91 [0.64-1.29],0.5884222292455874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL13B,ADP-ribosylation factor-like protein 13B,22998,148,1.13 [0.91-1.39],0.2586663111286681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,22998,148,1.21 [0.83-1.77],0.3245712143872022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARMCX2,Armadillo repeat-containing X-linked protein 2,22986,143,1.08 [0.86-1.36],0.5031051845422954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNT,Aryl hydrocarbon receptor nuclear translocator,26707,161,1.22 [0.88-1.70],0.2379256303045874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,22998,148,0.78 [0.55-1.12],0.1750662097788672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSA,Arylsulfatase A,27261,173,1.20 [0.91-1.60],0.1986930575660873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSB,Arylsulfatase B,27133,172,1.21 [0.96-1.54],0.1137155667281954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART3,Ecto-ADP-ribosyltransferase 3,27347,172,1.05 [0.70-1.57],0.807128036539508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART5,Ecto-ADP-ribosyltransferase 5,22986,143,0.93 [0.71-1.21],0.5812190480745207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARTN,Artemin,26707,161,1.03 [0.77-1.40],0.827438197729198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH1,Acid ceramidase,23531,145,1.33 [1.00-1.77],0.0518502327846519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH2,Neutral ceramidase,27073,171,0.96 [0.74-1.24],0.7451222746610411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,27073,171,1.77 [1.15-2.74],0.0097766367190756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR2,Asialoglycoprotein receptor 2,23771,148,1.78 [1.01-3.14],0.0472440901723375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPN,Asporin,23762,150,1.02 [0.58-1.80],0.9480009520098364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPSCR1,Tether containing UBX domain for GLUT4,23723,148,1.18 [0.94-1.49],0.145881387539627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASRGL1,Isoaspartyl peptidase/L-asparaginase,23148,148,1.04 [0.89-1.22],0.5995912076266072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASS1,Argininosuccinate synthase,22998,148,1.01 [0.83-1.24],0.8849733862066133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF2,Cyclic AMP-dependent transcription factor ATF-2,26588,162,0.96 [0.78-1.19],0.7277477695966298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF4,Cyclic AMP-dependent transcription factor ATF-4,22891,140,1.33 [0.87-2.02],0.1863546896722007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG16L1,Autophagy-related protein 16-1,23636,148,1.19 [0.99-1.43],0.0629959280887387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG4A,Cysteine protease ATG4A,26616,166,1.12 [0.90-1.41],0.3061056446007705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATOX1,Copper transport protein ATOX1,27351,173,1.21 [0.99-1.46],0.0583917725080953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,22998,148,0.80 [0.54-1.17],0.2502959766717229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,22998,148,1.03 [0.64-1.66],0.9151294085225128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,22998,148,1.10 [0.76-1.59],0.6138402738718416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B4,Protein ATP1B4,22891,140,1.62 [1.21-2.15],0.0010482054972987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP2B4,Plasma membrane calcium-transporting ATPase 4,22998,148,1.03 [0.80-1.32],0.8231548229754769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5F1D,"ATP synthase subunit delta, mitochondrial",22998,148,0.94 [0.68-1.30],0.718406104560343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5IF1,"ATPase inhibitor, mitochondrial",27391,171,1.05 [0.93-1.18],0.4636313930738237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5PO,"ATP synthase subunit O, mitochondrial",26588,162,0.98 [0.70-1.37],0.9112287662952768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6AP2,Renin receptor,26616,166,1.26 [0.95-1.67],0.1024909244569994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1D,V-type proton ATPase subunit D,27133,172,0.64 [0.37-1.10],0.1078445367736584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1F,V-type proton ATPase subunit F,26538,162,1.10 [0.90-1.35],0.3489984827433126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G1,V-type proton ATPase subunit G 1,23148,148,1.15 [0.93-1.42],0.1899851269527698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G2,V-type proton ATPase subunit G 2,22998,148,1.06 [0.91-1.23],0.4551580449089695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRAID,All-trans retinoic acid-induced differentiation factor,23636,148,1.61 [1.29-2.00],2.4301094356906457e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRN,"Attractin, Isoform 2",23803,149,0.93 [0.36-2.35],0.8703859807677827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN10,Ataxin-10,26588,162,1.08 [0.89-1.31],0.4570679760570847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2,Ataxin-2,22986,143,1.07 [0.94-1.22],0.3055990351742808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2L,Ataxin-2-like protein,23723,148,1.07 [0.78-1.48],0.6598864389137087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN3,Ataxin-3,23705,149,1.16 [0.91-1.48],0.2390231599807545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXIN1,Axin-1,27207,172,1.10 [0.96-1.27],0.1795491328825147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXL,Tyrosine-protein kinase receptor UFO,27347,172,1.59 [0.99-2.55],0.0531064635635522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZI2,5-azacytidine-induced protein 2,23723,148,1.37 [1.06-1.78],0.0168377974828271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZU1,Azurocidin,26380,166,1.13 [0.96-1.32],0.145749689140325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B2M,Beta-2-microglobulin,23803,149,1.39 [1.03-1.87],0.0289807589788793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,22998,148,1.08 [0.50-2.33],0.8434558528566195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23148,148,1.64 [1.06-2.52],0.0262898827887196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",27391,171,1.58 [0.98-2.56],0.0613154709278467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GAT1,"Beta-1,4-glucuronyltransferase 1",27261,173,0.94 [0.53-1.64],0.8214954368971024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BABAM1,BRISC and BRCA1-A complex member 1,23084,146,1.15 [0.69-1.91],0.5856617197499059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BACH1,Transcription regulator protein BACH1,27207,172,1.21 [1.01-1.45],0.041101947674282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG3,BAG family molecular chaperone regulator 3,27031,171,1.19 [0.84-1.68],0.3304744874070929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG4,BAG family molecular chaperone regulator 4,23084,146,1.31 [0.98-1.76],0.0696834578776438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG6,Large proline-rich protein BAG6,26751,160,1.24 [0.84-1.82],0.2780053206109039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,26616,166,1.28 [1.05-1.56],0.0153835850686943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,26616,166,1.73 [1.15-2.58],0.0077895186501072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BANK1,B-cell scaffold protein with ankyrin repeats,27207,172,1.08 [0.95-1.23],0.2671974998698835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAP18,Chromatin complexes subunit BAP18,23705,149,1.25 [1.04-1.50],0.0187504717150323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BATF,Basic leucine zipper transcriptional factor ATF-like,23097,146,1.01 [0.84-1.21],0.9359524719469218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAX,Apoptosis regulator BAX,26546,162,1.13 [0.97-1.32],0.1302480127867715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAM,Basal cell adhesion molecule,27261,173,1.82 [1.07-3.09],0.0265274509403704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAN,Brevican core protein,27073,171,0.78 [0.53-1.17],0.2272670126597317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23762,150,1.65 [1.07-2.53],0.0221271271301962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",22986,143,1.10 [0.84-1.45],0.4698119870261837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCHE,Cholinesterase,23334,145,1.24 [0.70-2.22],0.4615328483167635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2,Apoptosis regulator Bcl-2,23636,148,1.22 [0.98-1.54],0.0794938017962199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L1,Bcl-2-like protein 1,23705,149,1.11 [0.95-1.30],0.1946191223001338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27207,172,1.57 [1.12-2.19],0.0080821138873161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L15,Bcl-2-like protein 15,23084,146,1.14 [0.88-1.46],0.3162646790794352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7A,B-cell CLL/lymphoma 7 protein family member A,22891,140,1.10 [0.87-1.39],0.409570454641918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7B,B-cell CLL/lymphoma 7 protein family member B,23623,149,0.91 [0.63-1.31],0.5996697992583602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCR,Breakpoint cluster region protein,27207,172,1.10 [0.95-1.28],0.2049386039538924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BDNF,Brain-derived neurotrophic factor,23755,147,1.03 [0.85-1.24],0.753288685381662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BECN1,Beclin-1,23148,148,1.20 [0.94-1.54],0.1418727665215954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BEX3,Protein BEX3,22891,140,1.23 [0.95-1.60],0.1236236157939737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGLAP,Osteocalcin,23755,147,0.98 [0.83-1.16],0.8571225137579582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGN,Biglycan,26570,166,0.91 [0.81-1.02],0.1227224206478634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHLHE40,Class E basic helix-loop-helix protein 40,22986,143,1.10 [0.89-1.35],0.3953296820491506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,22998,148,1.30 [0.70-2.41],0.3976433543982737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BID,BH3-interacting domain death agonist,27207,172,1.07 [0.88-1.30],0.4911371813150966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIN2,Bridging integrator 2,27261,173,1.14 [0.99-1.32],0.0749222116130065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIRC2,Baculoviral IAP repeat-containing protein 2,26616,166,1.23 [0.99-1.52],0.0580041046202836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLMH,Bleomycin hydrolase,27587,172,1.45 [0.99-2.13],0.056394862458171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLNK,B-cell linker protein,23084,146,0.93 [0.60-1.43],0.7377091744064129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,22986,143,0.96 [0.76-1.20],0.6923374011078833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23705,149,1.39 [0.97-1.99],0.0760908427342005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLVRB,Flavin reductase,27261,173,0.94 [0.77-1.14],0.5159895971620224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP10,Bone morphogenetic protein 10,23256,143,1.32 [0.75-2.32],0.3443166156950826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP4,Bone morphogenetic protein 4,27031,171,1.27 [0.96-1.68],0.0933564100769888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP6,Bone morphogenetic protein 6,26707,160,1.55 [1.11-2.16],0.0103206117131084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMPER,BMP-binding endothelial regulator protein,23256,143,1.62 [0.85-3.10],0.1430692056159171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23762,150,1.26 [0.83-1.92],0.2779503689905777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23084,146,1.48 [1.08-2.03],0.01483085148255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOC,Brother of CDO,26751,160,1.45 [0.80-2.63],0.2221841287263917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA1,BolA-like protein 1,22986,143,1.23 [0.95-1.59],0.1203861429090336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA2_BOLA2B,BolA-like protein 2,23148,148,1.03 [0.78-1.36],0.8478072170872722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFA2,BPI fold-containing family A member 2,22299,145,0.95 [0.82-1.10],0.4921464254487587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB1,BPI fold-containing family B member 1,27181,170,0.89 [0.72-1.11],0.2919906703890492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB2,BPI fold-containing family B member 2,23714,149,1.04 [0.84-1.28],0.7487142958458166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRAP,BRCA1-associated protein,23428,147,1.13 [0.98-1.32],0.0987632933875048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD1,Bromodomain-containing protein 1,23310,148,1.09 [0.66-1.78],0.7441328125721377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD2,Bromodomain-containing protein 2,22986,143,1.14 [0.74-1.76],0.553375649816009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD3,Bromodomain-containing protein 3,22998,148,1.17 [0.90-1.53],0.2387902628488456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRDT,Bromodomain testis-specific protein,22998,148,1.48 [1.00-2.20],0.0501456113930105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRK1,Protein BRICK1,26588,162,1.31 [0.96-1.77],0.0855589908694723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRME1,Break repair meiotic recombinase recruitment factor 1,22986,143,1.11 [0.80-1.56],0.5274487521309316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRSK2,Serine/threonine-protein kinase BRSK2,23723,148,1.15 [0.79-1.67],0.4558090908206058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSG,Basigin,27493,172,1.50 [0.77-2.95],0.2349169480347617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSND,Barttin,22891,140,1.12 [0.72-1.74],0.6046892860710146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,27496,174,1.16 [0.84-1.60],0.3715100164806437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,27496,174,1.38 [1.13-1.69],0.0016677676722535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTC,Probetacellulin,26616,166,1.09 [0.92-1.30],0.3146164987167116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTD,Biotinidase,23803,149,1.38 [0.64-2.94],0.4096161040668884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTLA,B- and T-lymphocyte attenuator,22891,140,1.14 [0.98-1.32],0.0868274441923267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN1A1,Butyrophilin subfamily 1 member A1,23577,149,1.04 [0.72-1.50],0.8483957173632269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,27391,171,1.99 [1.22-3.24],0.0057529972491338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,27207,172,1.50 [1.09-2.06],0.0135367058388103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTNL10,Butyrophilin-like protein 10,22891,140,0.95 [0.62-1.44],0.7925138668134715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C19orf12,Protein C19orf12,26588,162,1.05 [0.86-1.30],0.6160003409039148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1GALT1C1,C1GALT1-specific chaperone 1,22998,148,1.42 [0.94-2.15],0.0944428652627281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QA,Complement C1q subcomponent subunit A,27396,170,1.12 [0.62-2.05],0.7021497484280135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23723,148,1.05 [0.86-1.29],0.6369013080998884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QL2,Complement C1q-like protein 2,23084,146,1.06 [0.75-1.52],0.7302200374811255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,27347,172,0.94 [0.69-1.29],0.714938745081485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23256,143,0.72 [0.49-1.06],0.0941340636176227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23723,148,1.16 [0.74-1.84],0.5162564644064978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23209,142,0.72 [0.53-0.97],0.0319451273544205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1R,Complement C1r subcomponent,23803,149,0.83 [0.34-1.99],0.6701028341883468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1RL,Complement C1r subcomponent-like protein,23765,149,0.94 [0.43-2.07],0.8801846810522211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1S,Complement C1s subcomponent,23803,149,0.96 [0.46-2.01],0.906658670772228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2,Complement C2,27300,172,1.37 [0.74-2.54],0.317783605733126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2CD2L,Phospholipid transfer protein C2CD2L,26538,162,0.98 [0.71-1.35],0.8920241963243416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2orf69,UPF0565 protein C2orf69,23097,146,1.12 [0.88-1.43],0.3607093679341633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C3,Complement C3,22575,141,1.22 [0.89-1.66],0.2148807047300087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C4BPB,C4b-binding protein beta chain,27351,173,1.08 [0.78-1.50],0.6275372629192959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C5,Complement C5,23803,149,2.14 [0.89-5.11],0.0884852262502033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,23240,143,2.11 [1.27-3.53],0.004159336965028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7orf50,Uncharacterized protein C7orf50,23705,149,1.09 [0.58-2.05],0.7804748080850269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C8B,Complement component C8 beta chain,23803,149,1.20 [0.72-2.01],0.4768662009880583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9,Complement component C9,23771,148,0.94 [0.68-1.28],0.679478222648724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9orf40,Uncharacterized protein C9orf40,23636,148,0.99 [0.82-1.19],0.8939399154912485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA1,Carbonic anhydrase 1,26624,169,0.89 [0.71-1.10],0.2665071157670811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA11,Carbonic anhydrase-related protein 11,26616,166,0.92 [0.59-1.42],0.6980703738576524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,27133,172,1.52 [1.04-2.24],0.0324401410138851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA13,Carbonic anhydrase 13,26964,168,1.11 [0.97-1.27],0.1363072770993625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA14,Carbonic anhydrase 14,27485,171,0.78 [0.52-1.15],0.2034796541955472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA2,Carbonic anhydrase 2,27171,173,1.02 [0.85-1.23],0.8198765831084256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA3,Carbonic anhydrase 3,27537,172,1.08 [0.87-1.34],0.4722520212219402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA4,Carbonic anhydrase 4,27587,172,1.14 [0.65-2.02],0.6434210600137127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA5A,"Carbonic anhydrase 5A, mitochondrial",26751,160,1.09 [0.94-1.26],0.2373770690283441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,27174,172,0.96 [0.77-1.18],0.6903354731866644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA7,Carbonic anhydrase 7,23310,148,1.21 [0.81-1.81],0.3517835889891235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA8,Carbonic anhydrase-related protein,23084,146,0.97 [0.53-1.79],0.9255501561364856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA9,Carbonic anhydrase 9,27485,171,1.34 [1.02-1.76],0.0327067601962246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CABP2,Calcium-binding protein 2,23097,146,1.16 [0.93-1.45],0.1944568074110802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,22986,143,1.34 [0.90-2.00],0.1461087051946216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,22998,148,1.03 [0.80-1.33],0.80227351155716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,22986,143,1.13 [0.88-1.44],0.3431331116384168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23723,148,1.10 [0.91-1.32],0.3216251468380378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACYBP,Calcyclin-binding protein,23208,143,1.12 [0.95-1.31],0.1697826089503789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CADPS,Calcium-dependent secretion activator 1,23097,146,0.86 [0.58-1.28],0.4614721392897781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB1,Calbindin,27133,172,1.21 [0.87-1.68],0.2474897118513273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB2,Calretinin,26588,162,1.05 [0.68-1.63],0.8151217240600453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCA,Calcitonin,27023,171,1.36 [1.11-1.65],0.0025887485106682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCB,Calcitonin gene-related peptide 2,23705,149,1.30 [0.95-1.79],0.1068259285116341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,27395,171,1.08 [0.95-1.23],0.2515571198446782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23148,148,1.21 [0.99-1.48],0.0575688123345656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALY,Neuron-specific vesicular protein calcyon,22998,148,1.00 [0.66-1.52],0.9901725338834612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,26616,166,1.14 [0.84-1.54],0.4078370813393899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23097,146,1.21 [0.93-1.56],0.1487220224070597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23723,148,1.12 [0.97-1.29],0.1247618775694345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CANT1,Soluble calcium-activated nucleotidase 1,27179,172,1.92 [1.00-3.69],0.0508178528054657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPG,Macrophage-capping protein,27045,168,0.99 [0.79-1.26],0.9612208983747323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,23623,149,1.00 [0.66-1.51],0.9979923290035628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPS,Calcyphosin,23705,149,1.11 [0.97-1.26],0.130304339690782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CARHSP1,Calcium-regulated heat-stable protein 1,26588,162,0.90 [0.69-1.18],0.4595615066669313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASC3,Protein CASC3,23097,146,1.29 [0.91-1.85],0.1561035355048447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP1,Caspase-1,26588,162,1.08 [0.89-1.31],0.4588322548450492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP10,Caspase-10,26588,162,1.14 [0.94-1.39],0.1838148761724282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP2,Caspase-2,27207,172,1.25 [1.04-1.50],0.0184462694401827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP3,Caspase-3,27587,172,1.13 [0.97-1.32],0.1092331088360536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP4,Caspase-4,23310,148,1.00 [0.92-1.10],0.9439123827482092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP7,Caspase-7,23705,149,1.10 [0.91-1.32],0.3207701534113515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP8,Caspase-8,27400,171,1.17 [0.96-1.44],0.1266173128200091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP9,Caspase-9,23084,146,0.97 [0.75-1.25],0.8147114349726596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASQ2,Calsequestrin-2,22998,148,0.92 [0.66-1.30],0.6559046235929205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAT,Catalase,23406,145,0.95 [0.71-1.26],0.7111443008662655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLIF,Cobalamin binding intrinsic factor,27210,172,1.06 [0.89-1.27],0.5108026430486718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN1,Cerebellin-1,22986,143,0.92 [0.77-1.11],0.3890855059052471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN4,Cerebellin-4,27485,171,0.84 [0.55-1.28],0.4091471909108813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBS,Cystathionine beta-synthase,23148,148,1.00 [0.73-1.36],0.9919481513823192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBX2,Chromobox protein homolog 2,22998,148,0.83 [0.54-1.29],0.4126135358360515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27073,171,1.09 [0.92-1.31],0.32188400965158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCAR2,Cell cycle and apoptosis regulator protein 2,23705,149,0.94 [0.70-1.27],0.6995680889547267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC134,Coiled-coil domain-containing protein 134,23623,149,1.18 [0.87-1.59],0.2789328934201396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC28A,Coiled-coil domain-containing protein 28A,23097,146,1.24 [0.72-2.12],0.4427245433802759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC50,Coiled-coil domain-containing protein 50,23723,148,1.24 [1.06-1.45],0.0071738282424041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,27255,172,1.15 [0.80-1.67],0.450376887505939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23148,148,1.22 [0.96-1.55],0.1060259572604605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL11,Eotaxin,27538,173,1.53 [1.07-2.18],0.0189658442661631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL13,C-C motif chemokine 13,27487,173,0.98 [0.81-1.19],0.8214159467567601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL14,C-C motif chemokine 14,27167,172,1.41 [1.04-1.92],0.028711306380782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL15,C-C motif chemokine 15,27587,172,1.46 [1.11-1.93],0.0076033305405786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL16,C-C motif chemokine 16,27587,172,1.10 [0.85-1.41],0.4660893253436807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL17,C-C motif chemokine 17,27217,168,1.02 [0.88-1.19],0.7772189524688521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL18,C-C motif chemokine 18,26860,170,1.19 [1.00-1.41],0.0502459413659394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL19,C-C motif chemokine 19,27496,174,1.01 [0.91-1.11],0.9062419287891302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL2,C-C motif chemokine 2,27031,171,1.02 [0.79-1.30],0.9055427698858372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL20,C-C motif chemokine 20,27538,173,1.07 [0.93-1.23],0.3354931914521918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,27391,171,1.31 [1.03-1.67],0.0267480313327626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,26999,167,0.86 [0.66-1.12],0.2678115260959597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL23,C-C motif chemokine 23,27391,171,0.87 [0.63-1.21],0.4115810647909432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL24,C-C motif chemokine 24,27344,169,0.91 [0.77-1.07],0.2504320132371184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL25,C-C motif chemokine 25,27538,173,1.48 [1.13-1.95],0.004753708975321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL26,C-C motif chemokine 26,27207,172,1.09 [0.95-1.24],0.225460116642865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL27,C-C motif chemokine 27,27255,172,0.90 [0.72-1.13],0.3580281206821849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL28,C-C motif chemokine 28,27120,171,1.14 [0.92-1.42],0.2403539926198923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL3,C-C motif chemokine 3,27207,172,1.18 [1.02-1.38],0.028894562553345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL4,C-C motif chemokine 4,27302,171,1.10 [0.93-1.31],0.2720993602391226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL5,C-C motif chemokine 5,27347,172,1.11 [0.98-1.27],0.1121284507509368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL7,C-C motif chemokine 7,27207,172,1.17 [0.95-1.43],0.1373898437091488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL8,C-C motif chemokine 8,27448,171,1.21 [0.96-1.51],0.1003229918346966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN1,CCN family member 1,27086,172,1.11 [0.92-1.32],0.2698945837373959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN2,CCN family member 2,27254,169,1.16 [0.92-1.46],0.2192342141151241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,27547,171,1.52 [1.05-2.20],0.0268349790656164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,27485,171,1.72 [1.29-2.30],0.0002397771687245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN5,CCN family member 5,27261,173,0.96 [0.68-1.36],0.8299557204777772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCND2,G1/S-specific cyclin-D2,23310,148,1.26 [0.82-1.95],0.2947146983351476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCNE1,G1/S-specific cyclin-E1,23084,146,1.07 [0.92-1.25],0.3814642742701566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCS,Copper chaperone for superoxide dismutase,27073,171,0.98 [0.74-1.30],0.9036759056806356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCT5,T-complex protein 1 subunit epsilon,26616,166,1.33 [1.02-1.73],0.0333152821491141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD101,Immunoglobulin superfamily member 2,23636,148,1.34 [0.93-1.92],0.1193344793118375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD109,CD109 antigen,27261,173,0.82 [0.55-1.23],0.3435802919936727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD14,Monocyte differentiation antigen CD14,26668,168,1.40 [1.02-1.92],0.035861726175874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD160,CD160 antigen,27538,173,1.11 [0.84-1.48],0.4555551060795603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,27347,172,1.19 [0.87-1.62],0.2673460437788499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164,Sialomucin core protein 24,27261,173,1.38 [0.99-1.91],0.0571717311306141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164L2,CD164 sialomucin-like 2 protein,23097,146,0.99 [0.64-1.52],0.9506915244235844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD177,CD177 antigen,27218,173,0.97 [0.88-1.08],0.6233692562471145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD1C,T-cell surface glycoprotein CD1c,27351,173,1.09 [0.62-1.91],0.7648060362867939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2,T-cell surface antigen CD2,22998,148,1.10 [0.76-1.59],0.6013783917294204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200,OX-2 membrane glycoprotein,27207,172,1.10 [0.66-1.85],0.7047103347509317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200R1,Cell surface glycoprotein CD200 receptor 1,27118,171,0.82 [0.55-1.22],0.3219528207557578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD207,C-type lectin domain family 4 member K,26678,170,1.04 [0.73-1.48],0.8266118397383768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD209,CD209 antigen,27322,170,0.97 [0.69-1.37],0.8626605575527981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD22,B-cell receptor CD22,27538,173,1.00 [0.72-1.39],0.98901423220945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD226,CD226 antigen,23084,146,1.36 [0.94-1.96],0.1046894578495334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,27538,173,1.23 [0.74-2.02],0.4234159856955584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD248,Endosialin,23755,147,1.12 [0.76-1.65],0.5736470678966014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,27351,173,1.48 [1.08-2.02],0.014040749069688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,27073,171,1.58 [1.11-2.24],0.0105333577872156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,27258,168,1.60 [1.09-2.35],0.0156782145174876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,26616,166,1.15 [0.79-1.66],0.4677875857836622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2AP,CD2-associated protein,27255,172,1.07 [0.87-1.31],0.517626376263355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300A,CMRF35-like molecule 8,23256,143,1.41 [0.83-2.40],0.199831261126811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,27496,174,1.59 [1.10-2.30],0.0139766261220671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,27383,171,1.41 [1.02-1.94],0.0376681181696944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LF,CMRF35-like molecule 1,27485,171,1.05 [0.85-1.30],0.656748321888157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LG,CMRF35-like molecule 9,27261,173,1.30 [0.91-1.86],0.1441682367499466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,27133,172,2.02 [1.36-3.02],0.000571035705543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD33,Myeloid cell surface antigen CD33,27351,173,0.94 [0.80-1.10],0.4392488968245897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD34,Hematopoietic progenitor cell antigen CD34,27406,174,0.89 [0.51-1.55],0.6795244791024055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD36,Platelet glycoprotein 4,23084,146,1.07 [0.75-1.51],0.7181023679624026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27133,172,1.18 [0.76-1.81],0.4644502214267219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3D,T-cell surface glycoprotein CD3 delta chain,22986,143,1.41 [1.01-1.97],0.0449816968127061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3E,T-cell surface glycoprotein CD3 epsilon chain,23310,148,1.29 [0.93-1.79],0.1239711221142645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3G,T-cell surface glycoprotein CD3 gamma chain,23084,146,1.06 [0.90-1.24],0.4970719596076315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,27162,172,1.22 [0.81-1.81],0.3391633284825129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40,Tumor necrosis factor receptor superfamily member 5,27255,169,1.33 [1.03-1.72],0.0306048304566145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40LG,CD40 ligand,27538,173,1.11 [0.93-1.32],0.2465484309034893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD46,Membrane cofactor protein,27074,172,1.75 [1.16-2.64],0.0073021257885327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,27344,169,1.48 [0.94-2.33],0.0868264417153058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5,T-cell surface glycoprotein CD5,27448,171,1.20 [0.81-1.76],0.3647885235070829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD55,Complement decay-accelerating factor,26282,166,1.40 [0.86-2.30],0.179845176206547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD58,Lymphocyte function-associated antigen 3,27218,168,1.46 [0.67-3.16],0.3376672028503544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD59,CD59 glycoprotein,26241,161,1.89 [1.10-3.24],0.0202382352130483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5L,CD5 antigen-like,23662,148,1.11 [0.80-1.56],0.5330131497383486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD6,T-cell differentiation antigen CD6,27493,172,0.93 [0.72-1.19],0.5434979058519387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD63,CD63 antigen,27031,171,1.13 [0.87-1.47],0.3630028553223492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD69,Early activation antigen CD69,27126,172,1.13 [0.97-1.32],0.1265271522038413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD7,T-cell antigen CD7,23036,146,1.27 [0.89-1.80],0.1872158110290716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD70,CD70 antigen,27207,172,1.06 [0.77-1.46],0.7364487040733034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD72,B-cell differentiation antigen CD72,23256,143,1.14 [0.78-1.66],0.4934748954931891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,27496,174,1.44 [0.99-2.08],0.05420628115634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD79B,B-cell antigen receptor complex-associated protein beta chain,27538,173,1.41 [1.06-1.86],0.0172591692181999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,23762,150,1.67 [1.10-2.53],0.0165511212357231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD82,CD82 antigen,23310,148,1.25 [0.92-1.70],0.1565992474643595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,27207,172,1.55 [1.06-2.27],0.0246557661314835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD84,SLAM family member 5,27207,172,1.53 [0.99-2.37],0.0539140161897655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD86,T-lymphocyte activation antigen CD86,23636,148,1.08 [0.63-1.85],0.772205424744039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD8A,T-cell surface glycoprotein CD8 alpha chain,27496,174,1.09 [0.83-1.42],0.5428890288044639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD93,Complement component C1q receptor,26210,163,1.62 [1.06-2.48],0.026618614703782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,27261,173,2.61 [1.34-5.06],0.0046734679560991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99L2,CD99 antigen-like protein 2,27261,173,1.81 [1.04-3.14],0.0356096841772952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDA,Cytidine deaminase,23713,150,0.99 [0.71-1.37],0.9297904041628604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDAN1,Codanin-1,23705,149,1.11 [0.60-2.06],0.7459384185658973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC123,Cell division cycle protein 123 homolog,22891,140,0.83 [0.62-1.10],0.1983116917752021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC25A,M-phase inducer phosphatase 1,22891,140,1.20 [0.86-1.68],0.2851511483672331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC26,Anaphase-promoting complex subunit CDC26,23595,148,1.16 [0.93-1.45],0.1769216789298466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC27,Cell division cycle protein 27 homolog,26616,166,0.96 [0.76-1.20],0.7023925300851788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC37,Hsp90 co-chaperone Cdc37,27351,173,1.15 [0.98-1.35],0.0776988557192493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC42BPB,Serine/threonine-protein kinase MRCK beta,23636,148,1.13 [0.97-1.31],0.1089548361239132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,27073,171,1.61 [1.27-2.06],0.0001155911839453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,26331,171,1.61 [1.24-2.08],0.0002718242778965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH15,Cadherin-15,27446,174,1.11 [0.84-1.45],0.456499988167148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH17,Cadherin-17,27255,172,1.18 [0.97-1.42],0.0919846237635326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH2,Cadherin-2,27255,172,1.64 [1.13-2.39],0.0097050891879193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH22,Cadherin-22,23310,148,1.08 [0.63-1.83],0.7889093772776297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH23,Cadherin-23,23705,149,1.44 [0.85-2.46],0.1758135592013998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH3,Cadherin-3,27496,174,1.05 [0.72-1.53],0.7938858679291185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH4,Cadherin-4,22986,143,1.30 [0.99-1.71],0.0601846479049429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH5,Cadherin-5,27587,172,1.65 [1.09-2.50],0.0186427112574633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH6,Cadherin-6,27255,172,1.33 [0.94-1.88],0.1124918754128979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR1,Cadherin-related family member 1,26588,162,1.04 [0.75-1.42],0.8250943834570941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR2,Cadherin-related family member 2,27133,172,1.01 [0.85-1.21],0.8899719207096927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR5,Cadherin-related family member 5,27255,172,0.87 [0.62-1.22],0.4255127037276327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK1,Cyclin-dependent kinase 1,22891,140,1.11 [0.71-1.72],0.6502680855701217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23723,148,0.95 [0.73-1.25],0.7375079077086957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKL5,Cyclin-dependent kinase-like 5,22986,143,1.16 [0.90-1.49],0.2563622204837251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN1A,Cyclin-dependent kinase inhibitor 1,27133,172,1.05 [0.93-1.19],0.4456840355760147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27133,172,1.07 [0.93-1.24],0.3453404813683954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDNF,Cerebral dopamine neurotrophic factor,27133,172,1.21 [0.80-1.81],0.3653492537722356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27306,168,1.20 [0.71-2.01],0.4997586469498785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDSN,Corneodesmosin,27446,172,1.16 [0.85-1.57],0.3548308987779609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27307,173,2.27 [1.25-4.10],0.0068900659744521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23636,148,0.91 [0.74-1.11],0.3412675082348881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23310,148,1.24 [1.05-1.47],0.0107460166598327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23636,148,1.49 [1.02-2.19],0.0392628943365925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23310,148,1.48 [1.15-1.91],0.002258651183488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27207,172,1.17 [1.01-1.36],0.0364254418703752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,26616,166,1.23 [0.96-1.58],0.0975271935561652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26261,165,1.06 [0.86-1.31],0.5962629928595198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23755,147,1.35 [0.90-2.01],0.145790654530676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,26751,160,1.16 [0.89-1.53],0.2743551726377077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPA,CCAAT/enhancer-binding protein alpha,23084,146,1.21 [0.85-1.71],0.28356741622886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPB,CCAAT/enhancer-binding protein beta,26751,160,0.98 [0.68-1.42],0.9199393780208132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA2A,Chymotrypsin-like elastase family member 2A,23755,147,0.91 [0.70-1.18],0.469227166227235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA3A,Chymotrypsin-like elastase family member 3A,27539,171,0.99 [0.78-1.25],0.9140690905797856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23256,143,1.11 [0.65-1.91],0.7027742966041015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEMIP2,Cell surface hyaluronidase,23084,146,1.03 [0.66-1.62],0.8812724195105633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEND1,Cell cycle exit and neuronal differentiation protein 1,22986,143,0.98 [0.74-1.30],0.9121248106832004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPF,Centromere protein F,23310,148,1.08 [0.82-1.42],0.6051444405907516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPJ,Centromere protein J,23310,148,0.93 [0.73-1.17],0.5299149583964927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP112,Centrosomal protein of 112 kDa,22998,148,1.07 [0.76-1.50],0.6951348986512824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP152,Centrosomal protein of 152 kDa,22891,140,1.14 [0.80-1.62],0.458921248315398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP164,Centrosomal protein of 164 kDa,26707,161,1.05 [0.86-1.28],0.6476730787691014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP170,Centrosomal protein of 170 kDa,23148,148,1.11 [0.91-1.35],0.2987231884321122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP20,Centrosomal protein 20,26616,166,1.22 [1.02-1.46],0.0276655844626387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP290,Centrosomal protein of 290 kDa,23310,148,1.01 [0.75-1.35],0.972492314523405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP350,Centrosome-associated protein 350,22891,140,1.06 [0.70-1.61],0.7863432708271254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP43,Centrosomal protein 43,26535,156,1.10 [0.89-1.35],0.3786681242024797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP85,Centrosomal protein of 85 kDa,26616,166,1.23 [1.00-1.51],0.0453161012365588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CERT,Ceramide transfer protein,26588,162,1.07 [0.85-1.34],0.5656858820802233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES1,Liver carboxylesterase 1,27315,171,1.16 [0.99-1.36],0.0643304352912602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES2,Cocaine esterase,27133,172,0.91 [0.71-1.17],0.4723963992812502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES3,Carboxylesterase 3,27133,172,1.09 [0.91-1.31],0.3501039238551077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN2,Centrin-2,26588,162,1.11 [0.90-1.36],0.3271213021768006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN3,Centrin-3,23636,148,1.21 [1.00-1.48],0.0554532104036831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFB,Complement factor B,23348,146,1.03 [0.63-1.67],0.91504965552527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFC1,Cryptic protein,26616,166,1.34 [1.04-1.73],0.0242019462233203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFD,Complement factor D,23803,149,1.67 [0.79-3.50],0.1775883783772473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFH,Complement factor H,22388,141,1.21 [0.60-2.45],0.5920076124844389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR2,Complement factor H-related protein 2,23621,149,1.32 [0.98-1.77],0.0698760258899919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR4,Complement factor H-related protein 4,23761,148,1.25 [1.00-1.57],0.0500639301980285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR5,Complement factor H-related protein 5,23451,145,0.91 [0.63-1.31],0.6063897992332657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFI,Complement factor I,23803,149,0.64 [0.30-1.39],0.2599102064953109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFP,Properdin,23803,149,0.45 [0.21-0.96],0.03949271521775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGA,Glycoprotein hormones alpha chain,27261,173,1.00 [0.84-1.19],0.9763652002747156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23771,148,1.31 [1.06-1.61],0.0117997147386262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGN,Cingulin,23097,146,1.13 [0.80-1.59],0.4799567127280525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,27255,172,1.70 [1.25-2.30],0.0006256389850885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,26616,166,1.08 [0.87-1.34],0.4627795905854216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAD,Chondroadherin,23256,143,0.89 [0.67-1.19],0.4398231419778031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23705,149,1.96 [1.44-2.68],2.29543268249356e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD6,MICOS complex subunit MIC25,23623,149,1.51 [0.99-2.29],0.0528969570531893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHEK2,Serine/threonine-protein kinase Chk2,26751,160,0.87 [0.57-1.34],0.5361120469994347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGA,Chromogranin-A,23755,147,1.16 [1.00-1.35],0.0431434898755034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGB,Secretogranin-1,27397,174,1.41 [1.03-1.95],0.0344458997783986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,26630,168,1.24 [1.05-1.46],0.0115750919806915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHIT1,Chitotriosidase-1,27361,172,0.99 [0.91-1.08],0.8594509986999813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHL1,Neural cell adhesion molecule L1-like protein,27304,171,0.77 [0.49-1.20],0.2448988359397224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHM,Rab proteins geranylgeranyltransferase component A 1,23097,146,1.10 [0.86-1.42],0.4548660136979234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP1A,Charged multivesicular body protein 1a,27073,171,1.07 [0.90-1.27],0.4358124041024899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP6,Charged multivesicular body protein 6,23762,150,1.14 [0.87-1.51],0.3419223771032437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHP1,Calcineurin B homologous protein 1,22986,143,1.07 [0.87-1.31],0.526156846073907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,27344,169,1.25 [0.80-1.94],0.3270732231255305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL2,Chordin-like protein 2,27255,172,1.15 [0.90-1.46],0.2597977063456293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRM1,Muscarinic acetylcholine receptor M1,23097,146,1.26 [0.88-1.80],0.2001135853483857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIAPIN1,Anamorsin,27351,173,1.21 [0.98-1.49],0.0732794734321536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CILP,Cartilage intermediate layer protein 1,23755,147,1.06 [0.79-1.42],0.6892530193824824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CINP,Cyclin-dependent kinase 2-interacting protein,23310,148,0.92 [0.63-1.33],0.6524313378105218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIRBP,Cold-inducible RNA-binding protein,23636,148,1.14 [0.96-1.34],0.1366178059084988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIT,Citron Rho-interacting kinase,23097,146,0.94 [0.66-1.33],0.7247241790049073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,27405,172,1.76 [1.11-2.78],0.0157791594061173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKB,Creatine kinase B-type,23755,147,1.19 [0.92-1.53],0.1901784991009483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27167,169,1.17 [0.95-1.44],0.1452616852758766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLASP1,CLIP-associating protein 1,22891,140,1.12 [0.91-1.38],0.2641174322451539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLC,Galectin-10,27214,172,1.09 [0.89-1.32],0.409518399340026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC10A,C-type lectin domain family 10 member A,27073,171,0.86 [0.59-1.25],0.4339679302413904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC11A,C-type lectin domain family 11 member A,27211,173,1.23 [0.93-1.63],0.1392858248773477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC12A,C-type lectin domain family 12 member A,23084,146,1.27 [0.61-2.64],0.520069616905222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,27261,173,1.58 [1.04-2.38],0.0306055561903577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1A,C-type lectin domain family 1 member A,26751,160,1.24 [0.81-1.89],0.3274774715682822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1B,C-type lectin domain family 1 member B,27496,174,1.11 [0.96-1.27],0.1484684214685111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC2L,C-type lectin domain family 2 member L,23097,146,1.08 [0.80-1.44],0.6262970749668625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC3B,Tetranectin,23223,146,0.75 [0.35-1.60],0.4603882131046894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4A,C-type lectin domain family 4 member A,27207,172,0.78 [0.54-1.14],0.2004071149419816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4C,C-type lectin domain family 4 member C,27207,172,1.06 [0.79-1.41],0.6988360106414667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4D,C-type lectin domain family 4 member D,27207,172,1.18 [0.95-1.46],0.1280415405420604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4G,C-type lectin domain family 4 member G,27207,172,1.36 [0.91-2.04],0.1325061126696162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4M,C-type lectin domain family 4 member M,23709,147,1.12 [0.81-1.54],0.500839158722912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC5A,C-type lectin domain family 5 member A,27167,172,1.59 [1.01-2.49],0.0429412843799157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,26616,166,1.39 [1.06-1.84],0.0182465861682179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,27538,173,1.19 [0.92-1.55],0.1835600590695238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLGN,Calmegin,23097,146,1.44 [1.06-1.97],0.0208107941712605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIC5,Chloride intracellular channel protein 5,23097,146,1.06 [0.65-1.71],0.8242338598430936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLINT1,Clathrin interactor 1,22891,140,0.90 [0.61-1.32],0.5810071463906217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIP2,CAP-Gly domain-containing linker protein 2,27207,172,1.12 [0.99-1.26],0.0676736418580251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLMP,CXADR-like membrane protein,27485,171,1.48 [0.77-2.85],0.2427816815026554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLNS1A,Methylosome subunit pICln,23097,146,1.16 [0.74-1.82],0.5232126181367684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27023,171,1.14 [0.99-1.31],0.0629504247306393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPS,Colipase,27220,173,1.02 [0.84-1.23],0.8657950329529546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSPN,Claspin,26538,162,0.92 [0.60-1.43],0.7229490045452124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN1,Calsyntenin-1,26588,162,0.88 [0.66-1.16],0.3598273132787312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN2,Calsyntenin-2,27538,173,1.41 [1.04-1.93],0.0294353888849443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN3,Calsyntenin-3,23705,149,1.38 [0.85-2.23],0.193625312844643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLTA,Clathrin light chain A,26751,160,1.00 [0.75-1.34],0.9922149874650132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLU,Clusterin,23803,149,0.82 [0.44-1.52],0.5237920465793572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLUL1,Clusterin-like protein 1,27215,172,1.12 [0.84-1.50],0.4369420156784025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMC1,COX assembly mitochondrial protein homolog,23762,150,1.14 [0.96-1.35],0.1236952924454543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMIP,C-Maf-inducing protein,23623,149,1.17 [0.97-1.40],0.1053983664579441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,27347,172,0.78 [0.59-1.03],0.0760189601073984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNGB3,Cyclic nucleotide-gated cation channel beta-3,22986,143,0.92 [0.67-1.26],0.5851965962263316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23103,148,1.23 [1.01-1.49],0.0397687834424881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY2,Protein canopy homolog 2,26751,160,1.11 [0.91-1.37],0.3114532296407118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY4,Protein canopy homolog 4,27133,172,1.04 [0.87-1.25],0.6420580631760082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNST,Consortin,27255,172,1.04 [0.92-1.18],0.5532393866137442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTF,Ciliary neurotrophic factor,22986,143,1.34 [0.86-2.09],0.1975505968100756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN1,Contactin-1,27587,172,0.71 [0.44-1.13],0.1506771512829729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN2,Contactin-2,27485,171,0.76 [0.56-1.03],0.0787274559199237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN3,Contactin-3,27261,173,0.91 [0.62-1.33],0.6216574315700266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN4,Contactin-4,27261,173,1.58 [0.91-2.76],0.1064777621287687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN5,Contactin-5,27324,174,0.59 [0.41-0.85],0.0044758276186977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP2,Contactin-associated protein-like 2,27207,172,0.94 [0.67-1.31],0.6992097734839555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP4,Contactin-associated protein-like 4,23097,146,1.05 [0.91-1.22],0.4729820349609869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COCH,Cochlin,23762,150,1.33 [0.97-1.82],0.0749595450749147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL15A1,Collagen alpha-1(XV) chain,23755,147,0.83 [0.46-1.51],0.542217211844552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,27369,171,1.73 [0.98-3.07],0.0600737527773233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL1A1,Collagen alpha-1(I) chain,27587,172,0.85 [0.51-1.42],0.5245681115395704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL24A1,Collagen alpha-1(XXIV) chain,23636,148,1.16 [0.87-1.55],0.3031211324092991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,23097,146,0.83 [0.67-1.04],0.1062519282351266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL2A1,Collagen alpha-1(II) chain,23148,148,1.17 [0.97-1.41],0.1100227659694496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL3A1,Collagen alpha-1(III) chain,23755,147,1.92 [1.02-3.63],0.0427917808254199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A1,Collagen alpha-1(IV) chain,27255,172,1.40 [1.01-1.94],0.0430724832496389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A4,Collagen alpha-4(IV) chain,23270,148,0.90 [0.68-1.20],0.4687118568416896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL5A1,Collagen alpha-1(V) chain,23256,143,1.44 [0.99-2.09],0.0536394141814192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,27587,172,1.69 [1.17-2.42],0.0047352617140306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A1,Collagen alpha-1(IX) chain,27207,172,1.03 [0.79-1.35],0.8231325770617041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A2,Collagen alpha-2(IX) chain,23310,148,1.19 [0.90-1.59],0.2283184009038877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,27258,168,2.06 [1.24-3.41],0.0053242912419962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD1,COMM domain-containing protein 1,23148,148,1.24 [0.96-1.59],0.0943969676319184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD9,COMM domain-containing protein 9,23623,149,1.15 [0.81-1.65],0.4320644113004159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMP,Cartilage oligomeric matrix protein,26947,171,0.91 [0.61-1.36],0.6506526221344482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMT,Catechol O-methyltransferase,26471,159,1.11 [0.93-1.31],0.2415667127125167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPB2,Coatomer subunit beta',22998,148,1.18 [0.82-1.69],0.3724665209730305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPE,Coatomer subunit epsilon,26588,162,0.98 [0.73-1.32],0.8922711419246553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23148,148,0.95 [0.66-1.36],0.7623939028693387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO1A,Coronin-1A,26673,168,1.16 [1.01-1.33],0.0373245298717056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO6,Coronin-6,22986,143,1.06 [0.69-1.63],0.7963929596578941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27133,172,1.08 [0.90-1.31],0.4039128105641353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX6B1,Cytochrome c oxidase subunit 6B1,23762,150,1.52 [0.97-2.38],0.0650677868200982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA1,Carboxypeptidase A1,27587,172,1.07 [0.85-1.35],0.5422183487804719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA2,Carboxypeptidase A2,27399,174,1.04 [0.84-1.27],0.7331988068923533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA4,Carboxypeptidase A4,22781,140,1.22 [0.83-1.77],0.3096874265901103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB1,Carboxypeptidase B,27587,172,1.07 [0.85-1.35],0.565740237237129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB2,Carboxypeptidase B2,23752,148,0.86 [0.43-1.74],0.6807274471882038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPE,Carboxypeptidase E,27283,171,0.78 [0.56-1.08],0.1325949802037102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPLX2,Complexin-2,22891,140,0.90 [0.52-1.53],0.6906151056596737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPM,Carboxypeptidase M,27367,174,1.59 [1.10-2.30],0.013040127008373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23084,146,1.56 [0.96-2.52],0.0737210542513941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPPED1,Serine/threonine-protein phosphatase CPPED1,27496,174,1.18 [0.97-1.44],0.0979789009149367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPQ,Carboxypeptidase Q,23709,147,1.24 [0.80-1.91],0.3337585719599746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPTP,Ceramide-1-phosphate transfer protein,22998,148,1.00 [0.68-1.48],0.995222063433589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPVL,Probable serine carboxypeptidase CPVL,27448,171,1.03 [0.74-1.44],0.8603550458819609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM1,Probable carboxypeptidase X1,27351,173,1.25 [1.03-1.50],0.0210790343319322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM2,Inactive carboxypeptidase-like protein X2,23762,150,1.35 [0.76-2.39],0.3007474178395249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR1,Complement receptor type 1,23677,146,0.99 [0.64-1.54],0.9685203386020802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR2,Complement receptor type 2,27347,172,1.07 [0.81-1.43],0.629431151886607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,26616,166,1.18 [1.01-1.36],0.0317502395129176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRADD,Death domain-containing protein CRADD,27023,171,1.14 [0.95-1.37],0.1457601196280879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREB3,Cyclic AMP-responsive element-binding protein 3,22891,140,1.32 [1.05-1.66],0.0162391874912888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREBZF,CREB/ATF bZIP transcription factor,22891,140,1.93 [1.22-3.07],0.005284419207895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREG1,Protein CREG1,26907,172,1.15 [0.80-1.66],0.4413428375876781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD1,Protein disulfide isomerase CRELD1,23256,143,1.47 [0.97-2.23],0.0689244045725453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD2,Protein disulfide isomerase CRELD2,27344,169,1.31 [1.02-1.68],0.0350338451961456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRH,Corticoliberin,26569,166,0.94 [0.80-1.11],0.4867385178799545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,27258,168,1.74 [1.07-2.82],0.0260231217838993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHR1,Corticotropin-releasing factor receptor 1,26751,160,0.98 [0.79-1.23],0.8929116653500057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIM1,Cysteine-rich motor neuron 1 protein,27391,171,2.06 [1.09-3.90],0.0252434020022469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,27073,171,1.09 [0.76-1.57],0.6292107863181127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP2,Cysteine-rich secretory protein 2,27485,171,0.78 [0.64-0.96],0.018602102122648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP3,Cysteine-rich secretory protein 3,23549,146,0.57 [0.32-0.99],0.0459484062334711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRKL,Crk-like protein,27304,169,1.12 [0.98-1.27],0.0883963762158254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRLF1,Cytokine receptor-like factor 1,27391,171,2.09 [1.24-3.53],0.0059915552808318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRNN,Cornulin,26461,167,1.06 [0.87-1.30],0.5461467788342376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAC1,Cartilage acidic protein 1,27587,172,1.24 [0.78-1.97],0.3709331716080597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,27073,171,1.24 [0.95-1.62],0.1154209520243176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAP,Cartilage-associated protein,23097,146,1.06 [0.77-1.44],0.7357881552600478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRX,Cone-rod homeobox protein,26751,160,0.92 [0.80-1.07],0.2780532601097918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB1,Beta-crystallin B1,23762,150,1.27 [1.00-1.61],0.0462874401923302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,23705,149,1.37 [1.21-1.54],2.191459089069534e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYGD,Gamma-crystallin D,23705,149,1.15 [0.98-1.35],0.0890824675297656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYM,Ketimine reductase mu-crystallin,22986,143,1.15 [0.96-1.38],0.1312734544363302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYZL1,Quinone oxidoreductase-like protein 1,23148,148,1.17 [0.98-1.38],0.080130924984461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSDE1,Cold shock domain-containing protein E1,22998,148,1.09 [0.97-1.23],0.1496933698779083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,27391,171,2.02 [1.27-3.21],0.0030354037860068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,23771,148,1.22 [0.82-1.82],0.3149166235901177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2,Granulocyte-macrophage colony-stimulating factor,22998,148,1.05 [0.67-1.63],0.8372784702973186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27073,171,1.17 [0.95-1.45],0.1312823347963448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RB,Cytokine receptor common subunit beta,23084,146,1.19 [0.83-1.72],0.341566551540195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3,Granulocyte colony-stimulating factor,26707,161,1.05 [0.79-1.40],0.7180620672885434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3R,Granulocyte colony-stimulating factor receptor,23084,146,0.95 [0.57-1.59],0.8524666023968275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSH1,Chorionic somatomammotropin hormone 1,23771,148,0.87 [0.51-1.49],0.6086451842850167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK1D,Casein kinase I isoform delta,23084,146,1.11 [0.87-1.41],0.4121477795047124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK2A1,Casein kinase II subunit alpha,23723,148,1.32 [0.94-1.85],0.1056212458891927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG4,Chondroitin sulfate proteoglycan 4,23755,147,1.21 [0.75-1.96],0.4246291929364402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG5,Chondroitin sulfate proteoglycan 5,22986,143,0.94 [0.67-1.31],0.709541644506371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSRP3,Cysteine and glycine-rich protein 3,22998,148,1.11 [0.96-1.29],0.1698109759348955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST1,Cystatin-SN,20598,123,0.95 [0.79-1.13],0.5344335072979483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,27306,172,1.92 [1.23-2.99],0.0043054240195713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST5,Cystatin-D,26801,168,0.98 [0.77-1.25],0.8652113371455361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST6,Cystatin-M,26529,163,0.84 [0.63-1.12],0.2424849147849429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST7,Cystatin-F,27302,171,1.14 [1.01-1.29],0.0285509808945891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSTB,Cystatin-B,26873,169,1.45 [1.06-1.97],0.0200158242227925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTAG1A_CTAG1B,Cancer/testis antigen 1,23263,148,1.35 [1.03-1.77],0.0288882648236166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTBS,Di-N-acetylchitobiase,23415,145,1.37 [0.75-2.50],0.3077116415570167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTF1,Cardiotrophin-1,26751,160,1.07 [0.91-1.26],0.4352115410734244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTHRC1,Collagen triple helix repeat-containing protein 1,23755,147,1.76 [1.06-2.94],0.0302624941390987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTLA4,Cytotoxic T-lymphocyte protein 4,23755,147,1.29 [0.81-2.06],0.277536658097596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTNNA1,Catenin alpha-1,22986,143,1.15 [0.79-1.68],0.4689952244585167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRB1,Chymotrypsinogen B,27261,173,1.06 [0.83-1.35],0.6585371461722098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRC,Chymotrypsin-C,27260,168,0.98 [0.79-1.21],0.8189717213748232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRL,Chymotrypsin-like protease CTRL-1,23705,149,1.11 [0.88-1.40],0.3689831093927141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSB,Cathepsin B,27283,171,1.02 [0.79-1.31],0.8718943538693116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSC,Dipeptidyl peptidase 1,27221,171,1.38 [1.02-1.86],0.0356268519159961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSD,Cathepsin D,25444,166,1.58 [1.20-2.08],0.0011433626517096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSE,Cathepsin E,23256,143,1.45 [1.08-1.96],0.0149647257201579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSF,Cathepsin F,27351,173,1.02 [0.73-1.43],0.895908734356749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSH,Pro-cathepsin H,26674,159,1.10 [0.91-1.33],0.3197137854450843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSL,Cathepsin L1,27255,172,2.02 [1.18-3.44],0.0099540922935363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSO,Cathepsin O,27538,173,1.25 [0.81-1.94],0.3150439310990247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSS,Cathepsin S,21393,138,2.07 [1.07-4.01],0.0300348175765126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSV,Cathepsin L2,27406,171,0.69 [0.50-0.96],0.0281960422037826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSZ,Cathepsin Z,27256,172,1.83 [1.21-2.78],0.004432946078368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CUZD1,CUB and zona pellucida-like domain-containing protein 1,23097,146,1.24 [0.88-1.75],0.2270367295520158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CWC15,Spliceosome-associated protein CWC15 homolog,23501,146,1.17 [0.93-1.47],0.1712774092014788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CX3CL1,Fractalkine,27073,171,1.49 [1.02-2.18],0.0388145961620897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,27207,172,1.29 [1.02-1.64],0.0304777761631516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL1,Growth-regulated alpha protein,27213,171,1.06 [0.93-1.21],0.3888663364601715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL10,C-X-C motif chemokine 10,27391,171,1.23 [1.03-1.47],0.023784697953846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL11,C-X-C motif chemokine 11,27496,174,1.16 [1.00-1.35],0.0482604054875872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL12,Stromal cell-derived factor 1,26707,161,1.20 [0.86-1.67],0.2925519170884061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL13,C-X-C motif chemokine 13,27496,174,1.09 [0.90-1.33],0.3713736321710839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL14,C-X-C motif chemokine 14,26707,161,1.16 [0.97-1.40],0.1056078691276051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL16,C-X-C motif chemokine 16,27540,172,1.54 [0.88-2.68],0.1279812180732548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL17,C-X-C motif chemokine 17,27538,173,1.28 [0.94-1.75],0.1228895710097836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL3,C-X-C motif chemokine 3,27255,169,1.07 [0.92-1.24],0.3734628864772108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL5,C-X-C motif chemokine 5,27167,172,1.06 [0.94-1.19],0.323781635559808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL6,C-X-C motif chemokine 6,27538,173,1.09 [0.92-1.29],0.3083715133461064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL8,Interleukin-8,27027,169,1.09 [0.91-1.31],0.3645735856814044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,27391,171,1.22 [1.01-1.46],0.0343227635760008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5A,Cytochrome b5,22891,140,0.90 [0.71-1.15],0.4002707712971325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5R2,NADH-cytochrome b5 reductase 2,23354,146,1.19 [0.91-1.56],0.1995986459548407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",22998,148,1.01 [0.84-1.21],0.935016566635863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTH3,Cytohesin-3,22891,140,0.67 [0.51-0.89],0.0051034740385351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTL1,Cytokine-like protein 1,23755,147,1.18 [0.60-2.31],0.625790642713326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAAM1,Disheveled-associated activator of morphogenesis 1,23256,143,1.13 [0.94-1.37],0.2009436402280752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAB2,Disabled homolog 2,27485,171,1.06 [0.94-1.19],0.3768004625604726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAG1,Dystroglycan,27391,171,1.33 [1.01-1.77],0.045540321404735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAND5,DAN domain family member 5,23084,146,1.20 [0.93-1.54],0.1573800595370082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPK2,Death-associated protein kinase 2,23084,146,1.09 [0.83-1.44],0.5164387216284594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27207,172,1.03 [0.92-1.15],0.6226429024160001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DARS1,"Aspartate--tRNA ligase, cytoplasmic",27023,171,1.08 [0.89-1.29],0.4410711788846699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBH,Dopamine beta-hydroxylase,23722,148,1.10 [0.93-1.29],0.2657433736413115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBI,Acyl-CoA-binding protein,27131,172,1.16 [0.98-1.37],0.0925208095701266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBN1,Drebrin,23084,146,1.34 [1.00-1.78],0.0487763657290006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBNL,Drebrin-like protein,27391,171,1.14 [0.98-1.32],0.082245826562331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",27351,173,1.59 [1.09-2.32],0.0160095185151954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCC,Netrin receptor DCC,23097,146,1.01 [0.50-2.05],0.9790132803288892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCDC2C,Doublecortin domain-containing protein 2C,22891,140,1.13 [0.91-1.40],0.2660623053772259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCLRE1C,Protein artemis,22891,140,1.21 [0.74-1.98],0.4522689847437989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCN,Decorin,26751,160,1.03 [0.56-1.91],0.9159588192699936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTD,Deoxycytidylate deaminase,23256,143,1.07 [0.90-1.27],0.4362625654951518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN1,Dynactin subunit 1,27485,171,1.10 [0.90-1.34],0.3759615963491682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN2,Dynactin subunit 2,27133,172,1.18 [1.03-1.35],0.016188306143659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN6,Dynactin subunit 6,26588,162,0.94 [0.77-1.15],0.5443000057570664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTPP1,dCTP pyrophosphatase 1,27255,172,0.97 [0.63-1.50],0.8998168664313337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D1,DCN1-like protein 1,22986,143,1.06 [0.87-1.29],0.5843178564944094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D2,DCN1-like protein 2,22891,140,0.95 [0.77-1.16],0.5951376793355379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCXR,L-xylulose reductase,27351,173,1.04 [0.81-1.34],0.7642522660158113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDA1,DET1- and DDB1-associated protein 1,22998,148,1.12 [0.78-1.59],0.5364191130374178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27133,172,1.42 [1.08-1.86],0.0115041717430584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDC,Aromatic-L-amino-acid decarboxylase,27210,172,1.11 [0.85-1.46],0.4384765276104864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDHD2,Phospholipase DDHD2,23723,148,1.18 [0.93-1.50],0.1617290599853423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDI2,Protein DDI1 homolog 2,23256,143,0.97 [0.79-1.18],0.7275372460195453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDR1,Epithelial discoidin domain-containing receptor 1,27496,174,1.94 [1.12-3.35],0.018209729631403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDT,D-dopachrome decarboxylase,23755,147,1.01 [0.69-1.46],0.9727317146107056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX1,ATP-dependent RNA helicase DDX1,23636,148,1.06 [0.79-1.42],0.712693468740047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX25,ATP-dependent RNA helicase DDX25,23097,146,1.11 [0.76-1.61],0.5976486268725063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX39A,ATP-dependent RNA helicase DDX39A,23084,146,0.80 [0.38-1.68],0.5554630035005922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX4,Probable ATP-dependent RNA helicase DDX4,23084,146,1.09 [0.83-1.43],0.5479260623610234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX53,Probable ATP-dependent RNA helicase DDX53,23097,146,0.99 [0.64-1.56],0.9823580003546384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX58,Antiviral innate immune response receptor RIG-I,26616,166,1.22 [0.99-1.49],0.0592319647868477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27207,172,1.16 [1.01-1.33],0.0382382398569867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFA1_DEFA1B,Neutrophil defensin 1,26689,169,1.13 [0.89-1.44],0.3196228383189879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB103A_DEFB103B,Beta-defensin 103,22906,144,1.36 [1.05-1.77],0.0188811471930237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB104A_DEFB104B,Beta-defensin 104,22986,143,1.11 [0.85-1.45],0.4369476494778914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB116,Beta-defensin 116,22986,143,1.07 [0.89-1.30],0.4708179064661653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB118,Beta-defensin 118,22986,143,0.91 [0.67-1.24],0.5494737530623939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB4A_DEFB4B,Beta-defensin 4A,26879,171,1.05 [0.96-1.15],0.2483168085303363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENND2B,DENN domain-containing protein 2B,22998,148,1.08 [0.81-1.44],0.5769611038963518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENR,Density-regulated protein,23084,146,1.17 [0.91-1.52],0.2230300757672257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DFFA,DNA fragmentation factor subunit alpha,27538,173,1.16 [0.96-1.41],0.1243066267062226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGCR6,Protein DGCR6,22986,143,1.26 [0.96-1.66],0.0991670739830364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKA,Diacylglycerol kinase alpha,23084,146,1.30 [0.98-1.72],0.0664943798092725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKZ,Diacylglycerol kinase zeta,26707,161,1.08 [0.73-1.61],0.7049830257028603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHODH,Dihydroorotate dehydrogenase,22998,148,0.82 [0.57-1.18],0.2779212005001877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHPS,Deoxyhypusine synthase,23623,149,1.11 [0.79-1.57],0.5466113644857622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23705,149,1.33 [1.00-1.75],0.0474825782315735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIABLO,"Diablo homolog, mitochondrial",27167,172,1.03 [0.91-1.17],0.5917954839601645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK1C,Divergent protein kinase domain 1C,23097,146,1.18 [0.84-1.66],0.327857907393131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK2B,Divergent protein kinase domain 2B,23256,143,1.04 [0.57-1.88],0.9073445836372276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK1,Dickkopf-related protein 1,27496,174,1.21 [0.97-1.52],0.0886369588642492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK3,Dickkopf-related protein 3,27587,172,1.17 [0.75-1.83],0.4946027395632494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK4,Dickkopf-related protein 4,27032,171,1.11 [0.84-1.48],0.4617939309445339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKKL1,Dickkopf-like protein 1,27133,172,1.02 [0.88-1.19],0.7567865090369501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLG4,Disks large homolog 4,23705,149,1.23 [1.00-1.51],0.0498986554339891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLGAP5,Disks large-associated protein 5,23723,148,1.12 [0.88-1.43],0.36572585484484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLK1,Protein delta homolog 1,27587,172,1.08 [0.84-1.39],0.5268871098494414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,27351,173,1.65 [1.06-2.56],0.0257117495380833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL4,Delta-like protein 4,23148,148,0.95 [0.77-1.17],0.6275080280437795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMD,Dystrophin,23148,148,1.41 [1.13-1.77],0.0027835180848067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMP1,Dentin matrix acidic phosphoprotein 1,23148,148,0.93 [0.73-1.18],0.5429965031316082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA1,DnaJ homolog subfamily A member 1,22891,140,0.97 [0.68-1.38],0.8646648196186806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA2,DnaJ homolog subfamily A member 2,27450,173,1.12 [0.95-1.31],0.1895962515879797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA4,DnaJ homolog subfamily A member 4,23705,149,1.06 [0.86-1.31],0.5632548672033889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB1,DnaJ homolog subfamily B member 1,27133,172,1.05 [0.90-1.22],0.5676125647697958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB14,DnaJ homolog subfamily B member 14,23636,148,1.24 [0.98-1.56],0.0673354922857249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB2,DnaJ homolog subfamily B member 2,23256,143,1.06 [0.80-1.42],0.6866575881816386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB6,DnaJ homolog subfamily B member 6,23031,140,1.06 [0.88-1.29],0.5237105286068386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB8,DnaJ homolog subfamily B member 8,26751,160,1.03 [0.81-1.30],0.8215534341720482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC21,DnaJ homolog subfamily C member 21,23705,149,1.25 [0.85-1.82],0.2582470791868815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC6,Putative tyrosine-protein phosphatase auxilin,23148,148,1.09 [0.91-1.31],0.351375452124544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC9,DnaJ homolog subfamily C member 9,23636,148,1.12 [0.92-1.38],0.2523312560151735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNER,Delta and Notch-like epidermal growth factor-related receptor,27212,168,0.79 [0.46-1.37],0.4049081042744505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNLZ,DNL-type zinc finger protein,22986,143,0.98 [0.82-1.17],0.8342720017876082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM1,Dynamin-1,23636,148,1.09 [0.95-1.26],0.2107056095615254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM3,Dynamin-3,23723,148,1.13 [0.86-1.49],0.3720337899794997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNMBP,Dynamin-binding protein,27073,171,1.26 [1.03-1.54],0.0266904750212031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPEP,Aspartyl aminopeptidase,23705,149,1.15 [0.88-1.51],0.3015660018249189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,27351,171,0.97 [0.75-1.25],0.8084091035418508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOC2B,Double C2-like domain-containing protein beta,23097,146,1.26 [0.87-1.82],0.2174366768839012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOCK9,Dedicator of cytokinesis protein 9,22986,143,0.88 [0.75-1.04],0.125815385055937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK1,Docking protein 1,23705,149,1.09 [0.97-1.23],0.1590411061100954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK2,Docking protein 2,27255,172,1.04 [0.93-1.17],0.4515046720824619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP1,Dipeptidase 1,27023,171,0.80 [0.62-1.03],0.084324087297224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP2,Dipeptidase 2,27133,172,1.07 [0.67-1.72],0.7729186236800987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP10,Inactive dipeptidyl peptidase 10,27207,172,1.21 [0.83-1.76],0.3206624001511534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP4,Dipeptidyl peptidase 4,26736,169,1.00 [0.63-1.59],0.9868155849908418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP6,Dipeptidyl aminopeptidase-like protein 6,27133,172,0.99 [0.66-1.48],0.9541434134690918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP7,Dipeptidyl peptidase 2,27025,172,1.11 [0.88-1.39],0.3796178429040531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPT,Dermatopontin,27587,172,0.92 [0.55-1.54],0.7604373730676002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPY30,Protein dpy-30 homolog,27389,170,1.20 [0.97-1.48],0.0907026589755609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRAXIN,Draxin,27073,171,1.19 [0.87-1.62],0.2729948053162899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRG2,Developmentally-regulated GTP-binding protein 2,27133,172,1.11 [0.87-1.40],0.4046337523620049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,26976,167,1.56 [1.07-2.27],0.0197321436165249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSCAM,Down syndrome cell adhesion molecule,23723,148,1.04 [0.67-1.61],0.8706547282953268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG2,Desmoglein-2,27261,173,1.40 [0.86-2.28],0.1746231445227377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG3,Desmoglein-3,27395,170,1.02 [0.69-1.53],0.9091650203744448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG4,Desmoglein-4,27048,172,0.84 [0.65-1.08],0.1780449132365064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTD1,D-aminoacyl-tRNA deacylase 1,23256,143,1.13 [0.94-1.36],0.18207414735985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTNB,Dystrobrevin beta,23582,149,1.72 [1.25-2.36],0.0009368642437724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX2,Probable E3 ubiquitin-protein ligase DTX2,23097,146,1.15 [0.93-1.42],0.210185683025094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX3,Probable E3 ubiquitin-protein ligase DTX3,27133,172,1.08 [0.62-1.90],0.7814545050461923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTYMK,Thymidylate kinase,23762,150,1.11 [0.89-1.39],0.3486884852243255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUOX2,Dual oxidase 2,26751,160,0.95 [0.78-1.16],0.6107322880759753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP13,Dual specificity protein phosphatase 13 isoform A,23623,149,1.01 [0.68-1.48],0.9752118495073836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP29,Dual specificity phosphatase 29,23097,146,1.03 [0.82-1.30],0.7816976643306722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP3,Dual specificity protein phosphatase 3,26588,162,1.16 [1.01-1.33],0.0343520287488381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23636,148,1.12 [0.96-1.30],0.1518056563497185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DXO,Decapping and exoribonuclease protein,23705,149,1.35 [0.97-1.88],0.0758776996290769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23623,149,1.24 [0.95-1.63],0.1142780564615159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT1,Dynein light chain Tctex-type 1,23097,146,0.96 [0.79-1.17],0.7204466776575387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT3,Dynein light chain Tctex-type 3,23623,149,1.08 [0.76-1.53],0.6551342148446888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27073,171,1.08 [0.93-1.24],0.311900287176137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBI3_IL27,Interleukin-27,27437,171,1.28 [0.83-1.97],0.2599621467812217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECE1,Endothelin-converting enzyme 1,26588,162,1.56 [1.09-2.22],0.0144395105948186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23762,150,1.17 [0.97-1.42],0.1029310080177608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHS1,"Enoyl-CoA hydratase, mitochondrial",23148,148,1.18 [1.01-1.38],0.0390184731212589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECI2,Enoyl-CoA delta isomerase 2,22998,148,1.10 [0.87-1.40],0.426553768040938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECM1,Extracellular matrix protein 1,23118,141,0.88 [0.58-1.35],0.5657698041175493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECSCR,Endothelial cell-specific chemotaxis regulator,22986,143,1.12 [0.85-1.48],0.4214830075755086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,27485,171,2.05 [1.47-2.84],1.8178970096622835e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDAR,Tumor necrosis factor receptor superfamily member EDAR,27207,172,1.03 [0.89-1.19],0.692278893481532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDDM3B,Epididymal secretory protein E3-beta,23623,149,0.76 [0.51-1.13],0.1778390088035492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,22998,148,0.92 [0.59-1.44],0.7260499079447733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDF1,Endothelial differentiation-related factor 1,23723,148,1.07 [0.87-1.32],0.5120229510459708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,26751,160,1.01 [0.67-1.53],0.9533673601241218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDN1,Endothelin-1,23148,148,1.73 [1.02-2.94],0.0428987933239839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDNRB,Endothelin receptor type B,23084,146,0.88 [0.59-1.29],0.5004456797289678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EEF1D,Elongation factor 1-delta,23762,150,1.20 [1.02-1.41],0.0296235901808242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB14,EF-hand calcium-binding domain-containing protein 14,23636,148,1.79 [1.17-2.74],0.0077173118848596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB2,Dynein regulatory complex protein 8,23310,148,1.18 [0.77-1.81],0.4399804461117225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27300,172,1.64 [1.07-2.51],0.0234763587557528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFHD1,EF-hand domain-containing protein D1,23723,148,1.38 [0.92-2.06],0.1174477359418718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,27221,173,1.85 [1.16-2.94],0.0096476905541748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,27031,171,2.14 [1.47-3.13],7.357176273351089e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNB2,Ephrin-B2,23097,146,1.03 [0.80-1.34],0.8113663249423629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGF,Pro-epidermal growth factor,27213,168,1.15 [1.01-1.32],0.0356315151144284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFL7,Epidermal growth factor-like protein 7,26616,166,1.21 [0.88-1.67],0.2443572356349211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFLAM,Pikachurin,23636,148,1.51 [0.99-2.31],0.0584903554667184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFR,Epidermal growth factor receptor,27587,172,0.44 [0.20-0.99],0.0484525599828373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGLN1,Egl nine homolog 1,27207,172,1.15 [0.93-1.42],0.2027370500357431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHBP1,EH domain-binding protein 1,23762,150,1.16 [0.95-1.42],0.1561245461573405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHD3,EH domain-containing protein 3,23148,148,1.00 [0.87-1.14],0.9609798187666696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23705,149,1.13 [0.87-1.47],0.3682430444638723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23551,146,1.14 [0.99-1.31],0.077228250833541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,22998,148,1.21 [0.97-1.51],0.0861061967840319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23148,148,1.28 [0.91-1.80],0.1613549152376268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4B,Eukaryotic translation initiation factor 4B,27073,171,1.16 [0.92-1.46],0.2131306713052898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4E,Eukaryotic translation initiation factor 4E,23084,146,1.13 [0.95-1.35],0.1569362367736413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27255,172,1.08 [0.89-1.33],0.4331945091244041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,27538,173,1.09 [0.95-1.25],0.2203143832257832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23723,148,1.25 [1.01-1.55],0.0446148952499512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5,Eukaryotic translation initiation factor 5,22998,148,1.10 [0.79-1.53],0.580185798392083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5A,Eukaryotic translation initiation factor 5A-1,26707,161,1.11 [0.69-1.76],0.6747667004875582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAC1,Zinc phosphodiesterase ELAC protein 1,23723,148,1.12 [0.93-1.35],0.2332935008955147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAVL4,ELAV-like protein 4,22986,143,1.18 [1.01-1.39],0.0429083878686172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELN,Elastin,23762,150,1.63 [1.08-2.48],0.0209301929383755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOA,Elongin-A,27133,172,1.11 [0.88-1.40],0.3655479805146799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOB,Elongin-B,22998,148,1.75 [1.44-2.12],1.7581970244056826e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENAH,Protein enabled homolog,26707,161,1.50 [1.16-1.96],0.0022608112259309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENDOU,Poly(U)-specific endoribonuclease,21936,135,0.90 [0.64-1.26],0.5428774148830124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENG,Endoglin,27587,172,2.17 [1.00-4.70],0.0499953852521127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO1,Alpha-enolase,27215,174,1.11 [0.94-1.32],0.2224863210609676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO2,Gamma-enolase,27496,174,1.12 [0.92-1.37],0.2620666486704668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO3,Beta-enolase,23148,148,1.04 [0.79-1.37],0.7652228966020911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOPH1,Enolase-phosphatase E1,23623,149,0.99 [0.74-1.32],0.9416578041346124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,22998,148,0.88 [0.49-1.58],0.6752955053002558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPEP,Glutamyl aminopeptidase,22998,148,1.00 [0.71-1.42],0.9938327107276952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,27587,172,1.50 [0.97-2.31],0.0671891030869466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,27391,171,0.89 [0.65-1.21],0.4568533857571552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23148,148,1.15 [0.75-1.76],0.5311217537408213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,26405,167,1.02 [0.87-1.20],0.7774065943297512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENSA,Alpha-endosulfine,23623,149,1.50 [1.20-1.86],0.0003171171819796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,26616,166,1.13 [0.84-1.54],0.4184407890861031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,26751,160,1.04 [0.53-2.05],0.8988313000869382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,26751,160,1.59 [0.90-2.78],0.108191225231362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTR1,Endosome-associated-trafficking regulator 1,23148,148,1.05 [0.80-1.38],0.7057708696821778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EP300,Histone acetyltransferase p300,23084,146,1.42 [0.97-2.08],0.0728109115770521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPB41L5,Band 4.1-like protein 5,23097,146,0.88 [0.67-1.16],0.3660360975764434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPCAM,Epithelial cell adhesion molecule,27263,168,0.97 [0.84-1.11],0.6322363297153111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPGN,Epigen,23623,149,1.31 [1.04-1.67],0.0244422738650163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA1,Ephrin type-A receptor 1,27351,171,1.64 [1.10-2.46],0.0156967554574825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA10,Ephrin type-A receptor 10,26588,162,1.07 [0.88-1.31],0.4831287540480815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,26285,162,2.12 [1.54-2.92],4.2036619711197886e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA4,Ephrin type-A receptor 4,23256,143,1.76 [1.00-3.09],0.0497304100356753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,27587,172,2.15 [1.32-3.50],0.0020837155073996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB6,Ephrin type-B receptor 6,27023,171,1.35 [0.88-2.08],0.1643340394989434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHX2,Bifunctional epoxide hydrolase 2,26751,160,1.06 [0.86-1.31],0.556798977350814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPN1,Epsin-1,23310,148,1.25 [0.94-1.68],0.1295238857677102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPO,Erythropoietin,27207,172,1.02 [0.86-1.22],0.8043704610789414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPPK1,Epiplakin,23148,148,1.20 [0.98-1.46],0.0715343370396587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,27437,170,1.68 [1.11-2.53],0.0134941937190607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB2,Receptor tyrosine-protein kinase erbB-2,27351,173,1.85 [1.07-3.19],0.0284077520984106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB3,Receptor tyrosine-protein kinase erbB-3,27177,168,1.32 [0.65-2.71],0.4425285829324696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB4,Receptor tyrosine-protein kinase erbB-4,27351,173,0.73 [0.43-1.27],0.2695342173213477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBIN,Erbin,27133,172,1.07 [0.94-1.22],0.3188701045443014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERC2,ERC protein 2,23097,146,0.99 [0.80-1.22],0.913957531546636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERCC1,DNA excision repair protein ERCC-1,22891,140,1.03 [0.63-1.69],0.914407131537693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EREG,Proepiregulin,27023,171,1.05 [0.89-1.24],0.5397376601886765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERI1,3'-5' exoribonuclease 1,23310,148,1.14 [0.73-1.79],0.5673726163911155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERMAP,Erythroid membrane-associated protein,23084,146,1.33 [0.94-1.88],0.1122749713323776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23623,149,1.59 [1.16-2.18],0.0042201774435994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP29,Endoplasmic reticulum resident protein 29,23256,143,1.08 [0.94-1.24],0.2619855396673124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP44,Endoplasmic reticulum resident protein 44,27086,172,1.02 [0.60-1.72],0.945408331282226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,22998,148,0.88 [0.61-1.27],0.502220070077832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,27587,172,2.01 [1.35-2.98],0.0005258091521515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESM1,Endothelial cell-specific molecule 1,27258,168,1.20 [0.81-1.79],0.3580436104036288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESPL1,Separin,22891,140,1.12 [0.87-1.45],0.3726732978982325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESR1,Estrogen receptor,23084,146,1.13 [0.89-1.45],0.3078279407850205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESYT2,Extended synaptotagmin-2,23705,149,1.24 [1.03-1.48],0.0230577445879652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI2B,Protein EVI2B,22891,140,0.99 [0.65-1.49],0.9438992683192864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI5,Ecotropic viral integration site 5 protein homolog,23084,146,1.14 [0.96-1.36],0.1354590424564572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVPL,Envoplakin,23310,148,1.46 [1.01-2.11],0.041899245163359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXOSC10,Exosome component 10,22998,148,0.84 [0.62-1.13],0.2533850081316117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXTL1,Exostosin-like 1,22998,148,0.99 [0.71-1.37],0.929607451878592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EZR,Ezrin,27496,174,1.09 [0.63-1.90],0.7511259581416045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F10,Coagulation factor X,23771,148,0.90 [0.49-1.65],0.7327235027017118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11,Coagulation factor XI,23452,146,0.90 [0.52-1.56],0.7103750753257303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11R,Junctional adhesion molecule A,27261,173,1.35 [1.07-1.69],0.0097561353289366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F12,Coagulation factor XII,23803,149,0.96 [0.67-1.39],0.8363623316255957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F13B,Coagulation factor XIII B chain,23662,148,1.00 [0.54-1.85],0.9997742678132756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2,Prothrombin,23803,149,0.95 [0.33-2.67],0.9154885247296012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2R,Proteinase-activated receptor 1,27344,169,1.38 [1.10-1.75],0.0061706372767717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F3,Tissue factor,27324,171,1.52 [0.96-2.41],0.074102191846378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F7,Coagulation factor VII,27305,172,1.45 [0.92-2.29],0.1131332450050362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F9,Coagulation factor IX,27300,172,1.04 [0.49-2.19],0.9280722491676868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",27258,168,1.27 [1.11-1.46],0.0004604787403842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP2,"Fatty acid-binding protein, intestinal",27255,172,1.21 [1.02-1.43],0.0262999413067475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",23762,150,1.51 [1.14-2.00],0.004012762919884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",27587,172,1.11 [0.85-1.45],0.4512892806173555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP5,Fatty acid-binding protein 5,27410,174,1.21 [1.01-1.46],0.0431698169892173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP6,Gastrotropin,26706,158,0.85 [0.66-1.11],0.234023601007632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP9,Fatty acid-binding protein 9,27207,172,1.00 [0.79-1.28],0.9687984714760878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FADD,FAS-associated death domain protein,27255,172,1.13 [0.95-1.35],0.1631249498298945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM13A,Protein FAM13A,23636,148,1.16 [0.93-1.46],0.1883250781979065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171A2,Protein FAM171A2,23723,148,1.08 [0.99-1.18],0.1011392022453253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171B,Protein FAM171B,23623,149,1.11 [0.65-1.90],0.6974951954678532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM172A,Cotranscriptional regulator FAM172A,23148,148,1.19 [0.92-1.53],0.1844919296505596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM20A,Pseudokinase FAM20A,23762,150,0.92 [0.53-1.60],0.7648384967157743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3B,Protein FAM3B,27133,172,1.57 [1.07-2.29],0.0196602203668137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,27210,172,1.87 [1.21-2.90],0.0048330069285797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3D,Protein FAM3D,23636,148,1.20 [0.99-1.44],0.0594188007922762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAP,Prolyl endopeptidase FAP,27587,172,0.75 [0.46-1.23],0.2580005013291579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FARSA,Phenylalanine--tRNA ligase alpha subunit,23097,146,1.04 [0.84-1.30],0.7044239210673517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAS,Tumor necrosis factor receptor superfamily member 6,27498,172,1.50 [1.13-2.00],0.005578623654268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FASLG,Tumor necrosis factor ligand superfamily member 6,27538,173,0.82 [0.57-1.17],0.2742549330895075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBLN2,Fibulin-2,23755,147,1.32 [0.82-2.14],0.2589020444319151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBN2,Fibrillin-2,23097,146,0.85 [0.65-1.10],0.2171425582529295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBP1,"Fructose-1,6-bisphosphatase 1",27255,172,0.99 [0.82-1.18],0.8801755323916016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23762,150,1.18 [0.95-1.45],0.1298019681359068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAR,Immunoglobulin alpha Fc receptor,27207,172,1.02 [0.77-1.35],0.9069399736000444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23723,148,1.33 [0.70-2.53],0.3771250983652323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER2,Low affinity immunoglobulin epsilon Fc receptor,27261,173,0.86 [0.65-1.14],0.2813101855837622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27128,172,1.06 [0.84-1.33],0.6369822620220216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,26616,166,0.99 [0.78-1.26],0.9624887960565744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27261,172,1.13 [0.86-1.48],0.3913317807426878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN1,Ficolin-1,23722,148,0.98 [0.75-1.28],0.880609890011946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN2,Ficolin-2,27134,172,1.10 [0.79-1.54],0.5802282173432586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL1,Fc receptor-like protein 1,27255,172,0.80 [0.59-1.08],0.1471078671283639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL2,Fc receptor-like protein 2,27407,171,1.05 [0.80-1.37],0.7260175947661108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL3,Fc receptor-like protein 3,26707,161,1.12 [0.88-1.44],0.3555330506485409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL5,Fc receptor-like protein 5,27261,173,0.99 [0.78-1.25],0.913041130414792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL6,Fc receptor-like protein 6,27207,172,1.05 [0.87-1.28],0.6036632103794992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRLB,Fc receptor-like B,26616,166,1.22 [1.00-1.48],0.0454976128232837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX1,"Adrenodoxin, mitochondrial",22998,148,1.10 [0.87-1.38],0.4338290167899755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX2,"Ferredoxin-2, mitochondrial",22998,148,1.08 [0.83-1.40],0.5575271421409448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FEN1,Flap endonuclease 1,26616,166,1.08 [0.89-1.30],0.4505271414497483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FES,Tyrosine-protein kinase Fes/Fps,26616,166,1.06 [0.80-1.41],0.6645370592443672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FETUB,Fetuin-B,27300,172,0.87 [0.59-1.28],0.4876390239117927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGA,Fibrinogen alpha chain,23224,145,0.54 [0.33-0.91],0.0208309894866952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23723,148,1.17 [0.97-1.42],0.1076165222710588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF12,Fibroblast growth factor 12,23084,146,0.86 [0.57-1.29],0.4718963300912102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF16,Fibroblast growth factor 16,23084,146,1.02 [0.74-1.41],0.9131415132469474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF19,Fibroblast growth factor 19,27391,171,1.06 [0.89-1.26],0.5019750975567685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF2,Fibroblast growth factor 2,27207,172,1.26 [1.04-1.52],0.0181969214840972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF20,Fibroblast growth factor 20,23084,146,1.03 [0.73-1.46],0.8500137080705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF21,Fibroblast growth factor 21,27437,171,1.09 [0.97-1.22],0.1346081066984487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,27442,170,1.28 [1.05-1.55],0.0122014045637904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF3,Fibroblast growth factor 3,23084,146,0.65 [0.34-1.22],0.1801887463076251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,26707,161,1.34 [0.89-2.02],0.1601943211102834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF6,Fibroblast growth factor 6,23084,146,0.74 [0.47-1.17],0.199991280182254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF7,Fibroblast growth factor 7,22891,140,1.03 [0.85-1.26],0.7494590954003167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF9,Fibroblast growth factor 9,22849,140,0.85 [0.58-1.25],0.4057830008949401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP1,Fibroblast growth factor-binding protein 1,27351,173,0.65 [0.43-0.97],0.0367909016867625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP2,Fibroblast growth factor-binding protein 2,23755,147,0.87 [0.63-1.19],0.3726097876009476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP3,Fibroblast growth factor-binding protein 3,23705,149,1.32 [0.86-2.01],0.2070921417773641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR2,Fibroblast growth factor receptor 2,27351,173,2.52 [1.42-4.49],0.0016734125202386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR4,Fibroblast growth factor receptor 4,23256,143,0.94 [0.69-1.26],0.6631274498151314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,23771,148,1.21 [0.94-1.55],0.1368148951025324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGR,Tyrosine-protein kinase Fgr,26588,162,1.14 [0.93-1.41],0.2074701607373487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FH,"Fumarate hydratase, mitochondrial",22986,143,0.95 [0.78-1.16],0.6304539812298233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIP2A,FHF complex subunit HOOK interacting protein 2A,22998,148,1.20 [0.92-1.55],0.1803188256267317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIT,Bis(5'-adenosyl)-triphosphatase,26588,162,1.06 [0.88-1.27],0.5638695961333314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FIS1,Mitochondrial fission 1 protein,27262,171,1.10 [0.93-1.31],0.2578456859872349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23723,148,1.07 [0.91-1.25],0.3956721394443998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,27317,167,1.07 [0.95-1.20],0.2933248573920407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27073,171,1.37 [1.01-1.86],0.0426250143238337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27073,171,1.16 [1.01-1.35],0.0402713890042411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,26538,162,1.17 [0.90-1.52],0.2406116445707555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBPL,FK506-binding protein-like,23636,148,1.28 [0.99-1.67],0.0595973848612376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLI1,Friend leukemia integration 1 transcription factor,26616,166,1.08 [0.96-1.23],0.2033141630815089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27073,171,1.40 [0.87-2.25],0.1647107678989006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT1,Vascular endothelial growth factor receptor 1,27090,172,0.91 [0.48-1.71],0.7673994477231141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3,Receptor-type tyrosine-protein kinase FLT3,26616,166,1.16 [0.77-1.75],0.4758397735718918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3LG,Fms-related tyrosine kinase 3 ligand,27538,173,0.88 [0.58-1.32],0.5321688525190655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT4,Vascular endothelial growth factor receptor 3,27351,173,0.99 [0.67-1.49],0.9765320891332464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMNL1,Formin-like protein 1,26588,162,1.13 [0.94-1.36],0.2051371829917292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMR1,Synaptic functional regulator FMR1,26616,166,1.32 [0.90-1.93],0.1579457911734801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FN1,Fibronectin,23803,149,1.18 [0.66-2.13],0.5701222026808092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNDC1,Fibronectin type III domain-containing protein 1,23705,149,1.29 [0.92-1.82],0.1384062542123943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23623,149,1.56 [1.11-2.17],0.0093699231307575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLH1,Glutamate carboxypeptidase 2,23084,146,1.07 [0.94-1.23],0.3044158269818934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR1,Folate receptor alpha,27218,173,1.67 [1.06-2.64],0.0273923736670705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,27496,174,1.30 [0.83-2.03],0.2570559900471293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR3,Folate receptor gamma,27264,173,0.99 [0.92-1.07],0.8284683180118753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOS,Proto-oncogene c-Fos,22849,140,0.88 [0.56-1.40],0.5957442308552587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOSB,Protein fosB,26588,162,0.95 [0.66-1.37],0.7972504148420894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXJ3,Forkhead box protein J3,23084,146,1.31 [0.96-1.78],0.0858660787455249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO1,Forkhead box protein O1,27207,172,1.12 [0.96-1.32],0.1523832739641089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO3,Forkhead box protein O3,26616,166,1.07 [0.93-1.23],0.3660252736109673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD4B,FERM domain-containing protein 4B,22998,148,1.15 [0.92-1.42],0.214713029445192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD7,FERM domain-containing protein 7,23097,146,0.83 [0.51-1.34],0.4380461995250612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRZB,Secreted frizzled-related protein 3,26979,170,0.74 [0.45-1.22],0.2376615781483644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSHB,Follitropin subunit beta,23148,148,1.10 [0.87-1.39],0.4357732625063347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FST,Follistatin,27344,169,1.05 [0.81-1.37],0.7001325733737693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL1,Follistatin-related protein 1,23148,148,1.97 [1.04-3.72],0.0368131572717771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,27213,168,1.82 [1.22-2.72],0.0032962885022652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FTCD,Formimidoyltransferase-cyclodeaminase,23664,149,1.11 [0.93-1.32],0.2511779354302202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUCA1,Tissue alpha-L-fucosidase,27432,171,0.89 [0.76-1.04],0.1549004308787926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUOM,Fucose mutarotase,23256,143,1.17 [0.92-1.49],0.2055076497229976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FURIN,Furin,27351,173,1.23 [0.82-1.83],0.3123194202146839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUS,RNA-binding protein FUS,26574,165,1.17 [0.83-1.63],0.3732972450271308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23261,148,1.04 [0.82-1.32],0.719756155741035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,27496,174,1.21 [0.91-1.61],0.1996738230631048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT8,"Alpha-(1,6)-fucosyltransferase",27073,171,1.00 [0.80-1.26],0.9713482231197824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXN,"Frataxin, mitochondrial",27485,171,1.12 [0.94-1.34],0.2189810379115332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXYD5,FXYD domain-containing ion transport regulator 5,26707,161,1.14 [0.93-1.40],0.2183747770611932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FYB1,FYN-binding protein 1,27220,173,1.11 [0.96-1.28],0.1692586388162061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD10,Frizzled-10,23097,146,0.75 [0.54-1.04],0.0842323924008432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD8,Frizzled-8,22986,143,1.16 [0.84-1.62],0.3706603076193749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAP,Gamma-aminobutyric acid receptor-associated protein,23623,149,1.27 [0.98-1.66],0.0749780975728601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23310,148,0.98 [0.77-1.26],0.895694621696671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,22986,143,0.77 [0.57-1.04],0.0843129002505928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD1,Glutamate decarboxylase 1,22891,140,0.92 [0.49-1.71],0.7879118122319488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD2,Glutamate decarboxylase 2,23084,146,0.90 [0.63-1.30],0.5901615852041404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23310,148,0.91 [0.64-1.29],0.5967989405954823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23148,148,1.19 [0.89-1.58],0.2413858227399504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAGE2A,G antigen 2A,22891,140,0.95 [0.73-1.25],0.7309889227749373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAL,Galanin peptides,27391,171,0.81 [0.65-1.00],0.0530681536085474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27133,172,1.63 [1.02-2.60],0.0414205965177326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,27485,171,0.96 [0.57-1.62],0.8851051735191768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,26707,161,1.10 [0.79-1.53],0.5768809080441526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23762,150,1.41 [0.82-2.43],0.215427761757346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT7,N-acetylgalactosaminyltransferase 7,27133,172,0.84 [0.44-1.57],0.5798618721382207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAMT,Guanidinoacetate N-methyltransferase,22998,148,1.34 [0.99-1.83],0.0596693397126684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22748,138,1.38 [0.82-2.32],0.2274734566897059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GART,Trifunctional purine biosynthetic protein adenosine-3,23723,148,0.96 [0.53-1.72],0.891686266772762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS2,Growth arrest-specific protein 2,23310,148,1.02 [0.76-1.37],0.8819402299442924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS6,Growth arrest-specific protein 6,27401,172,1.96 [1.17-3.29],0.011102205644362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GASK1A,Golgi-associated kinase 1A,22998,148,1.07 [0.74-1.53],0.7248308006276376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAST,Gastrin,23705,149,1.12 [1.01-1.24],0.0309744833429734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22891,140,0.83 [0.45-1.54],0.5604866853591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23148,148,1.18 [0.97-1.43],0.0942165319671862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBA,Lysosomal acid glucosylceramidase,23097,146,1.25 [0.95-1.64],0.111619872548964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP1,Guanylate-binding protein 1,23665,149,1.28 [1.02-1.60],0.033914738606882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP2,Guanylate-binding protein 2,26707,161,1.05 [0.83-1.32],0.7087347659477434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,26588,162,1.09 [0.82-1.43],0.5663923715218633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP6,Guanylate-binding protein 6,22998,148,0.81 [0.55-1.21],0.3124954614864753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GC,Vitamin D-binding protein,23803,149,0.96 [0.53-1.76],0.9025018771128922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCC1,GRIP and coiled-coil domain-containing protein 1,23705,149,1.11 [0.96-1.28],0.1700014006256228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCG,Pro-glucagon,26616,166,1.10 [0.98-1.22],0.0940571936378483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22696,136,0.98 [0.70-1.38],0.9250722379789604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCLM,Glutamate--cysteine ligase regulatory subunit,22998,148,1.12 [0.83-1.52],0.445163193666365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27133,172,1.58 [1.09-2.30],0.0169311131571873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,27587,172,1.73 [1.40-2.13],2.8239162174537415e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF2,Growth/differentiation factor 2,27255,172,1.10 [0.76-1.61],0.6099822813220631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDNF,Glial cell line-derived neurotrophic factor,26588,162,1.53 [1.11-2.10],0.0086873323654919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GET3,ATPase GET3,23762,150,1.03 [0.79-1.35],0.805249835988265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFAP,Glial fibrillary acidic protein,26574,166,1.27 [0.95-1.69],0.1061847118200175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFER,FAD-linked sulfhydryl oxidase ALR,26616,166,1.25 [1.02-1.54],0.0336502861662775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,26616,166,0.94 [0.83-1.06],0.2936434777517682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,27437,171,2.47 [1.58-3.86],6.966212080689862e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA2,GDNF family receptor alpha-2,27133,172,1.42 [0.76-2.65],0.2708640286982656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA3,GDNF family receptor alpha-3,26989,171,1.25 [0.78-2.00],0.3461206938557964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRAL,GDNF family receptor alpha-like,22986,142,0.90 [0.69-1.18],0.4507300451386308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGA1,ADP-ribosylation factor-binding protein GGA1,26588,162,0.94 [0.76-1.17],0.589677999029069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGACT,Gamma-glutamylaminecyclotransferase,23762,150,1.22 [0.99-1.51],0.0676825841188872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGCT,Gamma-glutamylcyclotransferase,23715,150,1.19 [0.87-1.62],0.2880052588922397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGH,Gamma-glutamyl hydrolase,26781,168,1.10 [0.74-1.63],0.6400467765734549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,27221,173,1.49 [1.17-1.89],0.0010104551940513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT5,Glutathione hydrolase 5 proenzyme,27073,171,1.43 [0.81-2.53],0.2159542855446055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH1,Somatotropin,27210,172,1.04 [0.96-1.12],0.3643208976044642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH2,Growth hormone variant,26616,166,0.98 [0.90-1.07],0.6767313240049883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,23256,143,0.62 [0.35-1.08],0.0926005049700404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRHR,Growth hormone-releasing hormone receptor,26588,162,0.97 [0.75-1.25],0.784955354566328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRL,Appetite-regulating hormone,27255,172,1.03 [0.87-1.22],0.707664826581254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GID8,Glucose-induced degradation protein 8 homolog,23723,148,1.18 [0.78-1.80],0.4308903460562971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIGYF2,GRB10-interacting GYF protein 2,23723,148,1.31 [1.08-1.59],0.0061011578801861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP7,GTPase IMAP family member 7,23256,143,1.01 [0.62-1.64],0.9627167697891316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP8,GTPase IMAP family member 8,22891,140,1.17 [0.89-1.54],0.2674016886404076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIP,Gastric inhibitory polypeptide,23148,148,0.98 [0.74-1.31],0.9083064574372444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC2,PDZ domain-containing protein GIPC2,23705,149,1.26 [0.75-2.10],0.3847501597904856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC3,PDZ domain-containing protein GIPC3,23636,148,1.12 [0.95-1.32],0.1636822765300604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPR,Gastric inhibitory polypeptide receptor,23084,146,0.74 [0.50-1.10],0.1379325837236303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIT1,ARF GTPase-activating protein GIT1,23084,146,1.12 [0.95-1.32],0.166011193334259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GJA8,Gap junction alpha-8 protein,22891,140,1.04 [0.81-1.33],0.7778358342439854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GKN1,Gastrokine-1,26065,157,1.27 [0.77-2.11],0.3460616959162048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLA,Alpha-galactosidase A,23208,143,1.40 [0.92-2.12],0.1156157079532845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLB1,Beta-galactosidase,27073,171,1.30 [0.94-1.79],0.1138712684601718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLI2,Zinc finger protein GLI2,23084,146,1.21 [0.78-1.87],0.4023232274219172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLO1,Lactoylglutathione lyase,26751,160,1.03 [0.82-1.31],0.7925404005080579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLOD4,Glyoxalase domain-containing protein 4,27215,169,1.34 [0.92-1.95],0.1214366988761572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLP1R,Glucagon-like peptide 1 receptor,22986,143,1.29 [0.91-1.84],0.1505076922430701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX,Glutaredoxin-1,27079,171,1.03 [0.82-1.30],0.788119289606773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23256,143,1.12 [0.94-1.34],0.2057728155544583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,26588,162,0.83 [0.59-1.16],0.2764295491690477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLYR1,Putative oxidoreductase GLYR1,23623,149,0.94 [0.72-1.24],0.6745329182916776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GM2A,Ganglioside GM2 activator,23175,142,1.17 [0.82-1.69],0.3854842621327526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMFG,Glia maturation factor gamma,23762,150,1.16 [0.93-1.44],0.1769159312177204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR,GMP reductase 1,27538,173,1.08 [0.83-1.41],0.5622600348685856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR2,GMP reductase 2,23256,143,1.12 [0.88-1.41],0.3514238043512998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNAS,Neuroendocrine secretory protein 55,23723,148,1.06 [0.89-1.25],0.513416638987704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,26616,166,1.19 [0.97-1.45],0.0891014918619979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23097,146,1.11 [0.85-1.45],0.4381818104603171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNLY,Granulysin,27261,173,1.08 [0.83-1.40],0.5517708096481877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA1,Glucosamine-6-phosphate isomerase 1,23148,148,1.00 [0.62-1.62],0.9837019175301512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA2,Glucosamine-6-phosphate isomerase 2,23256,143,1.37 [0.89-2.09],0.1529578755098272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLGA3,Golgin subfamily A member 3,23723,148,1.17 [0.97-1.42],0.1082748940347103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLM2,Protein GOLM2,27496,174,1.65 [0.94-2.89],0.0810835532865182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27207,172,1.11 [0.97-1.27],0.1438285582865776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GORASP2,Golgi reassembly-stacking protein 2,23636,148,1.42 [1.04-1.94],0.0272999595364127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOT1,"Aspartate aminotransferase, cytoplasmic",23755,147,1.34 [0.94-1.91],0.1015762035113716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BA,Platelet glycoprotein Ib alpha chain,27124,171,1.50 [1.00-2.25],0.051004267681256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BB,Platelet glycoprotein Ib beta chain,22998,148,1.20 [0.95-1.52],0.125075116179545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,26413,160,1.09 [0.94-1.28],0.2576310471396569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP5,Platelet glycoprotein V,23256,143,1.06 [0.68-1.65],0.809968185763006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP6,Platelet glycoprotein VI,27220,173,1.14 [0.98-1.33],0.0875132714721048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPA33,Cell surface A33 antigen,27133,172,0.98 [0.89-1.08],0.6495762668421747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC1,Glypican-1,27485,171,1.44 [0.91-2.27],0.1182139376710717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC5,Glypican-5,27073,171,0.96 [0.76-1.22],0.745914768500874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPD1,Glycerol-3-phosphate dehydrogenase,23623,149,1.21 [0.91-1.60],0.195209837145351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPHA2,Glycoprotein hormone alpha-2,23636,148,0.96 [0.69-1.34],0.8133587152465956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPI,Glucose-6-phosphate isomerase,23771,148,1.35 [0.99-1.85],0.0597313116800138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23636,148,0.93 [0.75-1.15],0.5033549481903568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPKOW,G-patch domain and KOW motifs-containing protein,26588,162,0.97 [0.59-1.60],0.9187881035000875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,26510,169,1.37 [0.84-2.22],0.2065654333899604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR101,Probable G-protein coupled receptor 101,22986,143,0.69 [0.49-0.98],0.0399442348088089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR158,Probable G-protein coupled receptor 158,23723,148,1.20 [0.82-1.75],0.3443634343087988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,23636,148,1.46 [1.16-1.85],0.0015054794609228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,26751,160,1.39 [1.13-1.71],0.001976357946997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPRC5C,G-protein coupled receptor family C group 5 member C,23623,149,1.25 [0.99-1.58],0.0637904796600401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRAP2,GRB2-related adapter protein 2,27255,172,1.05 [0.94-1.16],0.3918492006116654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23762,150,1.26 [1.00-1.60],0.0529804768345613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIK2,"Glutamate receptor ionotropic, kainate 2",23723,148,1.31 [0.97-1.78],0.0786762164267174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",22986,143,1.07 [0.82-1.39],0.6187723391075681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRK5,G protein-coupled receptor kinase 5,26751,160,1.05 [0.81-1.37],0.7141347947986058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRN,Progranulin,27138,170,1.66 [0.96-2.88],0.0686435618620241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRP,Gastrin-releasing peptide,23148,148,1.02 [0.76-1.35],0.9097166866392518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRPEL1,"GrpE protein homolog 1, mitochondrial",27133,172,1.26 [1.03-1.55],0.0251389153387462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRSF1,G-rich sequence factor 1,22768,140,1.02 [0.83-1.25],0.8360865719959487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSAP,Gamma-secretase-activating protein,26616,166,1.10 [0.96-1.26],0.1781268476207532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSN,Gelsolin,23689,146,1.14 [0.49-2.65],0.7552021567938572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSR,"Glutathione reductase, mitochondrial",23629,146,1.86 [0.92-3.77],0.0836714658368636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA1,Glutathione S-transferase A1,27214,172,1.03 [0.88-1.21],0.7053549750765427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA3,Glutathione S-transferase A3,26616,166,1.10 [0.93-1.31],0.2524054096709629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTM4,Glutathione S-transferase Mu 4,22998,148,1.03 [0.83-1.28],0.7652330094764982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTP1,Glutathione S-transferase P,26420,161,1.22 [1.02-1.46],0.0315887380264114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTT2B,Glutathione S-transferase theta-2B,23705,149,1.06 [0.99-1.13],0.0969945428548614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23310,148,1.05 [0.86-1.28],0.6504040576036219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTPBP2,GTP-binding protein 2,23097,146,1.13 [0.93-1.37],0.225151164019049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,27134,171,1.75 [1.19-2.57],0.004695360009834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCY2C,Heat-stable enterotoxin receptor,23310,148,0.95 [0.78-1.16],0.6226294620805086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUK1,Guanylate kinase,22998,148,1.21 [0.85-1.71],0.293483095214575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUSB,Beta-glucuronidase,27380,171,1.32 [1.07-1.62],0.0106838358829746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GYS1,"Glycogen [starch] synthase, muscle",26751,160,1.14 [0.98-1.33],0.0838696339451187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMA,Granzyme A,27538,173,1.06 [0.73-1.54],0.7586999494536999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMB,Granzyme B,27207,172,1.03 [0.83-1.27],0.8123028137897537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMH,Granzyme H,26751,160,0.99 [0.82-1.20],0.9199448564653678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),H2AP,Huntingtin-interacting protein M,22891,140,1.15 [0.88-1.50],0.3040559652408907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",22998,148,0.99 [0.78-1.26],0.9481022623147124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",27400,171,0.99 [0.83-1.19],0.9362773986201616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAO1,Hydroxyacid oxidase 1,27485,171,1.08 [0.98-1.19],0.1295121901679183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HARS1,"Histidine--tRNA ligase, cytoplasmic",27261,173,1.17 [0.98-1.39],0.0765531555072501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,27448,171,1.30 [1.05-1.60],0.0139547989976499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,27261,173,1.61 [1.12-2.33],0.0107883297723795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBEGF,Proheparin-binding EGF-like growth factor,27400,171,1.17 [0.97-1.40],0.1022169232766422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBQ1,Hemoglobin subunit theta-1,27485,171,0.88 [0.70-1.10],0.2619833174013844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBZ,Hemoglobin subunit zeta,23762,150,0.94 [0.81-1.09],0.4233697558925985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCG22,Protein PBMUCL2,22998,148,0.96 [0.71-1.31],0.8060454162060058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCLS1,Hematopoietic lineage cell-specific protein,27538,173,1.16 [0.91-1.47],0.2428896833451832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC8,Histone deacetylase 8,23084,146,1.22 [1.00-1.50],0.0499189824622507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC9,Histone deacetylase 9,22986,143,0.89 [0.67-1.19],0.4346736848529136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDDC2,5'-deoxynucleotidase HDDC2,23636,148,1.12 [0.80-1.58],0.5082313988710974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGF,Hepatoma-derived growth factor,27450,171,1.11 [0.96-1.27],0.1575322004730085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGFL2,Hepatoma-derived growth factor-related protein 2,23705,149,1.16 [0.92-1.47],0.2070917140440788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEBP1,Heme-binding protein 1,26751,160,0.92 [0.71-1.20],0.5597705608800744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEG1,Protein HEG homolog 1,23256,143,1.65 [0.90-3.00],0.1034034885020095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPACAM2,HEPACAM family member 2,23705,149,0.71 [0.48-1.03],0.0742193702985559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPH,Hephaestin,23762,150,1.96 [1.07-3.61],0.0304155562419603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEXIM1,Protein HEXIM1,27207,172,1.12 [0.95-1.31],0.1912360163480256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGF,Hepatocyte growth factor,27538,173,1.43 [0.98-2.08],0.0607857273457326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGFAC,Hepatocyte growth factor activator,23536,144,0.82 [0.50-1.35],0.4356577584096187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,26616,166,1.09 [0.92-1.30],0.3284955341287085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HHEX,Hematopoietically-expressed homeobox protein HHEX,23705,149,1.26 [1.03-1.54],0.0267397669814573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIF1A,Hypoxia-inducible factor 1-alpha,23084,146,0.90 [0.69-1.18],0.4396321525472574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1,Huntingtin-interacting protein 1,22998,148,0.95 [0.59-1.53],0.8304618658848315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1R,Huntingtin-interacting protein 1-related protein,23662,149,1.51 [1.17-1.94],0.0013168399912161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HJV,Hemojuvelin,23723,148,1.16 [0.85-1.59],0.3378143644722858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HK2,Hexokinase-2,26751,160,1.04 [0.63-1.71],0.8766607595733623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-A,"HLA class I histocompatibility antigen, A alpha chain",23723,148,1.12 [0.69-1.81],0.6479669637409495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27129,171,1.25 [0.87-1.80],0.225221366286877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27207,172,1.66 [1.07-2.56],0.0222540347578435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMBS,Porphobilinogen deaminase,27485,171,1.02 [0.76-1.37],0.8882534216934024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMCN2,Hemicentin-2,23214,143,1.13 [0.85-1.51],0.3902688909804062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23148,148,1.30 [0.98-1.74],0.0706756411366627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",22998,148,1.27 [0.94-1.73],0.1187587606297828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMMR,Hyaluronan mediated motility receptor,22851,140,1.14 [0.85-1.54],0.3841597266372074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX1,Heme oxygenase 1,26941,171,1.04 [0.78-1.39],0.7782420416993503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX2,Heme oxygenase 2,26588,162,1.43 [1.12-1.83],0.0038948639619545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNF1A,Hepatocyte nuclear factor 1-alpha,23097,146,0.77 [0.57-1.03],0.0760328557185624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,26941,171,1.28 [0.96-1.69],0.0913610491840084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,26673,160,1.07 [0.89-1.28],0.4712979520300224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23723,148,1.15 [0.85-1.56],0.3494785274486901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPCAL1,Hippocalcin-like protein 1,27538,173,1.09 [0.91-1.31],0.3615973035108751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPGDS,Hematopoietic prostaglandin D synthase,26616,166,0.79 [0.54-1.14],0.206498150148412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPSE,Heparanase,23426,144,1.07 [0.90-1.27],0.4265711027945702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRAS,GTPase Hras,23266,148,0.99 [0.85-1.16],0.9167188098135828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23148,148,1.29 [0.89-1.85],0.1747174685089356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRG,Histidine-rich glycoprotein,23662,148,1.28 [0.78-2.10],0.3324363447881579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS1BP3,HCLS1-binding protein 3,23148,148,1.14 [0.95-1.36],0.1482355155526607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27133,172,1.28 [0.90-1.81],0.1694376591837338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,27485,171,1.05 [0.71-1.55],0.8020847130379823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23084,146,1.89 [1.18-3.01],0.0077996839523246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSBP1,Heat shock factor-binding protein 1,23148,148,1.07 [0.91-1.27],0.398546421784826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27207,172,1.61 [1.14-2.26],0.0064552708486582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23705,149,1.20 [0.94-1.52],0.1484744758269052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B3,Testosterone 17-beta-dehydrogenase 3,22998,148,1.27 [0.96-1.67],0.0919442252172461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23148,148,0.96 [0.68-1.34],0.7938096297964767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSP90B1,Endoplasmin,26455,162,1.02 [0.83-1.25],0.869868750718306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA1A,Heat shock 70 kDa protein 1A,27351,171,1.05 [0.87-1.26],0.6354135105478232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA2,Heat shock-related 70 kDa protein 2,23623,149,1.46 [0.99-2.15],0.0587967192995642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB1,Heat shock protein beta-1,26808,170,1.19 [0.96-1.47],0.1097532680757676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,27485,171,1.35 [0.95-1.92],0.0966095271266191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27035,172,1.83 [1.15-2.92],0.0112357802920146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1A,5-hydroxytryptamine receptor 1A,22986,143,1.02 [0.84-1.24],0.8373440374302881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1B,5-hydroxytryptamine receptor 1B,22986,143,1.05 [0.73-1.51],0.7800382548316862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTRA2,"Serine protease HTRA2, mitochondrial",27351,173,1.24 [1.00-1.53],0.0498508687531566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYAL1,Hyaluronidase-1,27075,172,1.36 [0.76-2.41],0.3007163512814635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYOU1,Hypoxia up-regulated protein 1,27587,172,2.32 [1.27-4.23],0.0061216365229768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICA1,Islet cell autoantigen 1,26707,161,1.23 [1.04-1.46],0.0175336475818546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM1,Intercellular adhesion molecule 1,27129,172,2.12 [1.39-3.25],0.0005177858632504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM2,Intercellular adhesion molecule 2,27587,172,1.51 [0.98-2.33],0.0610176843262317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,27587,172,1.43 [0.85-2.39],0.1757612362656775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM4,Intercellular adhesion molecule 4,27207,172,0.85 [0.66-1.09],0.2003300769142055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM5,Intercellular adhesion molecule 5,27255,172,1.02 [0.75-1.38],0.8964969932350142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICOSLG,ICOS ligand,27133,172,1.44 [0.72-2.89],0.3071359694088288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ID4,DNA-binding protein inhibitor ID-4,23310,148,1.18 [0.87-1.60],0.2741428539858978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,26588,162,1.11 [0.83-1.47],0.4813843788107325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDO1,"Indoleamine 2,3-dioxygenase 1",23148,148,1.25 [1.00-1.55],0.046569267965509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDS,Iduronate 2-sulfatase,27538,173,0.59 [0.13-2.62],0.4867468298484865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDUA,Alpha-L-iduronidase,27485,171,0.77 [0.58-1.02],0.070074500404566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23054,144,1.82 [1.27-2.61],0.0012006524938366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23310,148,1.10 [0.83-1.46],0.4862283132738433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23310,148,1.35 [0.93-1.96],0.1171382962399515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNAR1,Interferon alpha/beta receptor 1,23636,148,1.14 [0.64-2.05],0.6542553790885655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNG,Interferon gamma,26707,161,1.00 [0.88-1.13],0.9859248770110708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,27391,171,2.04 [1.08-3.88],0.0288363793138451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR2,Interferon gamma receptor 2,27073,171,1.24 [0.97-1.59],0.0892695477189681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL1,Interferon lambda-1,26588,162,1.32 [1.00-1.76],0.0535845016162802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL2,Interferon lambda-2,22986,143,0.88 [0.67-1.17],0.3933124224188173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNLR1,Interferon lambda receptor 1,27207,172,1.37 [1.01-1.86],0.0439997546351075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNW1,Interferon omega-1,22998,148,1.19 [0.82-1.73],0.348694399147434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFT20,Intraflagellar transport protein 20 homolog,23097,146,1.15 [0.81-1.63],0.4237720740173054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGBP1,Immunoglobulin-binding protein 1,23723,148,1.10 [0.86-1.41],0.4427086149449877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,22986,143,0.94 [0.67-1.33],0.7352840676059039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23755,147,0.93 [0.51-1.71],0.8173476040994659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF1R,Insulin-like growth factor 1 receptor,27133,172,1.48 [0.88-2.52],0.1425648869923097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,22998,148,1.08 [0.78-1.49],0.6275345431415005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2R,Cation-independent mannose-6-phosphate receptor,27261,173,2.13 [1.19-3.82],0.0106666587946558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP1,Insulin-like growth factor-binding protein 1,27537,172,1.03 [0.92-1.16],0.578286436625395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,27542,172,1.17 [0.95-1.45],0.1349914291727861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP3,Insulin-like growth factor-binding protein 3,27347,172,0.68 [0.43-1.07],0.0938065492404192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,26891,169,1.57 [1.18-2.10],0.0022516184784294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP6,Insulin-like growth factor-binding protein 6,27126,170,1.53 [0.99-2.37],0.054928484655333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,27587,172,1.83 [1.28-2.60],0.0008005799178142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBPL1,Insulin-like growth factor-binding protein-like 1,27255,172,1.56 [1.07-2.26],0.0194850972506225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFL4,Insulin growth factor-like family member 4,23084,146,0.95 [0.76-1.19],0.6842761236810151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGHMBP2,DNA-binding protein SMUBP-2,22998,148,1.06 [0.81-1.40],0.6525772886572181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLC2,Immunoglobulin lambda constant 2,23752,149,1.59 [1.09-2.33],0.0162917762604933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLON5,IgLON family member 5,22891,140,0.99 [0.83-1.18],0.9178762829840924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF21,Immunoglobulin superfamily member 21,23148,148,0.91 [0.60-1.38],0.6519283536737169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF3,Immunoglobulin superfamily member 3,27133,172,1.44 [1.03-2.01],0.0344420251555602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF8,Immunoglobulin superfamily member 8,27255,172,1.63 [1.06-2.51],0.0264192150355425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF9,Protein turtle homolog A,23762,150,1.07 [0.88-1.29],0.5064028458713346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKBKG,NF-kappa-B essential modulator,27207,172,1.14 [0.98-1.32],0.0821757560604572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKZF2,Zinc finger protein Helios,26616,166,1.01 [0.87-1.17],0.9297247436266688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10,Interleukin-10,26707,161,1.01 [0.85-1.18],0.9498467375497794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RA,Interleukin-10 receptor subunit alpha,26707,161,1.19 [0.99-1.43],0.0628114139173698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,27391,171,1.35 [0.87-2.12],0.1835866388916542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL11,Interleukin-11,26707,161,0.93 [0.74-1.17],0.5405844323991393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12A_IL12B,Interleukin-12,27133,172,1.12 [0.95-1.32],0.1877553862950074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12B,Interleukin-12 subunit beta,27538,173,1.15 [0.90-1.47],0.252501630992234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,26707,161,1.30 [0.91-1.84],0.1487055733525473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB2,Interleukin-12 receptor subunit beta-2,23084,146,1.28 [0.90-1.81],0.1635702800780196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13,Interleukin-13,26707,161,0.73 [0.50-1.06],0.0993694917388492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA1,Interleukin-13 receptor subunit alpha-1,26921,172,1.49 [0.78-2.86],0.2253236308944767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA2,Interleukin-13 receptor subunit alpha-2,22986,143,1.27 [0.74-2.20],0.3876623787874633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15,Interleukin-15,27207,172,1.48 [1.01-2.16],0.0435752216032862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,26707,161,1.68 [1.13-2.49],0.0102820171513991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL16,Pro-interleukin-16,27538,173,1.04 [0.76-1.44],0.7915805594257315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17A,Interleukin-17A,26678,161,1.00 [0.73-1.39],0.985437578464309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,26707,161,1.22 [1.03-1.44],0.0246348257857552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17D,Interleukin-17D,26707,161,0.84 [0.53-1.34],0.4651898526011879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17F,Interleukin-17F,26707,161,1.09 [0.93-1.28],0.279056201225364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RA,Interleukin-17 receptor A,27261,173,1.14 [0.84-1.54],0.3936684703637916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RB,Interleukin-17 receptor B,26860,168,1.10 [0.85-1.43],0.4530164916544456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,27170,168,1.28 [0.98-1.67],0.0737692323985914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,27347,172,1.90 [1.29-2.81],0.0011763567641859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18R1,Interleukin-18 receptor 1,27538,173,1.56 [1.05-2.30],0.0258725118908573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18RAP,Interleukin-18 receptor accessory protein,26903,171,1.02 [0.95-1.11],0.5223667991948329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL19,Interleukin-19,26578,171,1.02 [0.84-1.24],0.8559704822632768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1A,Interleukin-1 alpha,26707,161,0.94 [0.72-1.23],0.6400125553366077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1B,Interleukin-1 beta,26578,161,1.11 [0.88-1.41],0.3615327857399019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R1,Interleukin-1 receptor type 1,27221,173,1.64 [0.92-2.94],0.0944168710632765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R2,Interleukin-1 receptor type 2,27216,168,2.47 [1.22-5.01],0.0118646776645594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RAP,Interleukin-1 receptor accessory protein,27261,173,1.18 [0.87-1.60],0.2788738849843987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL1,Interleukin-1 receptor-like 1,27498,172,1.46 [1.08-1.98],0.0130587802652761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL2,Interleukin-1 receptor-like 2,26707,161,1.22 [0.85-1.74],0.2862758010671189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RN,Interleukin-1 receptor antagonist protein,27214,171,1.20 [0.97-1.49],0.1002348967317762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2,Interleukin-2,26707,161,1.39 [0.89-2.18],0.1440733572524934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20,Interleukin-20,26707,161,0.93 [0.69-1.24],0.6111451825351611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RA,Interleukin-20 receptor subunit alpha,26707,161,0.70 [0.48-1.03],0.069206822398813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RB,Interleukin-20 receptor subunit beta,23084,146,0.80 [0.54-1.18],0.2656739228013658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL21R,Interleukin-21 receptor,23084,146,1.05 [0.80-1.37],0.7269155537992585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,23623,149,1.14 [0.92-1.42],0.2314633740997018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22RA1,Interleukin-22 receptor subunit alpha-1,26707,161,1.08 [0.79-1.47],0.6199723074749217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL24,Interleukin-24,26707,161,1.17 [0.91-1.50],0.2291793520955123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL25,Interleukin-25,22812,140,0.79 [0.50-1.26],0.3247376213237698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,27041,168,1.43 [1.03-1.97],0.0312117497054809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RB,Interleukin-2 receptor subunit beta,26707,161,0.86 [0.58-1.27],0.4453744225569597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RG,Cytokine receptor common subunit gamma,23623,149,1.17 [0.84-1.62],0.3570492159094037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3,Interleukin-3,22891,140,0.91 [0.70-1.19],0.4974929232742845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31,Interleukin-31,23084,146,0.91 [0.67-1.22],0.5230092100394121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31RA,Interleukin-31 receptor subunit alpha,22990,146,0.95 [0.64-1.41],0.7872645170627948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL32,Interleukin-32,27207,172,1.01 [0.74-1.38],0.9326378718224104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL33,Interleukin-33,26707,161,1.20 [0.84-1.73],0.3159232889891069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL34,Interleukin-34,26546,162,1.31 [0.88-1.95],0.1860951709378205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36A,Interleukin-36 alpha,23084,146,0.99 [0.75-1.31],0.9696700890691312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36G,Interleukin-36 gamma,22985,145,1.07 [0.86-1.34],0.5316694632158174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3RA,Interleukin-3 receptor subunit alpha,26707,161,2.00 [1.38-2.90],0.0002715142618551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4,Interleukin-4,26707,161,0.94 [0.82-1.08],0.3829476910959172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,27207,172,1.52 [1.08-2.14],0.0169906134107535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5,Interleukin-5,26707,161,0.95 [0.86-1.06],0.3703988187686906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5RA,Interleukin-5 receptor subunit alpha,27207,172,0.94 [0.74-1.20],0.6230649786302358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6,Interleukin-6,27133,172,1.05 [0.89-1.26],0.5491179748162967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6R,Interleukin-6 receptor subunit alpha,27078,172,0.91 [0.61-1.35],0.6460364422537621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6ST,Interleukin-6 receptor subunit beta,27255,172,1.91 [0.92-3.94],0.0805326805297406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7,Interleukin-7,27207,172,1.19 [0.97-1.46],0.1012985298121438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7R,Interleukin-7 receptor subunit alpha,27261,173,1.26 [0.97-1.64],0.0773326011479241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL9,Interleukin-9,23310,148,1.16 [0.92-1.45],0.2145472599693672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,26551,162,1.02 [0.80-1.31],0.8428899180734981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMMT,MICOS complex subunit MIC60,23623,149,1.57 [1.22-2.04],0.0005540761327857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPA1,Inositol monophosphatase 1,27073,171,1.11 [0.90-1.39],0.333311651498437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPACT,Protein IMPACT,23705,149,1.14 [0.87-1.50],0.3361699717558821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPG1,Interphotoreceptor matrix proteoglycan 1,22986,143,0.64 [0.35-1.17],0.1459726844038109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ING1,Inhibitor of growth protein 1,26538,162,1.23 [0.94-1.61],0.1235377886868677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBB,Inhibin beta B chain,23256,143,1.27 [0.95-1.72],0.1105445374461811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBC,Inhibin beta C chain,27261,173,1.23 [0.89-1.70],0.2099042808358303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP1,Inositol polyphosphate 1-phosphatase,27133,172,1.14 [0.89-1.45],0.2962168435713038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23148,148,1.12 [0.85-1.47],0.4171029552625011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23723,148,1.31 [0.98-1.74],0.0675065021904222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27133,172,1.07 [0.93-1.23],0.3209634503339948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL3,Insulin-like 3,23705,149,0.77 [0.61-0.97],0.0255258504231152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL4,Early placenta insulin-like peptide,23623,149,1.03 [0.77-1.38],0.8480837678373327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL5,Insulin-like peptide INSL5,23636,148,1.21 [1.04-1.41],0.0139862849837423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSR,Insulin receptor,23084,146,1.63 [0.64-4.12],0.3043742549010743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IPCEF1,Interactor protein for cytohesin exchange factors 1,27031,171,1.04 [0.89-1.21],0.6351530817382597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IQGAP2,Ras GTPase-activating-like protein IQGAP2,27133,172,1.20 [0.95-1.51],0.1327672665713516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",26751,160,1.16 [1.00-1.34],0.0477704145701209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK1,Interleukin-1 receptor-associated kinase 1,26707,161,1.19 [0.98-1.45],0.0867627718963282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK4,Interleukin-1 receptor-associated kinase 4,27207,172,1.09 [0.96-1.24],0.1945701691661244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26218,158,1.03 [0.70-1.51],0.8784596870862762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM1,Isthmin-1,27207,172,1.15 [0.82-1.63],0.4191931187054302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM2,Isthmin-2,23755,147,0.87 [0.60-1.28],0.4893361663322835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IST1,IST1 homolog,23469,147,1.14 [0.97-1.33],0.1198770566656589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA11,Integrin alpha-11,27207,172,0.86 [0.58-1.27],0.4422290879065792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA2,Integrin alpha-2,23256,143,0.92 [0.57-1.47],0.7178377091655375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,27261,173,2.29 [1.37-3.83],0.0014771285274532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA6,Integrin alpha-6,27207,172,0.94 [0.73-1.22],0.656752252920928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAL,Integrin alpha-L,23084,146,1.20 [0.83-1.73],0.3448838452656778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAM,Integrin alpha-M,27261,173,1.24 [0.82-1.89],0.3102401284254646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAV,Integrin alpha-V,27485,171,0.77 [0.33-1.75],0.5261996679189673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAX,Integrin alpha-X,23310,148,1.10 [0.84-1.45],0.4737503458478687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1,Integrin beta-1,27210,172,1.87 [1.08-3.25],0.0261627155713674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP1,Integrin beta-1-binding protein 1,26616,166,1.16 [0.84-1.61],0.3633401072773857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP2,Integrin beta-1-binding protein 2,26751,160,1.07 [0.94-1.21],0.3315207108007615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB2,Integrin beta-2,27083,171,1.38 [0.86-2.20],0.1783712288061799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB5,Integrin beta-5,27351,173,1.25 [0.89-1.76],0.19752460326139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB6,Integrin beta-6,26707,161,1.24 [0.77-1.99],0.3702416291032508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB7,Integrin beta-7,27485,171,1.43 [1.09-1.88],0.0108389040630957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGBL1,Integrin beta-like protein 1,23755,147,1.41 [0.94-2.13],0.1006142401571827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23803,149,1.50 [0.69-3.24],0.3061351754782846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,27347,172,1.20 [0.84-1.72],0.315323323503785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23803,149,1.05 [0.59-1.86],0.8658060483190851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23623,149,1.15 [0.83-1.59],0.3928736440819239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITM2A,Integral membrane protein 2A,27207,172,1.10 [0.88-1.38],0.4094144701013167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPA,Inosine triphosphate pyrophosphatase,22998,148,1.13 [0.90-1.42],0.2906709306841327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23148,148,1.20 [0.99-1.46],0.0619723271269272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",22986,143,0.84 [0.57-1.23],0.3659383564988124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",26588,162,0.90 [0.67-1.21],0.4784208712586961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IZUMO1,Izumo sperm-egg fusion protein 1,22891,140,0.99 [0.70-1.39],0.9451454197948264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM2,Junctional adhesion molecule B,27496,174,1.52 [0.93-2.48],0.0968230121580511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM3,Junctional adhesion molecule C,23256,143,1.35 [1.01-1.80],0.0425886968503212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JCHAIN,Immunoglobulin J chain,26707,161,1.15 [0.92-1.44],0.2215411645303926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22891,140,0.80 [0.58-1.11],0.179583092489486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JPT2,Jupiter microtubule associated homolog 2,23636,148,1.21 [1.01-1.45],0.0397616646407083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JUN,Transcription factor AP-1,26707,161,1.16 [0.92-1.47],0.1994528924732823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27133,172,1.02 [0.76-1.38],0.8760474266444395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZN,Kazrin,23636,148,1.14 [0.98-1.33],0.0818318090571028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNC4,Potassium voltage-gated channel subfamily C member 4,22986,143,1.09 [0.84-1.42],0.5222937927849762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNH2,Potassium voltage-gated channel subfamily H member 2,23097,146,1.05 [0.86-1.28],0.6171601074971009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNIP4,Kv channel-interacting protein 4,26588,162,1.09 [0.84-1.40],0.5234999025145035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCTD5,BTB/POZ domain-containing protein KCTD5,23264,147,1.44 [1.08-1.93],0.0140289245311012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDM3A,Lysine-specific demethylase 3A,23084,146,1.05 [0.89-1.24],0.5456156547479425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDR,Vascular endothelial growth factor receptor 2,27351,173,1.47 [0.85-2.53],0.168364541586893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KEL,Kell blood group glycoprotein,26588,162,1.05 [0.71-1.54],0.820327627702509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHDC3L,KH domain-containing protein 3,22891,140,1.01 [0.80-1.29],0.9075217765873664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHK,Ketohexokinase,23148,148,1.21 [0.95-1.55],0.1271735229867788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA0319,Dyslexia-associated protein KIAA0319,23705,149,1.19 [0.73-1.92],0.4899294644013792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549,UPF0606 protein KIAA1549,23310,148,0.91 [0.73-1.13],0.3742303437489039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549L,UPF0606 protein KIAA1549L,23310,148,1.61 [1.02-2.55],0.0405675907221751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA2013,Uncharacterized protein KIAA2013,23623,149,1.08 [0.84-1.39],0.5621052195916307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF1C,Kinesin-like protein KIF1C,22998,148,1.24 [0.86-1.78],0.2552314391603325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF20B,Kinesin-like protein KIF20B,22986,143,0.99 [0.81-1.22],0.9456176246824224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF22,Kinesin-like protein KIF22,22998,148,1.07 [0.94-1.22],0.3291450166903611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIFBP,KIF-binding protein,27133,172,1.11 [0.94-1.31],0.2263076398304329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23623,149,1.12 [0.94-1.34],0.2073976910035982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,26616,166,1.09 [0.91-1.29],0.3478341973055663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23636,148,1.07 [0.98-1.17],0.1403825061155416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,26616,166,1.03 [0.92-1.16],0.5664268184508697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22891,140,0.89 [0.71-1.11],0.300582684583592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL1,Kin of IRRE-like protein 1,22986,143,1.04 [0.80-1.35],0.7760573356846099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL2,Kin of IRRE-like protein 2,26588,162,1.34 [0.96-1.86],0.0882101641551234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIT,Mast/stem cell growth factor receptor Kit,27300,172,0.56 [0.36-0.88],0.0117646982688368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KITLG,Kit ligand,27255,172,0.91 [0.63-1.31],0.6041717760574844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLB,Beta-klotho,26588,162,1.06 [0.88-1.28],0.5352981025540555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLF4,Krueppel-like factor 4,22986,143,1.52 [1.08-2.13],0.0172038213348345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLHL41,Kelch-like protein 41,23723,148,0.90 [0.63-1.27],0.5392945156738213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK1,Kallikrein-1,26983,171,1.00 [0.90-1.11],0.9976062216793624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK10,Kallikrein-10,27260,173,1.16 [0.83-1.60],0.3847475344374825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,27089,173,1.83 [1.32-2.52],0.0002635471698307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK12,Kallikrein-12,26616,166,1.02 [0.92-1.12],0.7536562377976851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK13,Kallikrein-13,26654,169,0.99 [0.73-1.34],0.9654295203209357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK14,Kallikrein-14,27485,171,0.97 [0.73-1.30],0.8500131924658318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK15,Kallikrein-15,23585,149,1.17 [0.86-1.58],0.3208036737461661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK3,Prostate-specific antigen,23755,147,0.75 [0.57-0.99],0.0431055657632158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,27485,171,1.16 [0.93-1.43],0.1819363088094505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK6,Kallikrein-6,27311,173,0.99 [0.64-1.54],0.9819382039372768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK7,Kallikrein-7,22639,140,0.81 [0.52-1.24],0.3268422943422476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK8,Kallikrein-8,26351,170,1.15 [0.79-1.67],0.4779590674528099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLKB1,Plasma kallikrein,23324,145,0.75 [0.40-1.39],0.3556439589730767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,27538,173,1.57 [1.12-2.21],0.0088152526714181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,22986,143,1.01 [0.78-1.32],0.916226859287204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRD1,Natural killer cells antigen CD94,27538,173,1.14 [0.85-1.52],0.3810229293226872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRF1,Killer cell lectin-like receptor subfamily F member 1,23084,146,1.26 [0.95-1.67],0.1127644233331308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRK1,NKG2-D type II integral membrane protein,23705,149,1.07 [0.77-1.50],0.682424950868858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT14,"Keratin, type I cytoskeletal 14",25723,158,0.75 [0.43-1.29],0.2933158100573499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT17,"Keratin, type I cytoskeletal 17",22998,148,0.75 [0.48-1.18],0.2110600158470097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT18,"Keratin, type I cytoskeletal 18",27133,172,1.20 [1.03-1.41],0.0200488523555248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",27165,171,1.32 [1.10-1.59],0.0029877272812198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT5,"Keratin, type II cytoskeletal 5",26588,162,1.12 [0.84-1.48],0.43381801525772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT6C,"Keratin, type II cytoskeletal 6C",22998,148,0.87 [0.56-1.35],0.5261295924405573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT8,"Keratin, type II cytoskeletal 8",22986,143,1.07 [0.87-1.32],0.5240478016197019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYAT1,Kynurenine--oxoglutarate transaminase 1,27208,172,1.05 [0.83-1.33],0.6764774505393532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYNU,Kynureninase,27538,173,1.37 [1.03-1.81],0.0286030468518316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L1CAM,Neural cell adhesion molecule L1,27351,173,1.01 [0.63-1.62],0.9552002182208328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23762,150,1.20 [1.02-1.43],0.0298075827789193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACRT,Extracellular glycoprotein lacritin,23579,148,0.80 [0.57-1.12],0.1912476526658293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACTB2,Endoribonuclease LACTB2,27255,172,1.11 [0.91-1.36],0.2987323409255945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAG3,Lymphocyte activation gene 3 protein,27133,172,1.02 [0.73-1.41],0.9294623637861968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27258,168,1.79 [1.38-2.33],1.0508284715174277e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27073,171,0.99 [0.87-1.12],0.8715831932312017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA1,Laminin subunit alpha-1,22998,148,1.09 [0.84-1.42],0.5176444142625083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA4,Laminin subunit alpha-4,27391,171,1.58 [1.07-2.33],0.0222272591819906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMB1,Laminin subunit beta-1,23148,148,1.18 [0.69-2.00],0.5501897465271133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP1,Lysosome-associated membrane glycoprotein 1,23086,142,1.37 [0.93-2.00],0.1074350217268159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP2,Lysosome-associated membrane glycoprotein 2,26434,162,2.83 [1.32-6.10],0.0077284306567631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP3,Lysosome-associated membrane glycoprotein 3,27493,172,1.26 [0.97-1.63],0.0789182061454039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMTOR5,Ragulator complex protein LAMTOR5,23623,149,1.35 [0.99-1.86],0.0615875302134953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAP3,Cytosol aminopeptidase,26707,161,1.43 [1.12-1.81],0.0035738420586874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LARP1,La-related protein 1,23623,149,1.18 [0.96-1.47],0.122837852828417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT,Linker for activation of T-cells family member 1,27538,173,1.17 [0.97-1.40],0.0978723099274573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT2,Linker for activation of T-cells family member 2,27133,172,1.07 [0.96-1.19],0.2443271857940193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LATS1,Serine/threonine-protein kinase LATS1,23084,146,1.12 [0.93-1.35],0.2222993477786563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,27023,171,1.87 [1.31-2.68],0.0006412206428757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBP,Lipopolysaccharide-binding protein,27347,172,1.20 [0.95-1.51],0.1210931486784034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBR,Delta(14)-sterol reductase LBR,27496,174,1.01 [0.83-1.23],0.8972859921672773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCAT,Phosphatidylcholine-sterol acyltransferase,23771,148,0.61 [0.35-1.06],0.0779702228335452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN15,Lipocalin-15,23723,148,1.31 [1.09-1.59],0.0050770059477717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN2,Neutrophil gelatinase-associated lipocalin,26417,169,1.19 [0.84-1.68],0.3286053942259454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCP1,Plastin-2,23755,147,1.26 [0.92-1.72],0.155651882392404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLR,Low-density lipoprotein receptor,27323,168,0.81 [0.62-1.05],0.1091465701457801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLRAP1,Low density lipoprotein receptor adapter protein 1,23723,148,1.10 [0.94-1.29],0.2482577852547423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LECT2,Leukocyte cell-derived chemotaxin-2,23762,150,1.03 [0.81-1.30],0.8293194929390261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEFTY2,Left-right determination factor 2,27437,171,1.04 [0.80-1.36],0.774500057293587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEG1,Protein LEG1 homolog,22440,137,0.85 [0.67-1.09],0.2070687701155977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LELP1,Late cornified envelope-like proline-rich protein 1,22986,143,0.96 [0.77-1.20],0.7008325747596882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEO1,RNA polymerase-associated protein LEO1,23723,148,1.44 [1.08-1.92],0.0125883755201621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEP,Leptin,27255,172,0.94 [0.76-1.16],0.5636663441626093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEPR,Leptin receptor,27255,172,1.17 [0.76-1.80],0.486400667508199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LETM1,Mitochondrial proton/calcium exchanger protein,23723,148,1.41 [1.08-1.83],0.0104150059920662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS1,Galectin-1,27255,172,1.09 [0.73-1.63],0.6647657802681339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3,Galectin-3,27313,171,1.13 [0.72-1.79],0.5842850900187332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3BP,Galectin-3-binding protein,23803,149,1.59 [1.06-2.39],0.024793718917895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,27258,168,1.46 [1.15-1.84],0.0017811495898564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS7_LGALS7B,Galectin-7,27173,169,0.93 [0.66-1.31],0.6868530951144886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS8,Galectin-8,27496,174,1.11 [0.90-1.39],0.3267367694952047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,27255,169,1.84 [1.24-2.73],0.0024683988349349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGMN,Legumain,27391,171,1.54 [1.07-2.21],0.0202289369499185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHB,Lutropin subunit beta,26616,166,0.93 [0.78-1.10],0.3918450610756853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27303,171,1.15 [0.93-1.43],0.205992217377921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIF,Leukemia inhibitory factor,26588,162,0.97 [0.73-1.28],0.8238499101182705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIFR,Leukemia inhibitory factor receptor,27207,172,1.59 [0.93-2.71],0.0880247698931442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27261,173,1.12 [0.77-1.62],0.5612361674989812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23755,147,0.95 [0.86-1.06],0.3696784294819195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,22998,148,1.20 [0.92-1.56],0.1811626347994411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27210,172,1.56 [1.02-2.38],0.0393481014790008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23762,150,1.09 [0.88-1.34],0.445496567149564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,27587,172,1.57 [0.96-2.56],0.072207707966015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,27453,172,1.29 [0.87-1.91],0.2079195677904807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,26707,161,1.62 [1.20-2.19],0.0017077024907079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,27587,172,0.93 [0.77-1.12],0.4585962129139381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIPF,Gastric triacylglycerol lipase,23148,148,1.00 [0.77-1.29],0.981893578665936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB1,Lamin-B1,23589,148,1.06 [0.82-1.36],0.6679652008006176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB2,Lamin-B2,23705,149,1.90 [1.16-3.11],0.0104279496645041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD1,Leiomodin-1,23723,148,1.55 [1.12-2.17],0.0091299434562496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD2,Leiomodin-2,22986,143,1.05 [0.82-1.35],0.6802518543883631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LONP1,"Lon protease homolog, mitochondrial",23148,148,1.17 [0.98-1.40],0.0798974321353965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPA,Apolipoprotein(a),23213,143,0.93 [0.85-1.02],0.126357723053067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPCAT2,Lysophosphatidylcholine acyltransferase 2,27133,172,1.24 [0.97-1.59],0.0856492561008742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPL,Lipoprotein lipase,27255,172,0.94 [0.71-1.25],0.6629969399738486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPO,Lactoperoxidase,26418,164,1.09 [0.87-1.36],0.473424484574717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPP,Lipoma-preferred partner,22998,148,1.24 [0.98-1.57],0.0686886075955613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,22998,148,1.24 [1.00-1.54],0.0505084435109609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23097,146,1.11 [0.83-1.49],0.4851349821539682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRG1,Leucine-rich alpha-2-glycoprotein,23803,149,0.98 [0.54-1.77],0.9341633755978126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,27400,171,1.26 [0.85-1.87],0.2473223536708911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,22995,146,1.25 [0.76-2.06],0.3786463545644251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP1,Prolow-density lipoprotein receptor-related protein 1,27133,172,0.81 [0.48-1.36],0.4186082847867367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,27255,172,1.61 [1.12-2.32],0.0098136060381761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2,Low-density lipoprotein receptor-related protein 2,23097,146,1.27 [0.89-1.84],0.1921038703991312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2BP,LRP2-binding protein,23097,146,0.96 [0.79-1.16],0.6454176733673309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,27496,174,0.98 [0.77-1.24],0.8578147658772809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC25,Leucine-rich repeat-containing protein 25,27133,172,1.12 [0.80-1.58],0.511464392387919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC37A2,Leucine-rich repeat-containing protein 37A2,23636,148,1.24 [0.86-1.80],0.2502067068241417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC38,Leucine-rich repeat-containing protein 38,23097,146,1.02 [0.74-1.41],0.9133617785777948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC59,Leucine-rich repeat-containing protein 59,23762,150,1.35 [1.00-1.81],0.047438936947815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23623,149,1.44 [1.07-1.93],0.0160295459844048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRN1,Leucine-rich repeat neuronal protein 1,26707,161,0.86 [0.60-1.24],0.4194900073448715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23097,146,0.97 [0.65-1.43],0.8626648660077415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23723,148,0.89 [0.49-1.61],0.6965224870670236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM1,U6 snRNA-associated Sm-like protein LSm1,26616,166,0.90 [0.70-1.17],0.4406429354023217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM8,U6 snRNA-associated Sm-like protein LSm8,23310,148,1.13 [0.98-1.31],0.0881905716720325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSP1,Lymphocyte-specific protein 1,27207,172,1.07 [0.77-1.50],0.6832288376416299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA,Lymphotoxin-alpha,27207,172,0.74 [0.53-1.04],0.0802615535517267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA4H,Leukotriene A-4 hydrolase,27485,171,1.28 [1.02-1.59],0.0298711045258388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTB,Lymphotoxin-beta,23623,149,0.74 [0.45-1.23],0.2475548313801163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,27587,172,1.64 [1.09-2.46],0.0168677093985642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP3,Latent-transforming growth factor beta-binding protein 3,26616,166,1.46 [1.22-1.75],3.972656672658575e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,27129,168,1.80 [1.14-2.84],0.0120883143713464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTO1,Protein LTO1 homolog,26707,161,1.04 [0.75-1.44],0.8347078197443912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LUZP2,Leucine zipper protein 2,23623,149,0.97 [0.68-1.38],0.8779349411770585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LXN,Latexin,26951,170,1.03 [0.84-1.25],0.8050083930115591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,27122,170,1.51 [1.09-2.10],0.0139065171115676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY75,Lymphocyte antigen 75,27207,172,1.09 [0.77-1.55],0.6256816742963396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY9,T-lymphocyte surface antigen Ly-9,26965,165,1.28 [0.80-2.05],0.3049231044854328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,27073,171,1.53 [1.08-2.15],0.0159725700699355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYAR,Cell growth-regulating nucleolar protein,26616,166,1.02 [0.79-1.32],0.8652972365100523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYN,Tyrosine-protein kinase Lyn,27133,172,1.09 [0.93-1.28],0.3063629742957393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD1,Ly6/PLAUR domain-containing protein 1,26588,162,0.85 [0.65-1.11],0.2290863827059526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD3,Ly6/PLAUR domain-containing protein 3,27127,173,1.03 [0.69-1.52],0.8883815617835481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD8,Ly6/PLAUR domain-containing protein 8,26616,166,1.04 [0.80-1.36],0.7669273844291142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPLA2,Acyl-protein thioesterase 2,22986,143,1.07 [0.94-1.22],0.3224183811793574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23097,146,1.04 [0.89-1.20],0.6466106853989277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23803,149,1.50 [0.69-3.26],0.3087260506490095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYZL2,Lysozyme-like protein 2,22891,140,0.73 [0.44-1.21],0.2220216593050369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LZTFL1,Leucine zipper transcription factor-like protein 1,23256,143,1.09 [0.87-1.36],0.446420723414373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),M6PR,Cation-dependent mannose-6-phosphate receptor,23148,148,1.05 [0.73-1.52],0.7831256823722876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,26980,171,1.35 [1.10-1.65],0.0044760286449573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAEA,E3 ubiquitin-protein transferase MAEA,26616,166,1.08 [0.77-1.50],0.663725740717531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAG,Myelin-associated glycoprotein,23097,146,0.90 [0.65-1.27],0.5595766344294477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGEA3,Melanoma-associated antigen 3,23310,148,0.91 [0.77-1.08],0.2855616988840018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGED1,Melanoma-associated antigen D1,26616,166,1.09 [0.82-1.44],0.5510888802459676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC2,MAM domain-containing protein 2,23762,150,1.57 [1.02-2.42],0.0384914988957099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC4,Apical endosomal glycoprotein,23623,149,1.16 [0.87-1.53],0.3155698152083591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23148,148,0.99 [0.53-1.85],0.980389078754635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN2B2,Epididymis-specific alpha-mannosidase,23762,150,0.99 [0.76-1.29],0.9368909709989438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22891,140,0.81 [0.59-1.13],0.2166158168406438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANF,Mesencephalic astrocyte-derived neurotrophic factor,27391,171,1.08 [0.96-1.21],0.201171176565721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC1,MANSC domain-containing protein 1,27351,173,1.60 [0.99-2.58],0.0549978493429818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC4,MANSC domain-containing protein 4,22998,148,0.87 [0.68-1.12],0.2803188033716612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,22986,143,1.03 [0.62-1.71],0.918270620386714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,22998,148,1.10 [0.90-1.35],0.3561699475599138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2,Microtubule-associated protein 2,23705,149,1.28 [0.94-1.74],0.1227723840676994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23636,148,1.25 [0.99-1.59],0.0652879729072448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27207,172,1.08 [0.94-1.24],0.2656503598946463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,26616,166,1.13 [0.99-1.29],0.0681012094785604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27023,171,1.05 [0.93-1.19],0.4010682964237816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK13,Mitogen-activated protein kinase 13,22891,140,1.31 [0.97-1.78],0.082097270684031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK9,Mitogen-activated protein kinase 9,27207,172,0.89 [0.65-1.22],0.4605012088108567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPKAPK2,MAP kinase-activated protein kinase 2,23310,148,1.23 [1.00-1.51],0.0497956874460809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPRE3,Microtubule-associated protein RP/EB family member 3,22891,140,0.97 [0.86-1.10],0.6397142573577623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPT,Microtubule-associated protein tau,26588,162,1.30 [0.99-1.70],0.0578820234948993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARCO,Macrophage receptor MARCO,27255,172,0.74 [0.44-1.22],0.2333906898569741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARS1,"Methionine--tRNA ligase, cytoplasmic",23208,143,1.16 [0.96-1.40],0.1213206045403812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MASP1,Mannan-binding lectin serine protease 1,27023,171,1.37 [0.77-2.43],0.2856857348289171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,27306,168,1.46 [0.93-2.30],0.09957758279927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN3,Matrilin-3,27031,171,1.03 [0.67-1.58],0.8989160404064548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAVS,Mitochondrial antiviral-signaling protein,26616,166,1.12 [0.97-1.30],0.1208927931713119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAX,Protein max,26588,162,1.07 [0.93-1.22],0.3368680168799972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MB,Myoglobin,27587,172,1.16 [0.90-1.51],0.2451870286861631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MBL2,Mannose-binding protein C,23449,147,1.15 [0.99-1.34],0.0598485532764781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCAM,Cell surface glycoprotein MUC18,27347,172,1.27 [0.86-1.86],0.2275095817073092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23723,148,1.24 [0.91-1.68],0.1682105809428767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEMP1,Mast cell-expressed membrane protein 1,23084,146,1.10 [0.93-1.30],0.2782653611906415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCFD2,Multiple coagulation factor deficiency protein 2,27139,172,1.42 [1.05-1.93],0.0228098192797673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCTS1,Malignant T-cell-amplified sequence 1,23636,148,0.90 [0.48-1.69],0.7415375477773735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27073,171,1.01 [0.84-1.23],0.8925127669019228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDH1,"Malate dehydrogenase, cytoplasmic",23629,146,1.20 [0.83-1.74],0.3361348957811949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDK,Midkine,27274,173,1.36 [1.11-1.67],0.0034056241552669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDM1,Nuclear protein MDM1,23097,146,1.66 [1.04-2.65],0.0330691166932422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23148,148,1.15 [0.97-1.36],0.1004958795152391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED18,Mediator of RNA polymerase II transcription subunit 18,26616,166,1.15 [0.96-1.38],0.1237687044122407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED21,Mediator of RNA polymerase II transcription subunit 21,22998,148,0.85 [0.59-1.23],0.3931459048643188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF10,Multiple epidermal growth factor-like domains protein 10,27258,168,0.94 [0.66-1.35],0.7440436549520208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF11,Multiple epidermal growth factor-like domains protein 11,22998,148,1.23 [0.82-1.86],0.3191727984746106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF9,Multiple epidermal growth factor-like domains protein 9,27498,172,1.03 [0.53-1.99],0.927620658348602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MELTF,Melanotransferrin,23762,150,1.25 [0.74-2.12],0.4039431836882464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MENT,Protein MENT,23256,143,0.61 [0.30-1.24],0.1725473035894973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1A,Meprin A subunit alpha,23636,148,1.22 [0.99-1.51],0.0671158272861035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1B,Meprin A subunit beta,27255,172,0.91 [0.82-1.02],0.0975614230040535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEPE,Matrix extracellular phosphoglycoprotein,27258,168,1.07 [0.64-1.77],0.804688419835941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MERTK,Tyrosine-protein kinase Mer,27538,173,1.52 [0.92-2.51],0.10389868320194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MESD,LRP chaperone MESD,27261,173,1.10 [0.99-1.23],0.0819685067483797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MET,Hepatocyte growth factor receptor,27332,168,1.51 [0.77-2.94],0.2286490161095552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1,Methionine aminopeptidase 1,26588,162,1.13 [0.72-1.78],0.5884224995211067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27207,172,1.15 [0.98-1.35],0.0920222542071011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP2,Methionine aminopeptidase 2,27437,171,1.18 [0.93-1.50],0.1630183926324453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3,Microfibril-associated glycoprotein 3,26751,160,1.07 [0.82-1.39],0.634737989508392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3L,Microfibrillar-associated protein 3-like,23097,146,1.14 [0.93-1.39],0.2184884866221873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP4,Microfibril-associated glycoprotein 4,23256,143,1.76 [1.07-2.90],0.0253872659251996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP5,Microfibrillar-associated protein 5,27587,172,1.16 [0.84-1.62],0.370570465466988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFGE8,Lactadherin,27261,173,1.27 [0.94-1.72],0.1267340273402827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGLL,Monoglyceride lipase,27344,169,1.08 [0.92-1.27],0.3183847802405147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGMT,Methylated-DNA--protein-cysteine methyltransferase,27207,172,1.06 [0.95-1.19],0.2973637939640517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIA,Melanoma-derived growth regulatory protein,27351,173,1.14 [0.80-1.64],0.4650144413650748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICALL2,MICAL-like protein 2,23097,146,1.13 [0.91-1.40],0.2828655742569728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27207,172,1.00 [0.91-1.09],0.9444700485325548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIF,Macrophage migration inhibitory factor,27223,173,1.17 [0.96-1.42],0.124997823188789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,26707,161,1.47 [1.13-1.91],0.0043562755802784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23623,149,1.14 [0.98-1.32],0.0800946494865112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINK1,Misshapen-like kinase 1,23705,149,1.14 [0.96-1.35],0.1240851624553246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MITD1,MIT domain-containing protein 1,27073,171,1.08 [0.94-1.25],0.2684804149235019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MKI67,Proliferation marker protein Ki-67,23084,146,1.22 [0.86-1.72],0.2658712078683495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLLT1,Protein ENL,22891,140,1.01 [0.80-1.27],0.9544077756713292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLN,Promotilin,27207,172,1.10 [0.95-1.28],0.2073961062986187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MME,Neprilysin,27133,172,1.17 [1.00-1.36],0.0520636611530988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP1,Interstitial collagenase,26209,163,1.25 [1.07-1.46],0.005795157821277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP10,Stromelysin-2,27216,168,1.03 [0.82-1.29],0.8170445747521102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,27263,170,1.18 [0.91-1.53],0.212214010988384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP13,Collagenase 3,26588,162,1.17 [0.77-1.80],0.4583988827816361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP15,Matrix metalloproteinase-15,23762,150,1.28 [1.02-1.60],0.0338134089095279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP3,Stromelysin-1,27261,173,1.06 [0.80-1.39],0.6911443979462562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP7,Matrilysin,26706,160,1.19 [0.88-1.61],0.2544079034958304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP8,Neutrophil collagenase,27449,174,1.00 [0.83-1.19],0.9614449772495914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP9,Matrix metalloproteinase-9,27212,173,1.09 [0.88-1.36],0.4291451970960536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",22998,148,1.31 [0.98-1.76],0.064766935731182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MN1,Transcriptional activator MN1,23097,146,0.92 [0.69-1.23],0.5655304767013102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNAT1,CDK-activating kinase assembly factor MAT1,23310,148,1.01 [0.70-1.44],0.9778620154452324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNDA,Myeloid cell nuclear differentiation antigen,27214,172,1.07 [0.94-1.21],0.3081686971736014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOCS2,Molybdopterin synthase catalytic subunit,23256,143,1.20 [0.95-1.51],0.1310825123971843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOG,Myelin-oligodendrocyte glycoprotein,27485,171,1.06 [0.70-1.61],0.7654135491431017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORC3,MORC family CW-type zinc finger protein 3,23705,149,1.29 [0.80-2.08],0.3002780397740253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L1,Mortality factor 4-like protein 1,23310,148,1.19 [0.85-1.66],0.318346877270007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L2,Mortality factor 4-like protein 2,22891,140,1.32 [0.92-1.91],0.1334269505661239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORN4,MORN repeat-containing protein 4,22891,140,0.81 [0.63-1.05],0.1065022600552021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPHOSPH8,M-phase phosphoprotein 8,26751,160,1.07 [0.89-1.29],0.465145038508965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPI,Mannose-6-phosphate isomerase,27133,172,1.10 [0.94-1.28],0.2332779005177956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,27344,169,1.20 [0.99-1.46],0.0585006680022922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPO,Myeloperoxidase,27261,173,1.27 [0.97-1.65],0.0765490394946183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPRIP,Myosin phosphatase Rho-interacting protein,23574,149,0.98 [0.69-1.40],0.9255887869421524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,23771,148,1.36 [0.80-2.31],0.2595300935456738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRI1,Methylthioribose-1-phosphate isomerase,23097,146,1.14 [0.90-1.45],0.2617373435379565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL24,"39S ribosomal protein L24, mitochondrial",22998,148,1.43 [1.09-1.88],0.0095986455400023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL28,"39S ribosomal protein L28, mitochondrial",23723,148,0.71 [0.40-1.26],0.2415565562108923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL46,"39S ribosomal protein L46, mitochondrial",26588,162,1.06 [0.65-1.74],0.8122226519812283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL52,"39S ribosomal protein L52, mitochondrial",22851,140,1.18 [0.63-2.22],0.6100638000716663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23723,148,0.92 [0.73-1.16],0.4988725328534775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPS16,"28S ribosomal protein S16, mitochondrial",23084,146,1.14 [0.69-1.87],0.6108432541130437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLN,Mesothelin,27090,171,1.20 [0.95-1.51],0.1347658801687168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLNL,Mesothelin-like protein,23097,146,0.80 [0.51-1.25],0.3261401300331703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSMB,Beta-microseminoprotein,27158,171,0.93 [0.77-1.13],0.4575902589809533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,27496,174,1.63 [1.21-2.19],0.0012697140526454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSRA,Mitochondrial peptide methionine sulfoxide reductase,27351,173,1.19 [0.99-1.44],0.0574565911450579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MST1,Hepatocyte growth factor-like protein,23406,144,0.95 [0.75-1.20],0.6593825190764644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSTN,Growth/differentiation factor 8,26751,160,1.03 [0.78-1.35],0.8594856291417006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTDH,Protein LYRIC,23084,146,1.18 [1.00-1.40],0.0545435623099993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23705,149,1.51 [1.03-2.20],0.0332310991959081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23310,148,1.04 [0.90-1.20],0.5798311970198479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTIF3,"Translation initiation factor IF-3, mitochondrial",23636,148,1.16 [0.97-1.38],0.1058375651314243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTPN,Myotrophin,26751,160,0.89 [0.57-1.39],0.6140258390844826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTR,Methionine synthase,22998,148,0.98 [0.77-1.26],0.901167501132634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS1,Protein MTSS 1,23636,148,1.07 [0.93-1.23],0.3555094016054433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS2,Protein MTSS 2,23623,149,1.07 [0.92-1.26],0.3836848266858732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTUS1,Microtubule-associated tumor suppressor 1,23310,148,1.11 [0.85-1.44],0.4555244118248639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC13,Mucin-13,26588,162,1.04 [0.79-1.38],0.7686675511492452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC16,Mucin-16,27133,172,1.02 [0.95-1.09],0.6489085625941129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC2,Mucin-2,23755,147,0.99 [0.84-1.18],0.9269312534271564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUCL3,Mucin-like protein 3,22891,140,0.79 [0.52-1.21],0.2783050226154863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MVK,Mevalonate kinase,26707,161,1.22 [1.03-1.45],0.0204483778226216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MXRA8,Matrix remodeling-associated protein 8,23256,143,0.88 [0.53-1.48],0.6393203196296644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC1,"Myosin-binding protein C, slow-type",23762,150,1.33 [1.07-1.64],0.0093483015044225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC2,"Myosin-binding protein C, fast-type",23148,148,1.18 [1.01-1.37],0.0332873948259523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23723,148,1.20 [0.98-1.47],0.0817459642030449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYDGF,Myeloid-derived growth factor,23762,150,1.17 [1.00-1.37],0.0442770806356878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH4,Myosin-4,22998,148,0.94 [0.66-1.34],0.7259142610483285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH7B,Myosin-7B,22891,140,1.43 [1.08-1.88],0.0110736719745142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH9,Myosin-9,23755,147,1.08 [0.94-1.24],0.2589217780798065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",22998,148,0.96 [0.65-1.42],0.8490948744068916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL3,Myosin light chain 3,23148,148,1.23 [0.99-1.53],0.0609316354249978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL4,Myosin light chain 4,23148,148,0.85 [0.62-1.17],0.3095755120969368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL6B,Myosin light chain 6B,23097,146,1.05 [0.89-1.23],0.5596920648534887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23097,146,1.26 [0.93-1.69],0.1320343930162207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO6,Unconventional myosin-VI,23723,148,1.56 [1.16-2.09],0.0034301169752368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO9B,Unconventional myosin-IXb,26707,161,1.20 [0.99-1.45],0.0687252935972564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOC,Myocilin,27261,173,1.01 [0.75-1.35],0.9576283343060814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM1,Myomesin-1,22986,143,1.06 [0.76-1.46],0.7424116439705124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM2,Myomesin-2,22998,148,1.33 [0.99-1.78],0.0573781188513216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM3,Myomesin-3,23256,143,1.18 [0.99-1.40],0.0661207568301851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZB1,Marginal zone B- and B1-cell-specific protein,27353,170,1.26 [0.98-1.62],0.0720495188779851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZT1,Mitotic-spindle organizing protein 1,26616,166,1.16 [0.90-1.48],0.246453510515497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA10,N-alpha-acetyltransferase 10,22998,148,1.14 [0.84-1.55],0.3881488831216675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA80,N-alpha-acetyltransferase 80,23097,146,1.09 [0.95-1.24],0.2263476527455284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAAA,N-acylethanolamine-hydrolyzing acid amidase,26947,170,0.84 [0.66-1.07],0.1498936994362441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NACC1,Nucleus accumbens-associated protein 1,23623,149,1.22 [0.94-1.59],0.1289183808114998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NADK,NAD kinase,27255,172,1.11 [0.88-1.39],0.3759775307078205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGA,Alpha-N-acetylgalactosaminidase,23036,146,1.09 [0.84-1.41],0.5093713096145904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGK,N-acetyl-D-glucosamine kinase,23103,148,1.17 [0.89-1.54],0.2619916381962974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23256,143,1.15 [0.55-2.43],0.7104799114662024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAMPT,Nicotinamide phosphoribosyltransferase,26616,166,1.19 [0.97-1.47],0.0971663060698077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAP1L4,Nucleosome assembly protein 1-like 4,23595,148,1.52 [1.02-2.25],0.0384500508072581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAPRT,Nicotinate phosphoribosyltransferase,23705,149,1.37 [0.90-2.07],0.1439355395431263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NARS1,"Asparagine--tRNA ligase, cytoplasmic",23723,148,1.28 [0.91-1.79],0.1520111242381912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,27351,173,2.07 [1.27-3.36],0.0032636605101651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBN,Nibrin,26707,161,0.87 [0.64-1.17],0.3469713679403201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM1,Neural cell adhesion molecule 1,27347,172,1.24 [0.77-2.00],0.3738229408162286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM2,Neural cell adhesion molecule 2,27261,173,0.95 [0.58-1.56],0.8366748038356779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAN,Neurocan core protein,27496,174,0.77 [0.54-1.09],0.1447640108493416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCF2,Neutrophil cytosol factor 2,27169,171,1.07 [0.92-1.24],0.3847978154704509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCK2,Cytoplasmic protein NCK2,27391,171,1.07 [0.94-1.22],0.2807404853842214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCLN,Nicalin,26707,161,0.89 [0.65-1.20],0.4351416287498889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR1,Natural cytotoxicity triggering receptor 1,27166,171,1.52 [1.05-2.18],0.0246715543871228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23636,148,1.99 [1.27-3.12],0.0026816347195376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCS1,Neuronal calcium sensor 1,27485,171,1.97 [1.24-3.14],0.0042596055517867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDRG1,Protein NDRG1,26588,162,0.92 [0.73-1.14],0.4354636012595262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23623,149,1.07 [0.86-1.33],0.51771747015592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23043,146,1.44 [0.94-2.21],0.0974108820678998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23636,148,1.12 [0.94-1.33],0.1925869620300642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",26616,166,1.12 [0.96-1.31],0.1490730512851104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEB,Nebulin,22998,148,1.15 [0.78-1.70],0.4790968837590921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECAP2,Adaptin ear-binding coat-associated protein 2,22998,148,1.13 [0.91-1.40],0.2636006962771223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN1,Nectin-1,23084,146,0.79 [0.47-1.33],0.3828330345273829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,27210,172,2.39 [1.57-3.64],5.099040481263726e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN4,Nectin-4,27351,173,1.82 [1.25-2.67],0.0019595578159683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23084,146,0.89 [0.65-1.23],0.4803281313050102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD9,Enhancer of filamentation 1,23084,146,1.48 [1.02-2.14],0.0406606583824849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,26500,162,1.53 [1.12-2.07],0.006670083437476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEK7,Serine/threonine-protein kinase Nek7,23310,148,1.13 [0.94-1.35],0.2001466478835012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL1,Protein kinase C-binding protein NELL1,27351,173,0.58 [0.43-0.80],0.0007032990651157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL2,Protein kinase C-binding protein NELL2,27391,171,1.01 [0.63-1.63],0.9554301336559774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NENF,Neudesin,23623,149,1.02 [0.89-1.17],0.7706662649179172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEO1,Neogenin,23723,148,1.26 [0.65-2.44],0.501650826352968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEXN,Nexilin,23771,148,1.16 [0.93-1.45],0.1810536515022565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,27538,173,2.08 [1.31-3.31],0.0018879591344288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFAT5,Nuclear factor of activated T-cells 5,23084,146,1.22 [1.04-1.44],0.0174508351838816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27207,172,1.10 [0.96-1.27],0.175778998884648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",26707,161,1.03 [0.81-1.31],0.782048119773629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFE2,Transcription factor NF-E2 45 kDa subunit,23148,148,1.16 [0.94-1.42],0.1675563647222304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFIC,Nuclear factor 1 C-type,23723,148,1.03 [0.73-1.45],0.8799225036744116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB1,Nuclear factor NF-kappa-B p105 subunit,22998,148,1.14 [0.92-1.42],0.2149208520428815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB2,Nuclear factor NF-kappa-B p100 subunit,23310,148,1.16 [0.92-1.45],0.202428533257461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKBIE,NF-kappa-B inhibitor epsilon,26616,166,1.19 [0.91-1.56],0.2094232400355777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23636,148,1.12 [0.96-1.31],0.1445420900216122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFX1,Transcriptional repressor NF-X1,22998,148,1.12 [0.90-1.41],0.3115709341687304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFYA,Nuclear transcription factor Y subunit alpha,22998,148,1.29 [0.92-1.81],0.1326940068867108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGF,Beta-nerve growth factor,27073,171,1.79 [0.62-5.14],0.2777947329114745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGFR,Tumor necrosis factor receptor superfamily member 16,23762,150,1.38 [0.89-2.13],0.1549954349259503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGRN,Neugrin,23705,149,1.30 [0.68-2.48],0.4311097657778479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NHLRC3,NHL repeat-containing protein 3,22684,137,1.22 [0.72-2.07],0.450113278066975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID1,Nidogen-1,27256,172,1.34 [0.96-1.86],0.0842237197954475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID2,Nidogen-2,27261,173,1.20 [1.01-1.43],0.0396063744519481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NINJ1,Ninjurin-1,26616,166,1.07 [0.84-1.35],0.5852576928633191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT1,Deaminated glutathione amidase,23148,148,1.29 [0.92-1.81],0.1475502929999371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT2,Omega-amidase NIT2,23677,149,1.11 [0.90-1.37],0.3179713744933985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN1,Neuroligin-1,23097,146,1.02 [0.82-1.27],0.8545968502638002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN2,Neuroligin-2,22986,143,1.04 [0.76-1.44],0.7908518754429443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME1,Nucleoside diphosphate kinase A,23084,146,1.86 [0.98-3.52],0.056637813265635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME3,Nucleoside diphosphate kinase 3,27306,168,1.35 [0.80-2.26],0.2587964792930091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMI,N-myc-interactor,23538,148,1.14 [0.92-1.40],0.2408073017498256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27073,171,1.05 [0.88-1.25],0.613739320320982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMRK2,Nicotinamide riboside kinase 2,22891,140,1.16 [0.83-1.62],0.3733997589980298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23723,148,1.22 [1.01-1.47],0.0400157561840222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOMO1,Nodal modulator 1,27261,173,1.56 [0.91-2.70],0.1086940956348401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOP56,Nucleolar protein 56,22998,148,1.03 [0.90-1.18],0.6649998295021299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",26588,162,1.47 [1.13-1.92],0.0046208075464046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS2,"Nitric oxide synthase, inducible",22998,148,1.32 [0.92-1.90],0.1329957985315925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS3,"Nitric oxide synthase, endothelial",26588,162,1.11 [0.87-1.41],0.4118561671805583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH1,Neurogenic locus notch homolog protein 1,27587,172,1.76 [0.75-4.11],0.1919316576911346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH2,Neurogenic locus notch homolog protein 2,23755,147,2.08 [1.09-3.96],0.026237148921443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH3,Neurogenic locus notch homolog protein 3,27587,172,1.25 [0.85-1.83],0.2591537445235957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPC2,NPC intracellular cholesterol transporter 2,23353,143,1.57 [1.01-2.44],0.0432053813967776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,27255,172,1.21 [0.79-1.85],0.3793983328139589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS1,Nephrin,23084,146,0.97 [0.60-1.56],0.905519330448442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS2,Podocin,23084,146,1.07 [0.93-1.23],0.368245455002502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPL,N-acetylneuraminate lyase,23762,150,1.13 [0.80-1.59],0.4881050759670596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPB,Natriuretic peptides B,26751,160,0.94 [0.85-1.04],0.2399867040979843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPC,C-type natriuretic peptide,27207,172,1.46 [1.11-1.93],0.007754227865411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPR1,Atrial natriuretic peptide receptor 1,22998,148,1.09 [0.74-1.61],0.6521996073280731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTN,Neuroplastin,26616,166,1.01 [0.86-1.19],0.9203680283971988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX1,Neuronal pentraxin-1,27261,173,1.02 [0.72-1.44],0.9081272719307016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX2,Neuronal pentraxin-2,23755,147,1.29 [0.79-2.10],0.3013453249546597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTXR,Neuronal pentraxin receptor,27255,172,1.01 [0.69-1.49],0.942174395528062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPY,Pro-neuropeptide Y,27485,171,1.12 [0.91-1.38],0.2745404242114373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRCAM,Neuronal cell adhesion molecule,27255,172,1.21 [0.76-1.93],0.4310836120334435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRGN,Neurogranin,23771,148,1.11 [0.94-1.32],0.2273326046139828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRN1,Neuritin,23723,148,1.29 [0.94-1.77],0.1135896870039822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP1,Neuropilin-1,27394,172,1.44 [0.90-2.30],0.1250762520572315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP2,Neuropilin-2,27261,173,1.25 [0.79-1.97],0.3431084447538806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRTN,Neurturin,26707,161,1.22 [0.96-1.56],0.1088748298525336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRXN3,Neurexin-3,23097,146,0.81 [0.49-1.33],0.3945552126445532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NSFL1C,NSFL1 cofactor p47,27496,174,1.11 [0.91-1.35],0.3067608332820655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23762,150,1.18 [0.95-1.45],0.129667277872604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C1A,Cytosolic 5'-nucleotidase 1A,23705,149,1.79 [1.33-2.41],0.0001270741293691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C3A,Cytosolic 5'-nucleotidase 3A,27171,172,1.12 [0.96-1.31],0.158973207521206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5E,5'-nucleotidase,27351,173,1.12 [0.90-1.40],0.2988071157711008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF3,Neurotrophin-3,27207,172,1.26 [0.88-1.80],0.2084757737009097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF4,Neurotrophin-4,26616,166,0.94 [0.65-1.36],0.7417617486282113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK2,BDNF/NT-3 growth factors receptor,27255,172,0.76 [0.45-1.28],0.3011203066215935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK3,NT-3 growth factor receptor,27496,174,0.77 [0.42-1.41],0.3909600291820073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTproBNP,N-terminal prohormone of brain natriuretic peptide,27255,172,1.13 [0.99-1.28],0.0721502527640353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUB1,NEDD8 ultimate buster 1,27207,172,1.10 [0.94-1.29],0.2178855288923465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23623,149,0.99 [0.84-1.17],0.9478772813755132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUCB2,Nucleobindin-2,27437,171,1.45 [1.02-2.06],0.0380909762398634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDC,Nuclear migration protein nudC,27538,173,1.17 [0.94-1.45],0.158640304134934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23148,148,0.91 [0.48-1.72],0.7607978815518608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,22998,148,0.96 [0.70-1.32],0.8114396255721925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT16,U8 snoRNA-decapping enzyme,23595,148,1.13 [0.95-1.35],0.1787079793498694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27133,172,0.98 [0.78-1.25],0.8903952265039918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT5,ADP-sugar pyrophosphatase,27261,173,1.26 [0.99-1.61],0.0629041129620923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUMB,Protein numb homolog,23084,146,1.13 [0.93-1.37],0.204651232710887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUP50,Nuclear pore complex protein Nup50,22998,148,1.17 [0.77-1.76],0.4565692600546654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPE4,NXPE family member 4,22998,148,1.00 [0.64-1.57],0.9927595461821802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH1,Neurexophilin-1,26588,162,0.97 [0.66-1.41],0.8681991061076049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH3,Neurexophilin-3,23084,146,1.37 [0.80-2.34],0.2481808341070422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OBP2B,Odorant-binding protein 2b,26987,171,1.15 [0.93-1.42],0.1833374885279798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,23723,148,1.83 [1.34-2.49],0.000150548667873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ODAM,Odontogenic ameloblast-associated protein,26546,162,0.90 [0.69-1.18],0.4480575061305022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OFD1,Oral-facial-digital syndrome 1 protein,23310,148,1.16 [0.95-1.42],0.1506951126474437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGA,Protein O-GlcNAcase,23636,148,1.29 [1.04-1.61],0.0218248732595362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGFR,Opioid growth factor receptor,27133,172,1.22 [0.81-1.82],0.3357656251605404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,27261,173,1.38 [1.00-1.91],0.048053098347912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23310,148,1.01 [0.79-1.30],0.9178230256746818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLFM4,Olfactomedin-4,22389,133,1.03 [0.89-1.18],0.7089926909455326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLR1,Oxidized low-density lipoprotein receptor 1,26991,172,0.97 [0.77-1.22],0.8029037563660811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMD,Osteomodulin,27391,171,0.90 [0.67-1.21],0.477341720053515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMG,Oligodendrocyte-myelin glycoprotein,27133,172,0.79 [0.64-0.97],0.0256724691763782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMP,Olfactory marker protein,22986,143,0.88 [0.62-1.24],0.4670557830364303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPHN1,Oligophrenin-1,23705,149,1.09 [0.94-1.26],0.2435310150723973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPLAH,5-oxoprolinase,23148,148,1.14 [0.91-1.43],0.2448481638720507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPTC,Opticin,27133,172,0.82 [0.59-1.13],0.2180464248933791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ORM1,Alpha-1-acid glycoprotein 1,23722,149,0.64 [0.29-1.42],0.2693617631603876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSBPL2,Oxysterol-binding protein-related protein 2,23705,149,1.39 [1.05-1.84],0.0224090253955871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,27306,168,1.66 [1.10-2.49],0.0146356761728616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSM,Oncostatin-M,27080,172,1.09 [0.91-1.31],0.3544584320263846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSMR,Oncostatin-M-specific receptor subunit beta,27394,172,1.27 [0.67-2.42],0.4657591790220673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSTN,Osteocrin,23097,146,0.85 [0.56-1.29],0.4507687493382311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTOA,Otoancorin,22986,143,1.03 [0.77-1.38],0.8203990277698225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD6B,Deubiquitinase OTUD6B,23636,148,1.22 [0.94-1.58],0.1331508713613569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD7B,OTU domain-containing protein 7B,23723,148,1.21 [0.95-1.54],0.1270713492611876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23148,148,1.14 [0.91-1.43],0.2498675424871853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXT,Oxytocin-neurophysin 1,27496,174,1.02 [0.92-1.13],0.7035566995506841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),P4HB,Protein disulfide-isomerase,27132,173,1.59 [1.13-2.22],0.00773518293888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PACS2,Phosphofurin acidic cluster sorting protein 2,22998,148,1.25 [0.98-1.60],0.072344677722118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI2,Protein-arginine deiminase type-2,26707,161,1.02 [0.79-1.30],0.8857045231569818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI4,Protein-arginine deiminase type-4,26546,162,1.11 [0.94-1.32],0.2085289888200642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAEP,Glycodelin,27073,171,0.99 [0.88-1.11],0.8446704937879952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23723,148,1.05 [0.92-1.19],0.4932069509087154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23310,148,1.16 [0.85-1.58],0.3533101664275059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,26751,160,1.11 [0.87-1.42],0.4054867477035909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAGR1,PAXIP1-associated glutamate-rich protein 1,23148,148,0.90 [0.62-1.30],0.5811526458906211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22849,140,1.12 [0.83-1.51],0.4405620702879097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAK4,Serine/threonine-protein kinase PAK 4,26588,162,1.04 [0.83-1.31],0.7077495592884524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALLD,Palladin,23084,146,0.99 [0.66-1.47],0.9422906580979516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM,Paralemmin-1,23511,148,1.77 [1.10-2.84],0.0188304079129424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,23705,149,1.77 [1.24-2.54],0.0017442485912959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM3,Paralemmin-3,22998,148,1.04 [0.85-1.28],0.6896864591627326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAM,Peptidyl-glycine alpha-amidating monooxygenase,27440,172,1.10 [0.67-1.81],0.6960975888262511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAMR1,Inactive serine protease PAMR1,27261,173,0.80 [0.49-1.29],0.3579192780749908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAPPA,Pappalysin-1,26707,161,1.23 [0.91-1.66],0.1801807104966894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARD3,Partitioning defective 3 homolog,23310,148,1.01 [0.81-1.25],0.94356856196173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARK7,Parkinson disease protein 7,27261,173,1.12 [0.88-1.44],0.3606524572558406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARP1,Poly [ADP-ribose] polymerase 1,27207,172,1.01 [0.80-1.29],0.9107916333148608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAXX,Protein PAXX,23256,143,1.24 [0.88-1.73],0.213049296796721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBK,Lymphokine-activated killer T-cell-originated protein kinase,22891,140,1.26 [0.75-2.13],0.3898767588168434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBLD,Phenazine biosynthesis-like domain-containing protein,26588,162,1.14 [0.87-1.49],0.3324621050655116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23636,148,1.05 [0.63-1.75],0.8594230511118802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCARE,Photoreceptor cilium actin regulator,22986,143,0.79 [0.62-1.00],0.0540620328498415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23212,141,1.20 [0.87-1.66],0.2629818172939165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBP2,Poly(rC)-binding protein 2,23723,148,1.16 [0.93-1.44],0.1799515685006219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH1,Protocadherin-1,27450,172,1.30 [0.74-2.28],0.3687860598506666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH12,Protocadherin-12,23723,148,1.89 [1.10-3.24],0.0206166707149576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH17,Protocadherin-17,27255,172,1.46 [1.01-2.11],0.0444382477144552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH7,Protocadherin-7,23636,148,0.93 [0.58-1.49],0.7490592926769248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH9,Protocadherin-9,23636,148,1.48 [0.93-2.35],0.0960239916386748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDHB15,Protocadherin beta-15,23623,149,1.29 [0.90-1.86],0.1693563367608001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCNA,Proliferating cell nuclear antigen,22891,140,0.91 [0.68-1.21],0.5005627813115997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK7,Proprotein convertase subtilisin/kexin type 7,23623,149,0.88 [0.61-1.26],0.4725699243022888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK9,Proprotein convertase subtilisin/kexin type 9,27587,172,1.11 [0.79-1.56],0.5466738308522181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCYT2,Ethanolamine-phosphate cytidylyltransferase,23636,148,1.17 [0.95-1.43],0.1341680891967125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDAP1,28 kDa heat- and acid-stable phosphoprotein,23762,150,1.09 [0.93-1.27],0.3125805740631843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1,Programmed cell death protein 1,27445,171,1.36 [1.03-1.80],0.032611521000058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,27133,172,1.85 [1.24-2.75],0.0023358584351367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD5,Programmed cell death protein 5,27496,174,1.13 [0.91-1.42],0.2726774393125127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD6,Programmed cell death protein 6,27255,172,1.12 [0.90-1.38],0.3131404874060213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCL2,Phosducin-like protein 2,22891,140,0.87 [0.63-1.22],0.4263437730520727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22891,140,1.11 [0.86-1.43],0.4060610242441008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",22998,148,0.83 [0.61-1.13],0.2431854186427057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23256,143,1.06 [0.91-1.25],0.4359409891216778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFA,Platelet-derived growth factor subunit A,27587,172,1.19 [0.99-1.43],0.0697895907746158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFB,Platelet-derived growth factor subunit B,27391,171,1.16 [0.99-1.36],0.062296267329004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFC,Platelet-derived growth factor C,26616,166,1.68 [1.17-2.42],0.0051460875838257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRA,Platelet-derived growth factor receptor alpha,27255,172,1.22 [0.77-1.95],0.3936252799422371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRB,Platelet-derived growth factor receptor beta,27587,172,1.47 [0.99-2.18],0.0560633958586723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA2,Protein disulfide-isomerase A2,22891,140,1.21 [0.85-1.71],0.2869182845541577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA3,Protein disulfide-isomerase A3,23256,143,1.57 [1.02-2.40],0.0400869491222927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA4,Protein disulfide-isomerase A4,23755,147,1.23 [0.95-1.58],0.1102398218966378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA5,Protein disulfide-isomerase A5,22891,140,0.88 [0.66-1.17],0.3721086593714682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM5,PDZ and LIM domain protein 5,23723,148,1.11 [0.97-1.28],0.1264674216454938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM7,PDZ and LIM domain protein 7,27391,171,1.07 [0.96-1.19],0.2104914886660192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",26616,166,1.20 [0.96-1.50],0.1085265971970725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDRG1,p53 and DNA damage-regulated protein 1,23097,146,0.99 [0.74-1.33],0.9535854125375932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22891,140,1.10 [0.88-1.37],0.390173388900664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZD2,PDZ domain-containing protein 2,22998,148,1.30 [1.04-1.63],0.0201479282249221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23084,146,1.53 [1.15-2.05],0.0039589549653831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEAR1,Platelet endothelial aggregation receptor 1,27587,172,1.99 [1.09-3.60],0.0239438322797635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEBP1,Phosphatidylethanolamine-binding protein 1,27261,173,1.10 [0.88-1.38],0.404248661497695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECAM1,Platelet endothelial cell adhesion molecule,27261,173,1.70 [1.12-2.59],0.0124909045576149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECR,Peroxisomal trans-2-enoyl-CoA reductase,23148,148,1.24 [0.76-2.00],0.3875512046781576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PENK,Proenkephalin-A,23256,143,1.36 [0.84-2.19],0.2076982159148342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEPD,Xaa-Pro dipeptidase,23771,148,1.16 [0.63-2.12],0.6364061763792439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PER3,Period circadian protein homolog 3,23084,146,1.18 [1.04-1.33],0.0119195625630976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PF4,Platelet factor 4,23629,147,1.03 [0.88-1.21],0.6762689695277033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN2,Prefoldin subunit 2,26588,162,1.17 [0.92-1.48],0.2074548230839358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN4,Prefoldin subunit 4,22891,140,0.95 [0.69-1.30],0.7558508266573649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN6,Prefoldin subunit 6,23097,146,0.92 [0.71-1.20],0.5443868519182161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27086,172,1.15 [0.97-1.37],0.1114809959525925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGA4,Pepsin A-4,23771,148,1.24 [1.00-1.54],0.0470780264659343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23762,150,1.14 [0.86-1.50],0.3758162442848799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,27538,173,1.81 [1.22-2.67],0.0031297834442469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP1,Peptidoglycan recognition protein 1,27453,172,1.41 [1.06-1.89],0.0194619555996482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23493,145,0.59 [0.36-0.98],0.0395689516804643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP4,Peptidoglycan recognition protein 4,22998,148,1.04 [0.82-1.33],0.7371259947601811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGM2,Phosphoglucomutase-2,23097,146,0.93 [0.70-1.25],0.6437319905661493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGR,Progesterone receptor,23084,146,1.04 [0.90-1.21],0.5718902859513213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHACTR2,Phosphatase and actin regulator 2,23723,148,1.09 [0.95-1.25],0.2058833217958252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB1,Pleckstrin homology-like domain family B member 1,23636,148,1.35 [1.02-1.79],0.036636862900299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB2,Pleckstrin homology-like domain family B member 2,22891,140,0.93 [0.78-1.12],0.4670428286199534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27073,171,1.57 [1.00-2.44],0.0481155548460991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23256,143,1.44 [0.98-2.13],0.0630445225621785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI16,Peptidase inhibitor 16,23771,148,1.16 [0.63-2.16],0.6315595249453723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,26886,167,1.06 [0.83-1.36],0.6470378591334334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23723,148,1.07 [0.87-1.30],0.522300062086376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,26905,172,1.79 [1.25-2.58],0.0015862884042631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27207,172,1.15 [0.93-1.42],0.2107264542649279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27261,173,1.87 [1.17-2.99],0.0091669825953115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23084,146,1.14 [0.87-1.48],0.3419765307918211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,27261,173,1.45 [1.05-2.01],0.0240795736083827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,27255,172,1.26 [0.99-1.61],0.0623105761045237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23256,143,1.04 [0.82-1.32],0.7377840841516204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PITHD1,PITH domain-containing protein 1,22849,140,0.98 [0.80-1.20],0.8122505569631728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD1,Polycystin-1,23762,150,2.10 [1.16-3.80],0.0147526900544882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD2,Polycystin-2,22998,148,1.25 [0.98-1.60],0.0737666577913633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKLR,Pyruvate kinase PKLR,27304,169,0.97 [0.79-1.18],0.7649468750333311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKN3,Serine/threonine-protein kinase N3,23310,148,1.02 [0.83-1.25],0.8301627978018821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G10,Group 10 secretory phospholipase A2,27073,171,1.25 [1.00-1.57],0.0490395321984479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,27351,173,1.82 [1.10-2.99],0.0187927077441705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G1B,Phospholipase A2,27539,171,0.87 [0.64-1.19],0.3927078166668832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G2A,"Phospholipase A2, membrane associated",27170,169,1.03 [0.82-1.30],0.8007532527662282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G4A,Cytosolic phospholipase A2,27391,171,1.09 [0.94-1.28],0.2585282260840555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G7,Platelet-activating factor acetylhydrolase,27261,173,0.74 [0.50-1.10],0.1356109980631198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAT,Tissue-type plasminogen activator,27498,172,1.04 [0.80-1.37],0.7533972313738796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAU,Urokinase-type plasminogen activator,27261,173,1.01 [0.65-1.57],0.954551956188766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,27081,168,2.83 [1.76-4.56],1.727517770716912e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLB1,"Phospholipase B1, membrane-associated",23705,149,0.93 [0.72-1.21],0.5844615363802714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23084,146,1.16 [0.85-1.58],0.352167250537118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23705,149,1.17 [0.99-1.38],0.0577340113114841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLEKHO1,Pleckstrin homology domain-containing family O member 1,23705,149,1.14 [0.92-1.42],0.2348010126156546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLG,Plasminogen,23178,144,0.56 [0.27-1.14],0.109624336229018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN1,Perilipin-1,26588,162,0.97 [0.65-1.45],0.8699406988765584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN3,Perilipin-3,27255,172,1.30 [0.97-1.76],0.0828218403986724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLPBP,Pyridoxal phosphate homeostasis protein,27255,172,1.11 [0.91-1.35],0.3029366911720823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLSCR3,Phospholipid scramblase 3,23666,147,1.20 [0.93-1.56],0.1581915137306098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLTP,Phospholipid transfer protein,27492,172,0.89 [0.60-1.30],0.5353654006556118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC1,Plexin domain-containing protein 1,26616,166,1.30 [0.93-1.81],0.1188328365304123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC2,Plexin domain-containing protein 2,23705,149,1.99 [1.32-2.99],0.0010226662421381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNA4,Plexin-A4,27207,172,1.11 [0.94-1.30],0.2213430782458221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,27454,172,1.81 [1.04-3.13],0.0349580821194443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB3,Plexin-B3,27168,172,1.14 [0.86-1.51],0.3618519980866294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27116,172,0.99 [0.92-1.06],0.7529326700867831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMCH,Pro-MCH,22998,148,0.95 [0.78-1.17],0.6488372394890165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMM2,Phosphomannomutase 2,22998,148,1.25 [0.97-1.61],0.0824867074842298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMS1,PMS1 protein homolog 1,23097,146,0.89 [0.64-1.23],0.4724250193321792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMVK,Phosphomevalonate kinase,26544,160,1.06 [0.93-1.22],0.3547895606826374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIP,Pancreatic triacylglycerol lipase,23771,148,1.01 [0.78-1.30],0.9412650629551068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP1,Inactive pancreatic lipase-related protein 1,23705,149,1.17 [0.96-1.43],0.1175371229021156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP2,Pancreatic lipase-related protein 2,27258,168,0.96 [0.92-1.00],0.0384988065192763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA1,Paraneoplastic antigen Ma1,23148,148,0.98 [0.73-1.30],0.8686312144279594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA2,Paraneoplastic antigen Ma2,22986,143,0.95 [0.66-1.39],0.8047723514160379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",26707,161,0.93 [0.82-1.06],0.2570613372141357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL,Podocalyxin,27133,172,1.07 [0.45-2.57],0.8770394982448346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL2,Podocalyxin-like protein 2,27351,173,1.30 [0.81-2.10],0.2774410559859689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POF1B,Protein POF1B,23084,146,1.49 [1.15-1.95],0.0029383017407926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2A,DNA-directed RNA polymerase II subunit RPB1,23084,146,1.05 [0.62-1.77],0.8595779671651957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27133,172,1.20 [0.84-1.71],0.3274760487824283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POMC,Pro-opiomelanocortin,23148,148,0.88 [0.70-1.12],0.3060216530643534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON1,Serum paraoxonase/arylesterase 1,23771,148,0.69 [0.41-1.15],0.1536163821190521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON2,Serum paraoxonase/arylesterase 2,26751,160,1.05 [0.70-1.57],0.8120394823041593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON3,Serum paraoxonase/lactonase 3,27391,171,1.05 [0.66-1.67],0.8366896072652824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POSTN,Periostin,23755,147,0.85 [0.56-1.30],0.4507091837280865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPBP,Platelet basic protein,23630,147,1.12 [0.93-1.35],0.2311743751040955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPCDC,Phosphopantothenoylcysteine decarboxylase,27496,174,1.18 [0.89-1.55],0.2475486617909429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIB,Peptidyl-prolyl cis-trans isomerase B,27272,171,1.13 [0.97-1.30],0.1105527509745636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIE,Peptidyl-prolyl cis-trans isomerase E,23310,148,0.82 [0.61-1.10],0.1816194440531397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23755,147,1.23 [0.99-1.53],0.0675290863970343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPL,Periplakin,23084,146,1.32 [0.87-2.01],0.1954626638920656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1A,Protein phosphatase 1A,26616,166,1.16 [0.77-1.74],0.4723649674007375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1B,Protein phosphatase 1B,23084,146,1.08 [0.85-1.37],0.5400483339145742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1F,Protein phosphatase 1F,23762,150,1.23 [0.91-1.65],0.1743021412334263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPME1,Protein phosphatase methylesterase 1,27133,172,1.15 [0.92-1.42],0.2173391832558536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23623,149,1.14 [0.95-1.37],0.1658835368477746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,27351,173,1.10 [0.96-1.26],0.167516427352826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23310,148,1.21 [1.02-1.43],0.0321745436562705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23723,148,1.03 [0.85-1.25],0.7380577401322634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23723,148,1.44 [1.03-2.02],0.0326245566152035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R2,Protein phosphatase inhibitor 2,27255,172,1.11 [0.94-1.32],0.2050576959594816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R9B,Neurabin-2,27538,173,1.06 [0.92-1.22],0.429217597054321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23636,148,1.12 [0.98-1.27],0.093401700502665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP3R1,Calcineurin subunit B type 1,27073,171,1.29 [0.93-1.78],0.1268609376494292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPT1,Palmitoyl-protein thioesterase 1,23097,146,0.96 [0.77-1.19],0.6970505033155436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPY,Pancreatic prohormone,27246,173,0.91 [0.80-1.04],0.1671555061157776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PQBP1,Polyglutamine-binding protein 1,26616,166,1.04 [0.82-1.31],0.7653238941906766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAME,Melanoma antigen preferentially expressed in tumors,22891,140,1.38 [0.78-2.45],0.2695007048593977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAP1,Proline-rich acidic protein 1,23755,147,1.60 [1.09-2.34],0.0166575828770507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRC1,Protein regulator of cytokinesis 1,23623,149,1.23 [0.97-1.55],0.0825167668021622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRCP,Lysosomal Pro-X carboxypeptidase,27421,170,1.05 [0.69-1.62],0.8156071345812136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX1,Peroxiredoxin-1,26521,170,1.17 [1.01-1.35],0.0409108019414204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX2,Peroxiredoxin-2,23378,145,0.90 [0.70-1.16],0.4342518011734261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",26707,161,1.31 [1.09-1.57],0.0042937289876215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX5,"Peroxiredoxin-5, mitochondrial",27538,173,1.07 [0.88-1.30],0.5178860602821569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX6,Peroxiredoxin-6,27485,171,1.12 [0.90-1.39],0.3171569124601682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,26707,161,0.98 [0.62-1.57],0.944522803850418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRELP,Prolargin,27258,168,1.26 [0.70-2.28],0.4450506491580877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG2,Bone marrow proteoglycan,23755,147,1.06 [0.79-1.42],0.7145661587369835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG3,Proteoglycan 3,23755,147,1.05 [0.77-1.42],0.7699102920810579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,26707,161,1.30 [1.03-1.64],0.0263624533146379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23097,146,1.33 [0.86-2.07],0.2005194215264669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27255,172,1.05 [0.89-1.23],0.5562151923764027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23665,149,1.15 [0.95-1.39],0.1505388534439125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKCQ,Protein kinase C theta type,26707,161,1.36 [1.06-1.74],0.0158832804610241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKD2,Serine/threonine-protein kinase D2,22998,148,1.17 [0.87-1.55],0.296446676966474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKG1,cGMP-dependent protein kinase 1,23256,143,1.08 [0.95-1.23],0.2446183285642736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,26616,166,1.01 [0.82-1.24],0.9093746077512024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRL,Prolactin,27496,174,1.21 [1.03-1.43],0.0240540374320733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRND,Prion-like protein doppel,23705,149,1.15 [0.87-1.53],0.3240105845789657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROC,Vitamin K-dependent protein C,27300,172,0.96 [0.56-1.66],0.8918450746122168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROCR,Endothelial protein C receptor,22998,148,0.92 [0.58-1.45],0.723917518964611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROK1,Prokineticin-1,27207,172,1.03 [0.84-1.27],0.7795944410765445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROS1,Vitamin K-dependent protein S,23803,149,0.66 [0.35-1.25],0.2001019742190957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR4,Proline-rich protein 4,23089,140,1.19 [0.95-1.48],0.1232337690374681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR5,Proline-rich protein 5,23084,146,1.02 [0.74-1.42],0.8948312698534853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRRT3,Proline-rich transmembrane protein 3,23148,148,1.16 [0.77-1.75],0.4636608574956954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS2,Trypsin-2,27347,172,1.23 [0.95-1.58],0.1100525844903514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS22,Brain-specific serine protease 4,23084,146,0.93 [0.59-1.48],0.7637072886742182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS27,Serine protease 27,27167,172,1.10 [0.80-1.53],0.5571833439941012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS53,Serine protease 53,23705,149,1.02 [0.68-1.54],0.9212735379745428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,27165,171,1.81 [1.32-2.47],0.0001938516663331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,26588,162,1.04 [0.92-1.18],0.5369831763555298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTG,Protogenin,27485,171,1.44 [0.85-2.45],0.1789765933706578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTN3,Myeloblastin,26547,167,1.21 [0.94-1.58],0.1449767422566584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRUNE2,Protein prune homolog 2,23310,148,1.49 [1.00-2.23],0.0514315262718421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAP,Prosaposin,23527,146,1.69 [1.08-2.63],0.0212000810968745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAPL1,Proactivator polypeptide-like 1,23636,148,1.17 [0.86-1.58],0.3247492855818129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSCA,Prostate stem cell antigen,23636,148,1.11 [1.03-1.18],0.0031065551099954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSG1,Pregnancy-specific beta-1-glycoprotein 1,27073,171,1.12 [0.99-1.27],0.0830540878369928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSIP1,PC4 and SFRS1-interacting protein,27207,172,1.13 [0.93-1.36],0.2275376391746563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMA1,Proteasome subunit alpha type-1,26616,166,0.77 [0.55-1.07],0.1195816103917016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMC3,26S proteasome regulatory subunit 6A,22891,140,0.89 [0.52-1.53],0.6790085631875319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD1,26S proteasome non-ATPase regulatory subunit 1,23723,148,1.33 [1.00-1.77],0.047227951808277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD5,26S proteasome non-ATPase regulatory subunit 5,23097,146,0.98 [0.74-1.30],0.9028702630598524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD9,26S proteasome non-ATPase regulatory subunit 9,27133,172,0.86 [0.67-1.10],0.2267644192541471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME1,Proteasome activator complex subunit 1,27034,171,1.09 [0.77-1.56],0.6189126241332946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME2,Proteasome activator complex subunit 2,26943,170,1.11 [0.77-1.60],0.5646153578546984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG3,Proteasome assembly chaperone 3,27207,172,0.95 [0.74-1.23],0.7139877456574981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG4,Proteasome assembly chaperone 4,23084,146,0.88 [0.66-1.16],0.3618237334015045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSPN,Persephin,27207,172,0.98 [0.85-1.12],0.7436903559983437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSRC1,Proline/serine-rich coiled-coil protein 1,26616,166,1.02 [0.81-1.29],0.882609514460784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22409,136,1.04 [0.89-1.21],0.6417728430515532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",26588,162,1.15 [0.73-1.83],0.5418447932943362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,27035,172,1.80 [1.21-2.69],0.0036478533331296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGES2,Prostaglandin E synthase 2,22895,145,1.42 [1.08-1.87],0.0130502784490001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGR1,Prostaglandin reductase 1,23762,150,0.97 [0.80-1.18],0.7713472378472334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH,Parathyroid hormone,23097,146,0.94 [0.77-1.15],0.5232327947685944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27207,172,0.99 [0.69-1.40],0.9423588789646756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTK7,Inactive tyrosine-protein kinase 7,26588,162,1.32 [0.92-1.89],0.1300582636885734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTN,Pleiotrophin,26751,160,1.32 [1.01-1.73],0.0438766316381751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTP4A3,Protein tyrosine phosphatase type IVA 3,23084,146,1.14 [0.87-1.49],0.3404590483347193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27073,171,1.12 [0.95-1.33],0.1802939373872787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,27344,169,1.08 [0.92-1.26],0.3634611972791489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23038,146,0.88 [0.57-1.38],0.5808100762238639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRB,Receptor-type tyrosine-protein phosphatase beta,23762,150,0.87 [0.50-1.50],0.6101542148899637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRC,Receptor-type tyrosine-protein phosphatase C,23755,147,1.79 [0.93-3.42],0.0810711841086436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRF,Receptor-type tyrosine-protein phosphatase F,27587,172,1.42 [0.89-2.26],0.1401881072239112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRH,Receptor-type tyrosine-protein phosphatase H,23636,148,1.33 [0.97-1.82],0.0807855125696213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23636,148,2.09 [1.29-3.39],0.0027646568341862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRM,Receptor-type tyrosine-protein phosphatase mu,27163,172,1.34 [0.78-2.32],0.2916780167236213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,26982,171,1.40 [0.93-2.12],0.1104772343430959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRR,Receptor-type tyrosine-protein phosphatase R,23705,149,0.90 [0.58-1.40],0.6425337913627551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRS,Receptor-type tyrosine-protein phosphatase S,27587,172,1.38 [0.79-2.39],0.2550271184454888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23762,150,1.26 [0.79-2.03],0.3292323361359209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23256,143,1.11 [0.85-1.44],0.4469155445795629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTS,6-pyruvoyl tetrahydrobiopterin synthase,26470,162,1.30 [1.03-1.62],0.0246237558074449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTTG1,Securin,23310,148,0.93 [0.63-1.37],0.7091379955797279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTX3,Pentraxin-related protein PTX3,27207,172,0.86 [0.66-1.11],0.2484595059124424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVALB,Parvalbumin alpha,27354,171,1.03 [0.91-1.16],0.6392203841049213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVR,Poliovirus receptor,27496,174,1.40 [0.99-1.97],0.0574213581382098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXDNL,Peroxidasin-like protein,23623,149,1.05 [0.81-1.36],0.7032403939215776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXN,Paxillin,26588,162,1.11 [0.86-1.43],0.4221497951795853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYDC1,Pyrin domain-containing protein 1,23148,148,0.88 [0.59-1.30],0.5172037444422832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYY,Peptide YY,22998,148,1.14 [0.98-1.34],0.0891414928325034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PZP,Pregnancy zone protein,23803,149,0.83 [0.65-1.08],0.1624893205588138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QDPR,Dihydropteridine reductase,27127,171,1.27 [0.94-1.72],0.1231093719055785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QPCT,Glutaminyl-peptide cyclotransferase,27294,170,1.03 [0.63-1.71],0.8929111016866844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QSOX1,Sulfhydryl oxidase 1,23313,145,0.82 [0.50-1.32],0.4113979318357951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB10,Ras-related protein Rab-10,23762,150,1.24 [0.94-1.64],0.1289382344877095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB11FIP3,Rab11 family-interacting protein 3,23762,150,1.10 [0.95-1.28],0.1838980035501975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB27B,Ras-related protein Rab-27B,23762,150,1.14 [0.94-1.39],0.1865493440504949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB2B,Ras-related protein Rab-2B,23623,149,1.35 [1.06-1.73],0.0150021987439341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB33A,Ras-related protein Rab-33A,22998,148,1.25 [0.99-1.57],0.0562945606252035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB37,Ras-related protein Rab-37,26707,161,0.96 [0.81-1.15],0.670454765271962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB39B,Ras-related protein Rab-39B,22998,148,1.07 [0.91-1.25],0.3935258077343045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,22986,143,0.91 [0.67-1.24],0.5530123902793055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB44,Ras-related protein Rab-44,23623,149,1.27 [0.97-1.66],0.0838808588566455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6A,Ras-related protein Rab-6A,27207,172,0.85 [0.64-1.13],0.2529758452658487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6B,Ras-related protein Rab-6B,26588,162,1.39 [1.12-1.73],0.0025459156084988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEP1,Rab GTPase-binding effector protein 1,23256,143,1.18 [0.96-1.44],0.1123164256348178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEPK,Rab9 effector protein with kelch motifs,26616,166,1.17 [0.95-1.45],0.136652679708903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABGAP1L,Rab GTPase-activating protein 1-like,26707,161,1.10 [0.88-1.38],0.4073799696685186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAC3,Ras-related C3 botulinum toxin substrate 3,23097,146,0.87 [0.67-1.13],0.3070908757223601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD23B,UV excision repair protein RAD23 homolog B,26616,166,1.29 [0.99-1.69],0.0610430986310032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD51,DNA repair protein RAD51 homolog 1,23310,148,1.13 [0.89-1.44],0.3163616608965094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALB,Ras-related protein Ral-B,23084,146,1.26 [0.75-2.11],0.3821572339691181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALY,RNA-binding protein Raly,23623,149,1.05 [0.77-1.43],0.7512550430729652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP1,Ran-specific GTPase-activating protein,23148,148,1.00 [0.74-1.34],0.9825263404163752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP2,E3 SUMO-protein ligase RanBP2,22986,143,1.29 [0.82-2.02],0.2709315598056719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANGAP1,Ran GTPase-activating protein 1,26616,166,1.06 [0.80-1.39],0.6970505173689816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAP1A,Ras-related protein Rap-1A,23084,146,1.27 [1.08-1.48],0.0031163824206854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAPGEF2,Rap guanine nucleotide exchange factor 2,23310,148,1.20 [0.91-1.60],0.1956412482680877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES1,Retinoic acid receptor responder protein 1,26616,166,1.40 [1.04-1.87],0.0270452474573248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,27394,172,1.29 [0.98-1.69],0.0704690152297704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASA1,Ras GTPase-activating protein 1,26588,162,1.12 [0.74-1.68],0.5912568982259988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22891,140,0.90 [0.62-1.31],0.5749780797079129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASSF2,Ras association domain-containing protein 2,26616,166,1.15 [0.93-1.42],0.1997145350847446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,23723,148,1.63 [1.22-2.17],0.0009331273086736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBKS,Ribokinase,26627,168,1.00 [0.77-1.31],0.9737996136885976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM17,Splicing factor 45,23723,148,1.11 [0.91-1.35],0.3207682313219447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM19,Probable RNA-binding protein 19,22998,148,1.13 [0.84-1.53],0.4081543578096511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM25,RNA-binding protein 25,22891,140,0.86 [0.60-1.24],0.4208983458127292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP1,Retinol-binding protein 1,23097,146,1.00 [0.80-1.26],0.9775219536285872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP2,Retinol-binding protein 2,27133,172,1.30 [1.10-1.54],0.0025744731235119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP5,Retinol-binding protein 5,27133,172,1.24 [1.00-1.55],0.0546068390971119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP7,Retinoid-binding protein 7,23636,148,1.26 [1.00-1.59],0.0508708410376377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS,RNA-binding protein with multiple splicing,23084,146,1.01 [0.79-1.28],0.9521179673912532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS2,RNA-binding protein with multiple splicing 2,23148,148,1.09 [0.93-1.26],0.2825800774341886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCC1,Regulator of chromosome condensation,23623,149,1.03 [0.76-1.38],0.8666240460778688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCOR1,REST corepressor 1,26751,160,0.93 [0.67-1.30],0.6727318826541506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23148,148,1.21 [0.55-2.66],0.6277695419318527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REEP4,Receptor expression-enhancing protein 4,23723,148,1.18 [0.93-1.50],0.1697233811732532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,27084,170,1.46 [1.16-1.84],0.0013475684668647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,27587,172,1.32 [1.07-1.62],0.0085625581700785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,27587,172,1.23 [1.01-1.51],0.0427824445923101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3G,Regenerating islet-derived protein 3-gamma,23623,149,1.08 [0.74-1.58],0.676162127926514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,27306,168,1.23 [0.94-1.61],0.137608688800315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELB,Transcription factor RelB,23084,146,1.25 [0.98-1.61],0.0748369694315305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,27261,173,1.71 [1.07-2.72],0.0248693575363296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,27255,172,1.24 [1.05-1.45],0.0091413182817156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REPS1,RalBP1-associated Eps domain-containing protein 1,23084,146,1.13 [0.76-1.67],0.5572804935881979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REST,RE1-silencing transcription factor,22891,140,1.26 [0.85-1.87],0.2477533021438499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27133,172,0.94 [0.68-1.30],0.7019029339445372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RETN,Resistin,27190,171,1.22 [0.89-1.67],0.2095705771728101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REXO2,"Oligoribonuclease, mitochondrial",22998,148,1.16 [0.88-1.52],0.2936507605326262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RFC4,Replication factor C subunit 4,23623,149,1.06 [0.51-2.21],0.8707593322661802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGCC,Regulator of cell cycle RGCC,23723,148,1.07 [0.87-1.31],0.5457303834222778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23310,148,1.01 [0.79-1.29],0.9511765727844894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMA,Repulsive guidance molecule A,27496,174,1.04 [0.68-1.61],0.8481569191253251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMB,RGM domain family member B,27496,174,1.25 [0.75-2.07],0.3960865182692673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS10,Regulator of G-protein signaling 10,23723,148,1.25 [0.98-1.60],0.0669631808403509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS8,Regulator of G-protein signaling 8,26707,161,1.08 [0.89-1.31],0.4600060658914721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RHOC,Rho-related GTP-binding protein RhoC,26896,168,1.08 [0.96-1.22],0.2163829289414154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RICTOR,Rapamycin-insensitive companion of mTOR,23084,146,0.88 [0.62-1.26],0.4874261654304626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23256,143,1.13 [0.83-1.54],0.4418539332270773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILP,Rab-interacting lysosomal protein,27400,171,1.11 [0.90-1.39],0.3333261371675962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILPL2,RILP-like protein 2,23762,150,1.13 [0.96-1.33],0.1410049510793565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,22998,148,1.19 [1.00-1.43],0.0547292353076068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN1,Prorelaxin H1,23723,148,1.02 [0.82-1.27],0.8282508905626796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN2,Prorelaxin H2,23213,142,1.06 [0.93-1.21],0.3579841230848355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE1,Ribonuclease pancreatic,23771,148,1.97 [1.28-3.03],0.0020267922561154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE10,Inactive ribonuclease-like protein 10,23148,148,1.05 [0.77-1.44],0.7432177027645128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE3,Eosinophil cationic protein,27126,172,1.00 [0.88-1.13],0.9753850060513092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE4,Ribonuclease 4,22969,144,1.51 [0.88-2.59],0.1355755386898392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,23589,145,1.65 [1.15-2.38],0.0069046537599451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASEH2A,Ribonuclease H2 subunit A,23723,148,1.11 [0.83-1.48],0.4950122971923784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,27460,170,1.72 [1.11-2.66],0.0153344393133435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF149,E3 ubiquitin-protein ligase RNF149,23148,148,1.50 [0.94-2.41],0.0893646033339762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF168,E3 ubiquitin-protein ligase RNF168,23084,146,1.05 [0.72-1.54],0.7859616231320367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF31,E3 ubiquitin-protein ligase RNF31,23084,146,0.99 [0.64-1.54],0.9737778818713988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF4,E3 ubiquitin-protein ligase RNF4,23310,148,0.90 [0.70-1.16],0.4248892392623109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF41,E3 ubiquitin-protein ligase NRDP1,26616,166,1.19 [0.98-1.45],0.0748768369494412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF43,E3 ubiquitin-protein ligase RNF43,23310,148,1.04 [0.80-1.34],0.7799790577388447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF5,E3 ubiquitin-protein ligase RNF5,23148,148,0.99 [0.79-1.23],0.9094963649207592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO1,Roundabout homolog 1,27306,168,1.93 [1.16-3.22],0.0109889001682544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO2,Roundabout homolog 2,27496,174,1.40 [0.79-2.46],0.2443218393310858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO4,Roundabout homolog 4,23148,148,1.21 [0.50-2.95],0.6721448503816163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27255,172,1.23 [0.81-1.88],0.3339018135591187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RP2,Protein XRP2,27133,172,1.16 [0.85-1.59],0.3415663324556987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPA2,Replication protein A 32 kDa subunit,23084,146,0.98 [0.59-1.62],0.929699436999106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPE,Ribulose-phosphate 3-epimerase,23310,148,1.02 [0.82-1.28],0.8439736124206799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPGR,X-linked retinitis pigmentosa GTPase regulator,23097,146,1.07 [0.75-1.53],0.6988276355483005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPL14,60S ribosomal protein L14,23148,148,0.95 [0.64-1.42],0.8037973307193854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPS10,40S ribosomal protein S10,22998,148,1.36 [1.01-1.83],0.0426184632731616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRAS,Ras-related protein R-Ras,23097,146,1.08 [0.96-1.21],0.2151582957147328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2,Ribonucleoside-diphosphate reductase subunit M2,26616,166,1.16 [0.93-1.44],0.184670757171394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,26616,166,1.00 [0.82-1.23],0.962664941567497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRP15,RRP15-like protein,22986,143,0.97 [0.81-1.15],0.6977977184072468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO1,R-spondin-1,27073,171,1.35 [0.93-1.96],0.1102918814819435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,27485,171,1.42 [0.90-2.24],0.1328545584490593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTBDN,Retbindin,27133,172,1.07 [0.67-1.70],0.7876213429325477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTKN2,Rhotekin-2,22998,148,1.08 [0.83-1.41],0.5716524482050882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23723,148,1.09 [0.92-1.29],0.3053228093054313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4R,Reticulon-4 receptor,27485,171,1.15 [0.79-1.69],0.4601774568742363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RUVBL1,RuvB-like 1,26616,166,1.06 [0.94-1.20],0.3328318654640838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RWDD1,RWD domain-containing protein 1,27496,174,1.16 [0.94-1.42],0.1652288867732505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RYR1,Ryanodine receptor 1,22998,148,1.49 [1.08-2.07],0.0152812281070567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A11,Protein S100-A11,27031,171,1.12 [0.86-1.45],0.411289007129178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A12,Protein S100-A12,26886,171,1.12 [0.94-1.34],0.1915593628277584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A13,Protein S100-A13,23084,146,1.49 [1.01-2.21],0.0469263621422351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A14,Protein S100-A14,23723,148,1.19 [0.91-1.56],0.2052480033769239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A16,Protein S100-A16,26546,162,1.26 [1.03-1.53],0.0250483393380545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A3,Protein S100-A3,23623,149,0.98 [0.70-1.39],0.9304408875642748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A4,Protein S100-A4,27351,173,1.17 [0.92-1.48],0.1923054507297828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100G,Protein S100-G,23723,148,1.10 [0.78-1.55],0.5991135395360137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100P,Protein S100-P,26751,160,1.03 [0.80-1.32],0.8042547566974405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAA4,Serum amyloid A-4 protein,23803,149,0.87 [0.47-1.62],0.6669529864463148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAFB2,Scaffold attachment factor B2,23723,148,1.13 [0.66-1.92],0.658602060600268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAG,S-arrestin,22986,143,0.87 [0.63-1.21],0.4154108092486219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAMD9L,Sterile alpha motif domain-containing protein 9-like,27207,172,1.15 [0.96-1.38],0.1241924756057626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAP18,Histone deacetylase complex subunit SAP18,23310,148,1.10 [0.91-1.33],0.3293512503367941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SARG,Specifically androgen-regulated gene protein,23665,149,1.08 [0.94-1.25],0.2725455847678499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SART1,U4/U6.U5 tri-snRNP-associated protein 1,22998,148,1.15 [0.79-1.67],0.4695938078994766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT1,Diamine acetyltransferase 1,22998,148,0.92 [0.66-1.27],0.5955359363623127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT2,Thialysine N-epsilon-acetyltransferase,23310,148,1.35 [1.14-1.59],0.0004522332485132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SATB1,DNA-binding protein SATB1,23723,148,1.79 [1.27-2.53],0.0009874438469368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SBSN,Suprabasin,23709,147,1.01 [0.64-1.60],0.9761745074016824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCAMP3,Secretory carrier-associated membrane protein 3,27133,172,1.10 [0.94-1.28],0.2479028589703973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,27496,174,1.15 [0.73-1.81],0.546960846666368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB1,Scavenger receptor class B member 1,26588,162,1.16 [0.95-1.41],0.1556484755732837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,26575,168,1.55 [1.02-2.35],0.0394311794798082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF1,Scavenger receptor class F member 1,27587,172,1.51 [1.12-2.05],0.0074889893223136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,27496,174,1.52 [0.97-2.39],0.0699538068038478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG2,Secretogranin-2,27352,171,1.49 [0.99-2.24],0.0569355044469965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG3,Secretogranin-3,27306,168,1.81 [1.21-2.70],0.0039030608511514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB1A1,Uteroglobin,27301,171,1.12 [0.88-1.43],0.3584089066445488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB2A2,Mammaglobin-A,22998,148,1.03 [0.63-1.69],0.9064393874903164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A1,Secretoglobin family 3A member 1,23256,143,2.21 [1.18-4.17],0.0138449028234637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A2,Secretoglobin family 3A member 2,27344,169,1.05 [0.91-1.21],0.4988082631444056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGN,Secretagogin,26707,161,1.25 [0.92-1.69],0.15454851388664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCIN,Adseverin,22986,143,0.96 [0.77-1.21],0.7550354187195774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCLY,Selenocysteine lyase,27400,171,1.13 [0.86-1.48],0.3945905219672858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2A,Sodium channel protein type 2 subunit alpha,22986,143,0.71 [0.47-1.06],0.0915401694815363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2B,Sodium channel subunit beta-2,23097,146,1.20 [0.73-1.97],0.4835825232187014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3A,Sodium channel protein type 3 subunit alpha,23097,146,1.13 [0.76-1.66],0.54645790775331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3B,Sodium channel subunit beta-3,22986,143,1.16 [0.86-1.56],0.3435496860543889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN4B,Sodium channel subunit beta-4,23148,148,1.02 [0.70-1.48],0.919946495789596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCP2,Non-specific lipid-transfer protein,26616,166,0.85 [0.69-1.04],0.121303858113929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCPEP1,Retinoid-inducible serine carboxypeptidase,23054,147,1.48 [1.09-2.01],0.0113076380401999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRG1,Scrapie-responsive protein 1,23762,150,1.37 [0.80-2.35],0.2554895795472438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRIB,Protein scribble homolog,23148,148,0.97 [0.81-1.15],0.7019371293271759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRN1,Secernin-1,27207,172,1.21 [0.96-1.52],0.1041945486981864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCT,Secretin,23097,146,1.06 [0.76-1.49],0.7161332232446678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,27255,172,1.60 [1.19-2.15],0.0017945959290025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC4,Syndecan-4,27255,172,1.16 [0.86-1.57],0.3213871438163889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDCCAG8,Serologically defined colon cancer antigen 8,23623,149,1.12 [0.98-1.29],0.0990576711628262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDHB,Succinate dehydrogenase,23636,148,1.17 [0.95-1.43],0.1360403649295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDK2,Protein sidekick-2,23256,143,1.12 [0.74-1.70],0.5771517576149139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEC31A,Protein transport protein Sec31A,23148,148,1.05 [0.85-1.29],0.649270111764009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEL1L,Protein sel-1 homolog 1,23148,148,1.35 [0.94-1.93],0.1067465280536089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELE,E-selectin,27587,172,1.14 [0.87-1.48],0.346890917838538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELENOP,Selenoprotein P,23803,149,0.80 [0.40-1.63],0.5428102762741205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELL,L-selectin,23803,149,0.65 [0.33-1.27],0.2107565404257887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELP,P-selectin,27347,172,1.22 [0.98-1.54],0.0813647398430766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELPLG,P-selectin glycoprotein ligand 1,27207,172,0.98 [0.62-1.55],0.9411853521875791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3F,Semaphorin-3F,27255,172,1.13 [0.68-1.89],0.6345586297366823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3G,Semaphorin-3G,23256,143,1.18 [0.82-1.70],0.3696706552352534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4C,Semaphorin-4C,27133,172,1.02 [0.63-1.66],0.923068708225138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4D,Semaphorin-4D,27496,174,1.07 [0.69-1.69],0.7534521752850551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA6C,Semaphorin-6C,23084,146,1.31 [0.77-2.22],0.3144066813479219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA7A,Semaphorin-7A,27498,172,1.39 [0.87-2.21],0.1669136390218846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN3,Neuronal-specific septin-3,23723,148,1.03 [0.84-1.27],0.7823995583748978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN7,Septin-7,23310,148,0.90 [0.65-1.24],0.5176990809701156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN8,Septin-8,23658,148,1.54 [1.01-2.35],0.0424222967551068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN9,Septin-9,27133,172,1.05 [0.66-1.67],0.8351348463893141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA1,Alpha-1-antitrypsin,23347,144,1.31 [0.19-9.22],0.7880629449745984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA11,Serpin A11,27587,172,1.32 [0.95-1.85],0.1020542958187716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA12,Serpin A12,26465,169,1.05 [0.94-1.17],0.4154368133976688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA3,Alpha-1-antichymotrypsin,23703,149,0.97 [0.33-2.83],0.9614661769161912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA4,Kallistatin,23352,145,1.35 [0.69-2.63],0.3829317847882187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA5,Plasma serine protease inhibitor,23449,144,0.86 [0.52-1.42],0.563167263743912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA6,Corticosteroid-binding globulin,23803,149,1.78 [0.74-4.28],0.1989387754737724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA7,Thyroxine-binding globulin,23803,149,0.56 [0.24-1.30],0.176142545847363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA9,Serpin A9,26990,172,1.15 [0.96-1.38],0.1236303468688099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB1,Leukocyte elastase inhibitor,27174,173,1.16 [1.00-1.34],0.0475906129315811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB5,Serpin B5,26751,160,1.37 [1.02-1.83],0.0342166642772757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB6,Serpin B6,27408,174,1.23 [0.99-1.53],0.0677544020874368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB8,Serpin B8,27538,173,1.15 [0.94-1.42],0.1735293761882209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB9,Serpin B9,27073,171,1.17 [0.78-1.75],0.4459590231663854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINC1,Antithrombin-III,23752,148,1.16 [0.41-3.31],0.7827514534542108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPIND1,Heparin cofactor 2,23752,148,1.21 [0.69-2.15],0.5083861718840006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE1,Plasminogen activator inhibitor 1,27587,172,1.17 [0.95-1.43],0.1337853013873671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE2,Glia-derived nexin,23762,150,1.34 [1.06-1.69],0.0143865554474401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF1,Pigment epithelium-derived factor,23451,145,1.81 [1.03-3.18],0.0402819431339281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF2,Alpha-2-antiplasmin,23357,143,0.90 [0.28-2.89],0.863565111325741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPING1,Plasma protease C1 inhibitor,23752,148,2.12 [0.92-4.89],0.0794142045960815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINH1,Serpin H1,23310,148,1.07 [0.94-1.20],0.3042322768089142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI1,Neuroserpin,23208,143,0.96 [0.58-1.59],0.8676744479610128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI2,Serpin I2,23636,148,1.06 [0.81-1.39],0.6690992122821964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,26588,162,1.18 [0.96-1.45],0.1073018040340611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SETMAR,Histone-lysine N-methyltransferase SETMAR,26992,171,1.21 [0.78-1.87],0.4033605522031231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6,Seizure protein 6 homolog,23097,146,1.16 [0.70-1.90],0.5677110916010483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L,Seizure 6-like protein,27351,173,1.20 [0.74-1.96],0.4606056317058054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L2,Seizure 6-like protein 2,27133,172,0.95 [0.53-1.69],0.8582446113439042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SF3B4,Splicing factor 3B subunit 4,27133,172,1.06 [0.89-1.26],0.531563161907242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,26990,171,1.20 [0.89-1.62],0.2361024219909165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP4,Secreted frizzled-related protein 4,23256,143,1.01 [0.68-1.48],0.9797317557315476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA1,Pulmonary surfactant-associated protein A1,26616,166,1.04 [0.82-1.31],0.7497583034416422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA2,Pulmonary surfactant-associated protein A2,26616,166,1.07 [0.81-1.40],0.6442626414984469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPD,Pulmonary surfactant-associated protein D,27255,172,1.34 [1.09-1.64],0.0047177436019861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SGSH,N-sulphoglucosamine sulphohydrolase,23348,148,0.95 [0.72-1.27],0.7505581348813085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2B3,SH2B adapter protein 3,26616,166,1.09 [0.95-1.26],0.2201260755049643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2D1A,SH2 domain-containing protein 1A,27207,172,1.07 [0.85-1.35],0.5455456153284978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,22986,143,1.31 [1.08-1.58],0.005406918799227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BP1,SH3 domain-binding protein 1,23636,148,0.99 [0.71-1.37],0.936411053491148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GL3,Endophilin-A3,23182,147,1.10 [0.91-1.33],0.3111279396394775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GLB2,Endophilin-B2,23705,149,1.12 [0.89-1.41],0.3417672359986107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHBG,Sex hormone-binding globulin,23771,148,0.90 [0.68-1.19],0.4648595116093313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHC1,SHC-transforming protein 1,22891,140,0.90 [0.78-1.05],0.1813993999788914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHD,SH2 domain-containing adapter protein D,22950,148,1.07 [0.91-1.26],0.4227661027679605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHH,Sonic hedgehog protein,23084,146,1.24 [0.90-1.71],0.1953765773180863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHISA5,Protein shisa-5,23755,147,1.50 [0.87-2.60],0.1434996435723848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHMT1,"Serine hydroxymethyltransferase, cytosolic",27344,169,1.12 [0.95-1.30],0.1711291445940281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHPK,Sedoheptulokinase,23310,148,1.23 [0.89-1.71],0.2138473547230126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIAE,Sialate O-acetylesterase,27307,172,1.47 [1.12-1.94],0.0058880799490287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,27391,171,1.42 [1.05-1.93],0.0231665816488202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC10,Sialic acid-binding Ig-like lectin 10,27207,172,1.32 [0.89-1.95],0.1675866042891506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC15,Sialic acid-binding Ig-like lectin 15,26588,162,1.01 [0.85-1.20],0.886125979307631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC5,Sialic acid-binding Ig-like lectin 5,27261,173,0.97 [0.88-1.09],0.6454021421489522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC6,Sialic acid-binding Ig-like lectin 6,27485,171,1.17 [0.78-1.75],0.4482981627297971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC7,Sialic acid-binding Ig-like lectin 7,27255,172,1.30 [0.81-2.11],0.279138483808921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC8,Sialic acid-binding Ig-like lectin 8,23148,148,1.69 [1.20-2.37],0.0025708477274602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC9,Sialic acid-binding Ig-like lectin 9,27448,171,0.94 [0.60-1.48],0.8023852476870288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIL1,Nucleotide exchange factor SIL1,23148,148,0.93 [0.56-1.55],0.792354200279042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,27322,171,1.12 [0.88-1.43],0.3657652251545008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPB1,Signal-regulatory protein beta-1,27218,168,1.34 [1.00-1.81],0.0529389936606143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT1,NAD-dependent protein deacetylase sirtuin-1,23084,146,1.08 [0.91-1.27],0.4012795642741703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT2,NAD-dependent protein deacetylase sirtuin-2,27133,172,1.10 [0.95-1.28],0.2128674073067316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",26588,162,1.08 [0.85-1.37],0.5298154432327059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIT1,Signaling threshold-regulating transmembrane adapter 1,26707,161,1.15 [0.90-1.47],0.2792060466664796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP1,Src kinase-associated phosphoprotein 1,27023,171,0.93 [0.77-1.12],0.4341722254564827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP2,Src kinase-associated phosphoprotein 2,27391,171,1.06 [0.93-1.20],0.3776596697173923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKIV2L,Helicase SKI2W,22998,148,1.30 [0.94-1.79],0.1096107102518278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLA2,Src-like-adapter 2,23723,148,1.05 [0.91-1.23],0.4998457512360101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,26707,161,1.51 [1.19-1.91],0.0006585543082159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF6,SLAM family member 6,26616,166,1.64 [1.17-2.30],0.0039318343261352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF7,SLAM family member 7,27207,172,1.17 [0.94-1.47],0.1670881241088108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF8,SLAM family member 8,26616,166,1.30 [1.00-1.69],0.0490163040973714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC12A2,Solute carrier family 12 member 2,22998,148,1.18 [0.74-1.89],0.4941286832168745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC13A1,Solute carrier family 13 member 1,23623,149,1.17 [0.96-1.43],0.1147997944647126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC16A1,Monocarboxylate transporter 1,26588,162,1.15 [0.94-1.41],0.1867908840846983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC1A4,Neutral amino acid transporter A,23097,146,1.15 [0.87-1.50],0.3268599646139588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC27A4,Long-chain fatty acid transport protein 4,26588,162,1.09 [0.90-1.33],0.372921097759179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC28A1,Sodium/nucleoside cotransporter 1,22891,140,1.15 [0.90-1.45],0.2619690096647449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC34A3,Sodium-dependent phosphate transport protein 2C,22891,140,0.90 [0.63-1.28],0.5587499719297411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A14,Zinc transporter ZIP14,26588,162,1.51 [1.07-2.13],0.01879430596022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A5,Zinc transporter ZIP5,27207,172,1.15 [0.92-1.44],0.2098340077481909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC44A4,Choline transporter-like protein 4,23097,146,1.09 [0.89-1.33],0.4179696712856995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC4A1,Band 3 anion transport protein,23755,147,1.00 [0.72-1.40],0.9845750296556408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC51B,Organic solute transporter subunit beta,22998,148,1.10 [0.91-1.33],0.3048917164891402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23256,143,1.14 [0.94-1.38],0.1726264781675187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23636,148,1.09 [0.83-1.44],0.5170917096684136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22891,140,1.17 [0.91-1.50],0.2178979947769247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIT2,Slit homolog 2 protein,26588,162,0.96 [0.73-1.26],0.7506205302526352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK1,SLIT and NTRK-like protein 1,23084,146,0.84 [0.51-1.39],0.4936234804787253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK2,SLIT and NTRK-like protein 2,27485,171,1.24 [0.87-1.76],0.2343620008643411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK6,SLIT and NTRK-like protein 6,26751,160,1.29 [0.87-1.92],0.2061349251363271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLK,STE20-like serine/threonine-protein kinase,23310,148,1.09 [0.91-1.30],0.3608102441235221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLMAP,Sarcolemmal membrane-associated protein,23636,148,1.23 [1.03-1.47],0.0245327938181277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLURP1,Secreted Ly-6/uPAR-related protein 1,23574,145,1.24 [0.87-1.75],0.2310899823524419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD1,Mothers against decapentaplegic homolog 1,26616,166,1.14 [0.96-1.34],0.1351777035899705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD2,Mothers against decapentaplegic homolog 2,23623,149,1.23 [0.99-1.52],0.0633600248837151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD3,Mothers against decapentaplegic homolog 3,23623,149,1.15 [0.85-1.54],0.3713752612465634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD5,Mothers against decapentaplegic homolog 5,27133,172,0.93 [0.48-1.80],0.8342425254211912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMARCA2,Probable global transcription activator SNF2L2,26588,162,1.07 [0.89-1.29],0.4749362616907682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMC3,Structural maintenance of chromosomes protein 3,22891,140,0.71 [0.50-1.01],0.0546673695661379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMNDC1,Survival of motor neuron-related-splicing factor 30,23636,148,1.23 [1.00-1.52],0.0488530518510021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC1,SPARC-related modular calcium-binding protein 1,27485,171,1.36 [0.91-2.03],0.1308689604214393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC2,SPARC-related modular calcium-binding protein 2,27391,171,1.20 [0.85-1.70],0.2894338788640491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD1,Sphingomyelin phosphodiesterase,27363,174,1.30 [0.99-1.71],0.0610939423597653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD3,Sphingomyelin phosphodiesterase 3,23084,146,1.10 [0.86-1.42],0.4404947775366631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,27351,171,1.10 [0.89-1.37],0.3654271790313607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23623,149,0.81 [0.63-1.05],0.1079974550146579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMS,Spermine synthase,22986,143,1.05 [0.83-1.34],0.6681115743305717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMTN,Smoothelin,23662,149,1.14 [0.98-1.32],0.1015351059881123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP23,Synaptosomal-associated protein 23,27255,172,1.07 [0.92-1.26],0.3707701049862743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP25,Synaptosomal-associated protein 25,22986,143,1.28 [0.92-1.79],0.1455168008071619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP29,Synaptosomal-associated protein 29,27351,173,1.15 [0.99-1.33],0.0661571665666076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAPIN,SNARE-associated protein Snapin,23723,148,1.26 [0.97-1.64],0.081595352766507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCA,Alpha-synuclein,23256,143,0.98 [0.85-1.12],0.7358649100959496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCG,Gamma-synuclein,27073,171,1.14 [0.93-1.40],0.2025613146415793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23148,148,1.10 [0.71-1.73],0.6676956974975738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNRPB2,U2 small nuclear ribonucleoprotein B'',23705,149,1.33 [1.05-1.68],0.0179443970504248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNU13,NHP2-like protein 1,22998,148,1.03 [0.81-1.31],0.8103360040093704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX15,Sorting nexin-15,23256,143,1.15 [0.86-1.53],0.340399144445331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX18,Sorting nexin-18,23636,148,1.19 [0.86-1.65],0.2832201384556495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX2,Sorting nexin-2,23623,149,1.10 [0.92-1.33],0.3031493109327122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX5,Sorting nexin-5,23148,148,1.29 [0.79-2.10],0.3147311249773701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX9,Sorting nexin-9,27255,172,1.16 [0.96-1.40],0.1346350816633356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD1,Superoxide dismutase [Cu-Zn],26689,172,1.10 [0.84-1.45],0.4770487250203882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD2,"Superoxide dismutase [Mn], mitochondrial",27261,173,1.72 [1.28-2.32],0.0003456764232772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD3,Extracellular superoxide dismutase,23771,148,1.01 [0.78-1.31],0.9600342818816028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORBS1,Sorbin and SH3 domain-containing protein 1,23723,148,1.39 [1.06-1.84],0.0191668592894196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,26616,166,1.59 [1.10-2.29],0.0131651436585415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORD,Sorbitol dehydrogenase,27356,171,1.12 [0.92-1.37],0.2691100165906472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORT1,Sortilin,27210,172,1.49 [1.04-2.14],0.0281743503658965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOST,Sclerostin,27210,172,0.81 [0.58-1.15],0.2378343499078998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23097,146,1.04 [0.76-1.40],0.8192345342653589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX2,Transcription factor SOX-2,23683,148,0.99 [0.50-1.94],0.9677338591185004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX9,Transcription factor SOX-9,23097,146,1.85 [1.05-3.27],0.032559440903706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23723,148,1.51 [1.01-2.24],0.0436166376211132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPAG1,Sperm-associated antigen 1,23723,148,0.94 [0.71-1.25],0.6896764139643886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARC,SPARC,27351,173,1.09 [0.90-1.33],0.3666034846688309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARCL1,SPARC-like protein 1,27259,172,1.44 [0.92-2.25],0.1080077677595962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPART,Spartin,23256,143,1.22 [1.00-1.50],0.0500317037389244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPESP1,Sperm equatorial segment protein 1,23762,150,1.23 [0.72-2.11],0.4465373472949375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,27261,173,1.60 [1.24-2.08],0.0003803023634885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK2,Serine protease inhibitor Kazal-type 2,23256,143,0.93 [0.62-1.40],0.7407042184863388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK4,Serine protease inhibitor Kazal-type 4,27207,172,1.05 [0.86-1.29],0.6043728938770703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK5,Serine protease inhibitor Kazal-type 5,27261,173,1.29 [0.86-1.95],0.2156543250583665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK6,Serine protease inhibitor Kazal-type 6,27485,171,1.26 [0.98-1.62],0.074197833424866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK8,Serine protease inhibitor Kazal-type 8,22998,148,1.05 [0.70-1.56],0.8243894162340933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,27183,173,1.87 [1.16-3.04],0.010902526193371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT2,Kunitz-type protease inhibitor 2,27391,171,2.02 [1.46-2.80],2.2739182490639777e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT3,Kunitz-type protease inhibitor 3,23636,148,0.92 [0.82-1.03],0.1593945122917024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPOCK1,Testican-1,27073,171,0.59 [0.34-1.01],0.0532155569714165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,27306,168,1.73 [1.21-2.48],0.0027155352398064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,27125,171,2.00 [1.38-2.88],0.0002319042529586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,27542,172,1.47 [1.11-1.94],0.0067373633884772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23084,146,1.16 [0.83-1.64],0.3835276895967835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRING1,SREBP regulating gene protein,22891,140,0.98 [0.74-1.31],0.9139491389788102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR1B,Cornifin-B,23310,148,0.99 [0.82-1.20],0.8944441583843592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR3,Small proline-rich protein 3,23705,149,0.98 [0.79-1.21],0.831616907455005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRY2,Protein sprouty homolog 2,26707,161,1.07 [0.92-1.24],0.4003953617105968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",22986,143,1.06 [0.66-1.70],0.8190926639689581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTLC1,Serine palmitoyltransferase 1,23705,149,1.33 [0.95-1.86],0.1012150300381581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRC,Proto-oncogene tyrosine-protein kinase Src,27304,173,1.09 [0.97-1.21],0.1550858038226435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRP14,Signal recognition particle 14 kDa protein,27133,172,1.17 [0.95-1.45],0.1488201505793085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPK2,SRSF protein kinase 2,27207,172,1.07 [0.91-1.25],0.4241608324214803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,23762,150,1.54 [0.96-2.46],0.0721550427864721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSB,Lupus La protein,26588,162,0.94 [0.73-1.20],0.6032096377357619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23084,146,1.14 [0.75-1.72],0.5482269298714288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27210,172,0.97 [0.85-1.10],0.617688907794949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,27347,172,1.23 [0.89-1.69],0.2139710708152767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSH3,Protein phosphatase Slingshot homolog 3,22891,140,1.08 [0.63-1.86],0.7756874014421579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSNA1,Sjoegren syndrome nuclear autoantigen 1,23636,148,1.41 [1.07-1.86],0.0148750410231432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST13,Hsc70-interacting protein,23256,143,1.08 [0.81-1.43],0.5975589241987018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27133,172,0.93 [0.67-1.30],0.683362860380641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",27587,172,1.30 [0.82-2.05],0.265509525478731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23084,146,0.96 [0.67-1.37],0.8139045618307008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAB2,Stabilin-2,23755,147,1.31 [0.75-2.27],0.338777441302352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAM,Signal transducing adapter molecule 1,23623,149,1.18 [0.81-1.73],0.3888892864745219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAMBP,STAM-binding protein,27023,171,1.16 [0.94-1.43],0.1661387614904494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT2,Signal transducer and activator of transcription 2,23084,146,1.14 [0.93-1.40],0.2101892905521126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT5B,Signal transducer and activator of transcription 5B,27133,172,1.03 [0.93-1.14],0.5443207373669412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22891,140,1.12 [0.89-1.39],0.3399204373794098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC1,Stanniocalcin-1,27496,174,1.23 [0.90-1.67],0.1896533713233948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC2,Stanniocalcin-2,27222,172,2.04 [1.19-3.49],0.0090871356398281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STEAP4,Metalloreductase STEAP4,22986,143,0.90 [0.71-1.14],0.375146867289986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STIP1,Stress-induced-phosphoprotein 1,27223,173,1.20 [0.98-1.46],0.0725761863144249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK11,Serine/threonine-protein kinase STK11,26751,160,1.15 [0.95-1.39],0.1463086337074155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK24,Serine/threonine-protein kinase 24,26588,162,1.09 [0.87-1.36],0.4605062796689331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK4,Serine/threonine-protein kinase 4,27255,172,1.06 [0.91-1.24],0.4624622459784188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STOML2,"Stomatin-like protein 2, mitochondrial",22891,140,0.94 [0.78-1.13],0.4827283380469082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX16,Syntaxin-16,26616,166,1.12 [0.90-1.40],0.2992240867978516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX1B,Syntaxin-1B,23097,146,1.28 [0.96-1.70],0.0881809649482566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX3,Syntaxin-3,23705,149,0.97 [0.65-1.45],0.8806366264967432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX4,Syntaxin-4,27133,172,1.23 [1.02-1.48],0.0308476042327772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX5,Syntaxin-5,23084,146,1.21 [0.88-1.66],0.2467927124450385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX6,Syntaxin-6,26616,166,1.12 [0.93-1.36],0.2295392515494032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX7,Syntaxin-7,23084,146,0.95 [0.69-1.30],0.7290191071361263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX8,Syntaxin-8,27207,172,1.30 [1.01-1.68],0.0439719530049076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP1,Syntaxin-binding protein 1,23723,148,1.09 [0.89-1.34],0.4038449282738666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP3,Syntaxin-binding protein 3,26616,166,1.27 [0.96-1.68],0.0922671921918766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGP1,SURP and G-patch domain-containing protein 1,23636,148,1.32 [0.92-1.89],0.1295431658372353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGT1,Protein SGT1 homolog,26616,166,1.14 [0.96-1.35],0.1306028055823027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT1A1,Sulfotransferase 1A1,27496,174,1.05 [0.95-1.17],0.3205084323058449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT2A1,Bile salt sulfotransferase,27207,172,1.08 [0.86-1.36],0.5241634277322793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF1,Formylglycine-generating enzyme,23084,146,1.01 [0.80-1.27],0.9621869358183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,27496,174,1.17 [0.91-1.52],0.2275901496392992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUOX,"Sulfite oxidase, mitochondrial",23723,148,1.28 [1.03-1.60],0.0289980294115502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD1,Sushi domain-containing protein 1,26751,160,1.19 [0.89-1.60],0.242156633361135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD2,Sushi domain-containing protein 2,27261,173,1.45 [0.95-2.22],0.0883000249204381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD4,Sushi domain-containing protein 4,23623,149,1.23 [0.89-1.70],0.2022170372390786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD5,Sushi domain-containing protein 5,23116,143,1.12 [0.70-1.78],0.6396187007324575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SV2A,Synaptic vesicle glycoprotein 2A,23097,146,1.30 [1.05-1.61],0.0152562260119945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SWAP70,Switch-associated protein 70,23636,148,1.65 [1.20-2.28],0.0023306180902281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYAP1,Synapse-associated protein 1,23256,143,1.09 [0.82-1.44],0.5505314814132454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,22986,143,0.91 [0.68-1.23],0.5534971932602133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYT1,Synaptotagmin-1,23705,149,1.10 [0.75-1.61],0.6381694854836033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYTL4,Synaptotagmin-like protein 4,23762,150,1.19 [0.98-1.45],0.0844035887645072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23310,148,1.13 [0.97-1.31],0.1178682808759686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACC3,Transforming acidic coiled-coil-containing protein 3,27133,172,1.07 [0.95-1.20],0.2602431685662937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACSTD2,Tumor-associated calcium signal transducer 2,24147,155,0.90 [0.55-1.47],0.6799128958333435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TADA3,Transcriptional adapter 3,23623,149,1.36 [0.92-2.00],0.1231229956039676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,27133,172,1.23 [0.85-1.78],0.2766095531003237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAGLN3,Transgelin-3,22891,140,1.20 [0.96-1.49],0.1140170168485178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TALDO1,Transaldolase,23660,147,1.26 [0.90-1.76],0.1860926113786381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TANK,TRAF family member-associated NF-kappa-B activator,26707,161,1.13 [0.92-1.38],0.2416451311181447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAP1,Antigen peptide transporter 1,23310,148,0.89 [0.67-1.19],0.4420397458467714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARBP2,RISC-loading complex subunit TARBP2,26588,162,1.12 [0.94-1.34],0.1910945889507937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23097,146,0.84 [0.66-1.07],0.1507837049758061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23623,149,1.33 [0.90-1.95],0.1524381525097454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAX1BP1,Tax1-binding protein 1,23705,149,1.21 [0.97-1.52],0.0971560732291855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D17,TBC1 domain family member 17,26588,162,1.07 [0.80-1.43],0.6432199124550079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D23,TBC1 domain family member 23,27133,172,1.06 [0.91-1.22],0.4704795657014707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D5,TBC1 domain family member 5,27207,172,1.16 [0.99-1.36],0.0659868866447063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCA,Tubulin-specific chaperone A,23256,143,1.10 [0.91-1.32],0.3156042318762386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCB,Tubulin-folding cofactor B,27073,171,1.12 [0.98-1.29],0.1048479667914861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCC,Tubulin-specific chaperone C,27073,171,1.11 [0.94-1.31],0.2379801194524792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBL1X,F-box-like/WD repeat-containing protein TBL1X,26616,166,1.19 [1.01-1.41],0.035962062626486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBR1,T-box brain protein 1,23097,146,0.90 [0.63-1.29],0.5709496592121244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1A,T-cell leukemia/lymphoma protein 1A,27028,171,0.96 [0.83-1.10],0.5510422901597434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1B,T-cell leukemia/lymphoma protein 1B,26751,160,1.02 [0.87-1.21],0.7886381619517676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN1,Transcobalamin-1,23274,143,1.07 [0.67-1.71],0.7760047502487943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,27542,172,1.43 [0.95-2.14],0.0846611013737587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCOF1,Treacle protein,23762,150,1.64 [1.12-2.39],0.0102101384084875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCP11,T-complex protein 11 homolog,23310,148,0.90 [0.66-1.21],0.4684848935610384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCTN3,Tectonic-3,23762,150,1.40 [0.82-2.39],0.2121125526115386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDGF1,Teratocarcinoma-derived growth factor 1,26588,162,0.98 [0.89-1.08],0.7100569274663563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDO2,"Tryptophan 2,3-dioxygenase",23097,146,1.07 [0.73-1.57],0.721579848388626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDP1,Tyrosyl-DNA phosphodiesterase 1,23623,149,1.04 [0.83-1.29],0.7416458194105305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDRKH,Tudor and KH domain-containing protein,26588,162,1.09 [0.93-1.28],0.3112299489192091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEF,Thyrotroph embryonic factor,22998,148,1.30 [0.95-1.78],0.0955970133915763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEK,Angiopoietin-1 receptor,27351,173,1.35 [0.73-2.50],0.3419307385557026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TERF1,Telomeric repeat-binding factor 1,23084,146,1.04 [0.62-1.76],0.8755778951934852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TET2,Methylcytosine dioxygenase TET2,23266,148,0.95 [0.80-1.12],0.5156363618703876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX101,Testis-expressed protein 101,23097,146,0.63 [0.42-0.95],0.0280308997239712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX33,Testis-expressed protein 33,23310,148,1.23 [0.90-1.69],0.188152201545916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TF,Serotransferrin,23803,149,1.38 [0.68-2.81],0.3691949412884607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFAP2A,Transcription factor AP-2-alpha,22986,143,1.16 [0.91-1.47],0.2266598260317071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,27122,173,1.25 [1.08-1.46],0.0033469441676913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,27344,169,1.37 [1.10-1.71],0.0046883380142274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,27212,171,1.10 [0.85-1.43],0.4781410921503233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI,Tissue factor pathway inhibitor,27167,172,1.21 [0.80-1.84],0.3690322754080584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI2,Tissue factor pathway inhibitor 2,27261,173,1.38 [1.07-1.77],0.0114045204682507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFRC,Transferrin receptor protein 1,27355,172,0.99 [0.70-1.41],0.9682303687840466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TG,Thyroglobulin,23623,149,0.91 [0.79-1.04],0.1643978117224654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,27207,172,1.38 [1.06-1.80],0.0172827321994882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB1,Transforming growth factor beta-1 proprotein,27493,172,1.57 [1.13-2.19],0.0079186443535069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB2,Transforming growth factor beta-2 proprotein,23623,149,0.98 [0.73-1.32],0.9170897872308632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBI,Transforming growth factor-beta-induced protein ig-h3,27078,172,1.63 [1.01-2.65],0.046749909628592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR1,TGF-beta receptor type-1,23084,146,1.09 [0.53-2.23],0.8107334683861499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,27351,173,1.76 [1.22-2.56],0.0027611522851988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR3,Transforming growth factor beta receptor type 3,27587,172,1.93 [1.26-2.96],0.0023686403703435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGM2,Protein-glutamine gamma-glutamyltransferase 2,27214,172,0.94 [0.79-1.12],0.4754780488220899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGOLN2,Trans-Golgi network integral membrane protein 2,23771,148,2.51 [1.42-4.41],0.0014286360092313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THAP12,52 kDa repressor of the inhibitor of the protein kinase,22849,140,1.03 [0.86-1.22],0.7813134495898445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBD,Thrombomodulin,27255,172,1.43 [0.89-2.31],0.1387540044898697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,27261,173,1.68 [1.23-2.30],0.0011691663927425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS4,Thrombospondin-4,27256,172,1.05 [0.78-1.42],0.7267049558899346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THOP1,Thimet oligopeptidase,27125,171,0.98 [0.63-1.52],0.9184828700628292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THPO,Thrombopoietin,26751,160,1.27 [0.89-1.82],0.190637880865747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THRAP3,Thyroid hormone receptor-associated protein 3,22998,148,0.98 [0.85-1.13],0.7697375235359216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THSD1,Thrombospondin type-1 domain-containing protein 1,22900,146,1.63 [1.12-2.37],0.0110914452227812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THTPA,Thiamine-triphosphatase,23586,148,1.12 [0.93-1.33],0.2228698238628297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THY1,Thy-1 membrane glycoprotein,27496,174,1.35 [0.85-2.15],0.2055523492111532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIA1,Nucleolysin TIA-1 isoform p40,26449,156,1.06 [0.94-1.19],0.3125774108942439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIE1,Tyrosine-protein kinase receptor Tie-1,27587,172,1.00 [0.73-1.38],0.998322781106405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",26538,162,1.20 [0.90-1.59],0.2108222058861051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23310,148,1.04 [0.68-1.59],0.844213495168013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,27347,172,1.17 [0.86-1.57],0.3167113845091656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23762,150,1.35 [0.94-1.94],0.1086507816359514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23705,149,1.16 [0.97-1.39],0.1062800738158909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,26938,171,2.46 [1.69-3.60],3.0905903488634627e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP2,Metalloproteinase inhibitor 2,23762,150,1.40 [0.94-2.08],0.099742234901039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP3,Metalloproteinase inhibitor 3,27391,171,1.10 [1.00-1.21],0.0586067103699108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,27261,173,1.36 [1.00-1.85],0.0498010583014896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TINAGL1,Tubulointerstitial nephritis antigen-like,27164,172,0.95 [0.52-1.75],0.8722258390950834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJAP1,Tight junction-associated protein 1,27351,173,1.15 [0.98-1.35],0.0807607576710778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJP3,Tight junction protein ZO-3,22986,143,1.19 [0.86-1.66],0.2895592642737057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TK1,"Thymidine kinase, cytosolic",23310,148,1.15 [0.84-1.59],0.3855312727006378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR1,Toll-like receptor 1,23084,146,1.34 [0.76-2.35],0.3076539705054564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR2,Toll-like receptor 2,23310,148,1.49 [0.76-2.91],0.2481991220955022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR3,Toll-like receptor 3,27538,173,1.23 [0.98-1.55],0.0802776333623824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR4,Toll-like receptor 4,23084,146,1.16 [0.67-2.01],0.5907469735133352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23097,146,1.10 [0.83-1.46],0.5162597113774303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED1,Transmembrane emp24 domain-containing protein 1,23310,148,1.00 [0.75-1.33],0.9827323579698414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED10,Transmembrane emp24 domain-containing protein 10,22998,148,1.03 [0.76-1.40],0.8660292844654975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED4,Transmembrane emp24 domain-containing protein 4,22998,148,0.92 [0.68-1.24],0.5855405495777615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED8,Protein TMED8,23636,148,1.15 [0.99-1.34],0.0735222157527649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM106A,Transmembrane protein 106A,23623,149,1.22 [1.00-1.49],0.0524685252426544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM132A,Transmembrane protein 132A,23148,148,0.98 [0.76-1.26],0.8897700711418339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM25,Transmembrane protein 25,23723,148,1.06 [0.75-1.48],0.7546727641617695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMOD4,Tropomodulin-4,22891,140,1.12 [0.77-1.64],0.5556730458642656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11B,Transmembrane protease serine 11B,22986,143,0.98 [0.79-1.21],0.8431527755813142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11D,Transmembrane protease serine 11D,23658,148,1.63 [1.19-2.24],0.0024122752393343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS15,Enteropeptidase,27133,172,1.12 [0.97-1.30],0.131681563147591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS5,Transmembrane protease serine 5,26944,171,0.99 [0.70-1.42],0.967977269599244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMSB10,Thymosin beta-10,27261,173,1.17 [0.98-1.40],0.0815987915801559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNC,Tenascin,27347,172,1.23 [0.94-1.62],0.1369231179701763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNF,Tumor necrosis factor,26705,160,1.20 [0.89-1.62],0.2389955273225414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23636,148,1.52 [1.16-2.00],0.0024182816821188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,26707,161,0.96 [0.66-1.41],0.8509324903226121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23256,143,1.12 [0.88-1.44],0.349342805897197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27073,171,2.04 [1.53-2.72],1.184150829702852e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27073,171,1.30 [1.06-1.58],0.0096631099215508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27311,171,1.13 [0.86-1.49],0.3788899006121414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,27538,173,1.76 [1.28-2.41],0.000484429233051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27258,168,1.35 [0.86-2.12],0.1989025622754456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27351,173,1.85 [1.30-2.64],0.0006615156837774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27306,168,1.29 [0.88-1.89],0.1847869770342153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,26707,161,1.06 [0.76-1.47],0.7523323666694527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27306,168,2.21 [1.47-3.33],0.0001414193576607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23256,143,0.97 [0.65-1.43],0.8591617749352518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,27485,171,1.57 [1.04-2.35],0.0298262533727919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27261,173,2.19 [1.45-3.30],0.0002000864392714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27261,173,1.52 [1.20-1.92],0.0005031656643553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,27496,174,1.38 [0.85-2.23],0.1883485491539786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,27493,172,1.57 [1.14-2.16],0.0057813938585417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27073,171,1.26 [1.01-1.58],0.0425904182561672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,27496,174,1.25 [0.95-1.65],0.1087434640082024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27073,171,1.40 [1.04-1.88],0.0258633300607336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF10,Tumor necrosis factor ligand superfamily member 10,27538,173,0.94 [0.56-1.58],0.8253340482145075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF11,Tumor necrosis factor ligand superfamily member 11,27207,172,1.04 [0.83-1.30],0.7342806965690089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF12,Tumor necrosis factor ligand superfamily member 12,27538,173,0.85 [0.54-1.35],0.5015823981715953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,27391,171,1.80 [1.09-2.95],0.0209005662737971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,27540,172,1.83 [1.23-2.72],0.0026824971194603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF14,Tumor necrosis factor ligand superfamily member 14,27073,171,1.13 [0.89-1.42],0.3129741963983611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF8,Tumor necrosis factor ligand superfamily member 8,23755,147,1.29 [0.84-1.98],0.2507788964482894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNIP1,TNFAIP3-interacting protein 1,23705,149,1.14 [0.96-1.36],0.1293376237975023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNN,Tenascin-N,23755,147,1.00 [0.71-1.43],0.9815427906948232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNNI3,"Troponin I, cardiac muscle",26751,160,1.16 [0.97-1.39],0.1082224458981512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNPO1,Transportin-1,23310,148,0.82 [0.52-1.31],0.4076631580721167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNR,Tenascin-R,27073,171,0.75 [0.55-1.03],0.0736509179183826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNXB,Tenascin-X,27261,173,0.91 [0.54-1.54],0.7204684581404315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23762,150,1.16 [0.96-1.41],0.123582507707821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1,DNA topoisomerase 1,23636,148,0.98 [0.85-1.14],0.788521814415065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1MT,"DNA topoisomerase I, mitochondrial",22891,140,0.94 [0.67-1.32],0.7208484799173258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP2B,DNA topoisomerase 2-beta,23084,146,1.09 [0.90-1.33],0.3774807123736382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOR1AIP1,Torsin-1A-interacting protein 1,23148,148,1.36 [1.08-1.73],0.0104840912809448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53,Cellular tumor antigen p53,26616,166,1.30 [0.95-1.78],0.0976248325078429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53BP1,TP53-binding protein 1,23084,146,1.13 [0.95-1.34],0.1775148515400176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53I3,Quinone oxidoreductase PIG3,22747,138,1.08 [0.80-1.47],0.602803743654569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53INP1,Tumor protein p53-inducible nuclear protein 1,26751,160,0.93 [0.59-1.45],0.7339721166159829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP73,Tumor protein p73,23097,146,0.83 [0.52-1.32],0.4401627637706425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPBGL,Trophoblast glycoprotein-like,23097,146,1.10 [0.77-1.58],0.5981443423806074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPD52L2,Tumor protein D54,23256,143,1.06 [0.91-1.23],0.4586826037973655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPK1,Thiamin pyrophosphokinase 1,23762,150,1.39 [0.79-2.45],0.2571659950251673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPM3,Tropomyosin alpha-3 chain,22998,148,1.18 [0.84-1.66],0.3415691509911278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPMT,Thiopurine S-methyltransferase,26616,166,0.99 [0.82-1.19],0.8788260501544232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPP1,Tripeptidyl-peptidase 1,27076,166,1.33 [1.01-1.73],0.0389580818844387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP2,Tubulin polymerization-promoting protein family member 2,23310,148,0.91 [0.74-1.12],0.3655898824887784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP3,Tubulin polymerization-promoting protein family member 3,26588,162,0.91 [0.63-1.32],0.6152965637972776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPR,Nucleoprotein TPR,22998,148,1.29 [1.02-1.63],0.0314564915078004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPRKB,EKC/KEOPS complex subunit TPRKB,22891,140,0.87 [0.65-1.17],0.3520480390664742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSAB1,Tryptase alpha/beta-1,27493,173,1.46 [1.13-1.90],0.0041365910564009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSD1,Tryptase delta,23723,148,1.36 [0.98-1.87],0.0634871289383477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSG1,Tryptase gamma,23084,146,1.16 [0.67-2.03],0.5932351933992508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPT1,Translationally-controlled tumor protein,26707,161,1.02 [0.82-1.26],0.8626951073179054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF2,TNF receptor-associated factor 2,27207,172,1.13 [0.94-1.37],0.185752822806655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3,"TNF receptor-associated factor 3, Isoform 2",23084,146,1.16 [0.78-1.73],0.4568944587331487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,22998,148,0.87 [0.60-1.26],0.4654082606901111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23310,148,1.11 [0.94-1.31],0.2296936827033453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREH,Trehalase,23755,147,1.18 [0.95-1.46],0.1404581760564144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,27258,168,1.58 [1.23-2.04],0.0003264987608238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML1,Trem-like transcript 1 protein,23771,148,1.29 [0.97-1.71],0.0809514063660555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,27261,173,1.41 [0.95-2.09],0.0870449433595056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIAP1,TP53-regulated inhibitor of apoptosis 1,27485,171,1.11 [0.90-1.37],0.3323296509629577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM21,E3 ubiquitin-protein ligase TRIM21,27207,172,1.03 [0.87-1.22],0.7472889559720686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM24,Transcription intermediary factor 1-alpha,23263,148,1.21 [0.97-1.51],0.0842898816500874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23636,148,1.19 [1.03-1.38],0.0167498418454411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM26,Tripartite motif-containing protein 26,22891,140,0.86 [0.63-1.18],0.3492718795571659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM40,E3 ubiquitin ligase TRIM40,23097,146,0.89 [0.71-1.11],0.2934199992498636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM5,Tripartite motif-containing protein 5,27207,172,1.16 [0.99-1.36],0.0615926509977201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM58,E3 ubiquitin-protein ligase TRIM58,23623,149,1.15 [0.96-1.37],0.1283727764141293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRPV3,Transient receptor potential cation channel subfamily V member 3,22998,148,1.00 [0.73-1.38],0.9951021754495456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC1,Hamartin,23084,146,1.02 [0.83-1.27],0.8417441544346178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC22D1,TSC22 domain family protein 1,23723,148,1.10 [0.88-1.37],0.4212238844238676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSHB,Thyrotropin subunit beta,27255,172,0.88 [0.76-1.03],0.119331100825137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSLP,Thymic stromal lymphopoietin,26751,160,1.01 [0.81-1.27],0.9261519005840312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSNAX,Translin-associated protein X,22998,148,1.10 [0.75-1.63],0.61781617454404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN1,Tetraspanin-1,26751,160,0.67 [0.38-1.17],0.1592637592445258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN15,Tetraspanin-15,22998,148,0.91 [0.65-1.26],0.5667626424308033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN7,Tetraspanin-7,22986,143,1.07 [0.90-1.26],0.4524853998351269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN8,Tetraspanin-8,23636,148,1.04 [0.89-1.20],0.636151855500283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPYL1,Testis-specific Y-encoded-like protein 1,23084,146,1.19 [0.82-1.72],0.3596999135926525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TST,Thiosulfate sulfurtransferase,26543,162,1.03 [0.86-1.24],0.7553224119473961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTF2,Transcription termination factor 2,23097,146,1.11 [0.81-1.52],0.5168127910191658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTN,Titin,22998,148,1.15 [0.93-1.41],0.1991311103698546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTR,Transthyretin,23536,147,0.84 [0.46-1.56],0.5872845393680313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TUBB3,Tubulin beta-3 chain,22986,143,1.48 [0.87-2.53],0.152373505844395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TWF2,Twinfilin-2,23755,147,1.15 [0.96-1.39],0.1369371519173972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXK,Tyrosine-protein kinase TXK,23310,148,1.01 [0.83-1.24],0.91014640766031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXLNA,Alpha-taxilin,27073,171,1.09 [0.93-1.27],0.2738560854130181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXN,Thioredoxin,23368,145,1.19 [0.87-1.63],0.2858852927701882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC15,Thioredoxin domain-containing protein 15,27351,173,1.80 [1.14-2.85],0.0123985761934546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC5,Thioredoxin domain-containing protein 5,27496,174,1.17 [0.96-1.41],0.1191149529295906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC9,Thioredoxin domain-containing protein 9,23705,149,1.10 [0.83-1.46],0.4982164999406211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNL1,Thioredoxin-like protein 1,22939,143,1.03 [0.88-1.21],0.7352728219748991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27261,173,1.32 [1.00-1.75],0.0527238754902477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYMP,Thymidine phosphorylase,27075,171,1.16 [0.94-1.41],0.1624400328404433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRO3,Tyrosine-protein kinase receptor TYRO3,27255,172,1.11 [0.69-1.79],0.6654485081336117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23084,146,0.84 [0.66-1.08],0.1776757653556816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBAC1,Ubiquitin-associated domain-containing protein 1,27133,172,0.92 [0.63-1.33],0.6463197338067665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2B,Ubiquitin-conjugating enzyme E2 B,23623,149,1.47 [0.91-2.37],0.1138354764159496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23762,150,1.43 [1.13-1.83],0.0035544230040528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23084,146,1.16 [0.91-1.48],0.2256608661624646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBQLN3,Ubiquilin-3,22998,148,0.98 [0.69-1.39],0.9131399167148472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBXN1,UBX domain-containing protein 1,23256,143,1.18 [0.94-1.48],0.14421774780415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23636,148,1.08 [0.96-1.21],0.1792047006709146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UGDH,UDP-glucose 6-dehydrogenase,22998,148,1.04 [0.90-1.21],0.5863865356906657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UHRF2,E3 ubiquitin-protein ligase UHRF2,22998,148,1.17 [0.81-1.70],0.3981578755025866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,27073,171,1.55 [1.11-2.17],0.0100742130568738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UMOD,Uromodulin,27507,172,0.86 [0.68-1.10],0.2295001884981195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC5D,Netrin receptor UNC5D,23084,146,1.10 [0.61-1.99],0.7544937844634444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC79,Protein unc-79 homolog,22891,140,1.15 [0.88-1.50],0.3158640510788436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNG,Uracil-DNA glycosylase,23623,149,1.12 [0.72-1.74],0.6246190502876754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPB1,Beta-ureidopropionase,23762,150,1.04 [0.88-1.23],0.6263422996619269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3A,Uroplakin-3a,22986,143,0.91 [0.65-1.26],0.5560172235680765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3BL1,Uroplakin-3b-like protein 1,23269,148,1.11 [0.87-1.42],0.4115829733846367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROD,Uroporphyrinogen decarboxylase,23256,143,1.08 [0.86-1.35],0.5074472068338738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROS,Uroporphyrinogen-III synthase,23097,146,0.93 [0.73-1.18],0.5331496900450162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USO1,General vesicular transport factor p115,27133,172,1.08 [0.93-1.26],0.2859167256515905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP25,Ubiquitin carboxyl-terminal hydrolase 25,23623,149,1.22 [0.99-1.52],0.0643074558857679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP28,Ubiquitin carboxyl-terminal hydrolase 28,23705,149,1.29 [0.92-1.83],0.1440600877569192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP47,Ubiquitin carboxyl-terminal hydrolase 47,22998,148,1.03 [0.86-1.24],0.7222516047321081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP8,Ubiquitin carboxyl-terminal hydrolase 8,26751,160,1.06 [0.92-1.23],0.3933441444479183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UXS1,UDP-glucuronic acid decarboxylase 1,26616,166,1.43 [1.17-1.74],0.0003797903514234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP5,Vesicle-associated membrane protein 5,26751,160,1.19 [0.96-1.48],0.1059278201011238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP8,Vesicle-associated membrane protein 8,23084,146,1.25 [1.05-1.49],0.0110757984413735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASH1,Tubulinyl-Tyr carboxypeptidase 1,27207,172,1.06 [0.90-1.25],0.4895556239343127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASN,Vasorin,26818,171,1.35 [0.83-2.21],0.2290530345712533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASP,Vasodilator-stimulated phosphoprotein,23771,148,1.04 [0.84-1.29],0.7362309606365149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27133,172,0.79 [0.40-1.55],0.485980124277605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAV3,Guanine nucleotide exchange factor VAV3,22986,143,1.16 [0.99-1.36],0.069526397029634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,27300,172,1.78 [1.11-2.85],0.0167980991842728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAN,Versican core protein,27496,174,1.40 [0.90-2.16],0.1321092758661253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCPKMT,Protein-lysine methyltransferase METTL21D,22891,140,1.13 [0.96-1.32],0.1360930822712728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFA,Vascular endothelial growth factor A,27445,173,1.25 [1.01-1.55],0.0412347361490819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFB,Vascular endothelial growth factor B,23084,146,1.27 [0.73-2.20],0.399021464845629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFC,Vascular endothelial growth factor C,27351,173,1.18 [0.93-1.50],0.1684955840975132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFD,Vascular endothelial growth factor D,27487,173,1.37 [0.92-2.03],0.1173699388442637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VGF,Neurosecretory protein VGF,23723,148,1.50 [0.92-2.45],0.1013754790699811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIM,Vimentin,26751,160,1.15 [1.00-1.30],0.0419512081417409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIPR1,Vasoactive intestinal polypeptide receptor 1,23148,148,0.89 [0.46-1.70],0.716950067233022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIT,Vitrin,23762,150,1.29 [0.86-1.94],0.2199903305045404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VMO1,Vitelline membrane outer layer protein 1 homolog,27133,172,1.01 [0.83-1.23],0.9167216094765088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN1,Pantetheinase,23771,148,1.05 [0.85-1.31],0.6538725932671197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN2,Vascular non-inflammatory molecule 2,27133,172,0.96 [0.72-1.29],0.7947671424862849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS28,Vacuolar protein sorting-associated protein 28 homolog,23310,148,1.28 [1.04-1.58],0.0218906527168685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS37A,Vacuolar protein sorting-associated protein 37A,27133,172,1.09 [0.92-1.28],0.3327977912246898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS4B,Vacuolar protein sorting-associated protein 4B,23623,149,1.12 [0.95-1.31],0.1886592689687341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS53,Vacuolar protein sorting-associated protein 53 homolog,27133,172,1.09 [0.92-1.30],0.3168083122526974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10,V-set and immunoglobulin domain-containing protein 10,23623,149,1.36 [0.97-1.91],0.0732891127045804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,22998,148,1.83 [1.26-2.64],0.0013970456698562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG2,V-set and immunoglobulin domain-containing protein 2,23623,149,1.56 [1.25-1.94],8.334085865880446e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,27222,172,1.72 [1.27-2.34],0.000518263220661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27214,172,1.25 [1.02-1.53],0.0283288679763261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSNL1,Visinin-like protein 1,23705,149,1.14 [0.76-1.70],0.5278709853305845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM1,V-set and transmembrane domain-containing protein 1,26588,162,1.08 [0.82-1.44],0.5842610561750776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2B,V-set and transmembrane domain-containing protein 2B,23310,148,1.23 [0.90-1.69],0.1925529513412066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,26751,160,1.13 [0.91-1.41],0.2658400022418216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,27496,174,0.99 [0.82-1.19],0.9016114445533946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTCN1,V-set domain-containing T-cell activation inhibitor 1,26616,166,1.25 [0.82-1.91],0.2953324723160082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23256,143,1.21 [0.93-1.56],0.1563604921053931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA1,von Willebrand factor A domain-containing protein 1,27437,171,1.27 [0.92-1.75],0.1428795783903037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA5A,von Willebrand factor A domain-containing protein 5A,22891,140,1.05 [0.87-1.27],0.5878510025141097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,26981,171,1.22 [0.86-1.73],0.2616943476861985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2L,von Willebrand factor C domain-containing protein 2-like,23723,148,1.23 [0.96-1.59],0.1069058663102471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWF,von Willebrand factor,27587,172,0.96 [0.80-1.16],0.6729003952993979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WARS,"Tryptophan--tRNA ligase, cytoplasmic",27261,173,1.12 [0.79-1.60],0.5257265455178364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WAS,Wiskott-Aldrich syndrome protein,26707,161,1.03 [0.84-1.26],0.7990440401982856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF1,Wiskott-Aldrich syndrome protein family member 1,26751,160,1.09 [0.94-1.27],0.2452067979861492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF3,Wiskott-Aldrich syndrome protein family member 3,26588,162,0.92 [0.78-1.09],0.3398225354857946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASHC3,WASH complex subunit 3,23705,149,1.16 [0.95-1.41],0.1350017504400491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASL,Neural Wiskott-Aldrich syndrome protein,23084,146,1.19 [0.96-1.47],0.1151134097565312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WDR46,WD repeat-containing protein 46,23623,149,1.32 [0.91-1.91],0.1425701800396434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC1,WAP four-disulfide core domain protein 1,23157,148,1.21 [0.98-1.50],0.0725389394986238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC12,WAP four-disulfide core domain protein 12,27448,171,1.03 [0.84-1.27],0.7520844586370066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,25859,165,2.19 [1.64-2.91],9.6134808953438e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",26992,171,0.73 [0.52-1.02],0.0669562275901108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27306,168,1.11 [0.76-1.64],0.5878106039674857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WIF1,Wnt inhibitory factor 1,27485,171,0.95 [0.64-1.40],0.7772636866564958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,26707,161,1.40 [0.89-2.21],0.1408556723188149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27073,171,1.03 [0.81-1.32],0.8043429574457188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XCL1,Lymphotactin,27485,171,0.98 [0.77-1.25],0.8599339980442608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XG,Glycoprotein Xg,27448,170,1.40 [0.92-2.16],0.1199885671417877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XIAP,E3 ubiquitin-protein ligase XIAP,23084,146,1.25 [0.96-1.62],0.1045596062924116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XPNPEP2,Xaa-Pro aminopeptidase 2,27351,173,0.87 [0.75-1.01],0.0585072808888444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XRCC4,DNA repair protein XRCC4,26588,162,1.32 [0.95-1.84],0.0926305376965251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YAP1,Transcriptional coactivator YAP1,23705,149,1.96 [1.15-3.32],0.0126549397376706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23636,148,1.08 [0.97-1.20],0.1720329355884134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YES1,Tyrosine-protein kinase Yes,27133,172,1.05 [0.94-1.19],0.3823109531968117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YJU2,Splicing factor YJU2,23623,149,1.73 [1.18-2.54],0.0052402419758455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YOD1,Ubiquitin thioesterase OTU1,22998,148,0.95 [0.74-1.22],0.6840753184178607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YTHDF3,YTH domain-containing family protein 3,26707,161,1.09 [0.93-1.29],0.2895805781106575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YWHAQ,14-3-3 protein theta,23256,143,1.16 [0.93-1.43],0.1845451945698469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YY1,Transcriptional repressor protein YY1,23084,146,1.38 [0.83-2.31],0.21324969893617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBP1,Z-DNA-binding protein 1,23084,146,1.33 [0.97-1.83],0.0755283023950744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB16,Zinc finger and BTB domain-containing protein 16,26616,166,1.11 [0.92-1.34],0.2799308323770741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB17,Zinc finger and BTB domain-containing protein 17,26751,160,1.16 [0.85-1.58],0.3398157973857838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZCCHC8,Zinc finger CCHC domain-containing protein 8,22998,148,0.95 [0.73-1.24],0.6997859289058559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZFYVE19,Abscission/NoCut checkpoint regulator,23636,148,1.19 [1.00-1.42],0.0456978778784129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZHX2,Zinc fingers and homeoboxes protein 2,23705,149,1.33 [0.92-1.90],0.1259699933220931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF174,Zinc finger protein 174,23084,146,1.05 [0.71-1.56],0.8044145954243294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF75D,Zinc finger protein 75D,23310,148,0.79 [0.59-1.07],0.1260637378696462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF830,Zinc finger protein 830,23623,149,0.90 [0.73-1.12],0.3499467825857064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRD2,Protein ZNRD2,23636,148,1.07 [0.85-1.33],0.57524961795278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23623,149,1.28 [1.00-1.66],0.0543755317330373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP3,Zona pellucida sperm-binding protein 3,23148,148,1.00 [0.94-1.06],0.9366253422560256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP4,Zona pellucida sperm-binding protein 4,22891,140,1.05 [0.66-1.65],0.847920740294656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZPR1,Zinc finger protein ZPR1,22986,143,0.93 [0.78-1.12],0.4460553732036151
